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INTRODUCTION 
4 INTRODUCTION 
environment. Strains which cause outbreaks in hospitals are often resistent against 
commonly used antimicrobial agents, e.g. Jj-Iactams. In chaper 3 the extensive literature on 
this subject was critically reviewed. The focus in part 1 was on the current epidemiology of 
methicillin-resistant S. aureus and in part 2 on nasal carriage. The epidemiology, underlying 
mechanisms, identification of patients at risk of infection and effects of elimination strategies 
are discussed. 
To elucidate the epidemiological behaviour of S. aureus it is essential to have reliable typing 
methods available. Recently developed molecular typing techniques seem highly promising. 
Several of these genotyping techniques are evaluated in chapter 4. In a multicenter study the 
reproducibility of the arbitrary primer polymerase chain reaction was evaluated using a 
welldefined collection of S. aureus strains (part 1). In part 2 this technique, and several 
others, were used to evaluate and succesfully control an outbreak of multi-resistant S. 
aureus in the University Hospital Rotterdam. 
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CHAPTER ONE 
SURGICAL WOUND INFECTIONS IN CARDIO-THORACIC SURGERY 
PART ONE 
SURVEILLANCE OF POSTOPERATIVE INFECTIONS IN THORACIC SURGERY 
JAJW Kluytmans, JW Mouton, APWM Maat, MAAJ Manders, MF Michel and 
JHT Wagenvoort. 
Adapted from: Journal of Hospital Infection 1994;27:139-47 
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SUMMARY 
Postoperative infections (Pis) are serious complications of thoracic surgery. To gain insight 
into the nature and the scope of the problem, an 18 month prospective surveillance was 
conducted at the department of thoracic surgery of the University Hospital Rotterdam, 
Dijkzigt. Pis were classified according to CDC criteria. One hundred and ninety-four out of 
983 patients (19.7%) developed one or more Pis and in these 194 patients, 268 Pis were 
diagnosed. The incidence of Pis was 2.0 per 100 days of postoperative stay. The mean 
postoperative length of stay (LOS) of the 194 patients with Pis was 14.1 days longer than 
those without Pis. Deep surgical wound infections (DSWls) were associated with the longest 
prolongation of the median postoperative LOS in the hospital (30 days longer). Although 
lower than DSWls, incisional surgical wound infections also had a significant prolongation of 
stay (median 10 days longer). Staphylococcus aureus was the most important pathogen 
associated with surgical wound infections (SWls). Phage typing of 29 strains causing SWI 
showed only two identical pairs, so only a minority of infections could be explained by cross-
infection. Older age, and more complicated procedures (e.g. cardiac valve operations) were 
independent, statistically significant risk factors for the development of Pis. Since there is a 
progressive trend towards operating on older patients and performing more complicated 
procedures, the incidence of Pis is expected to increase. Therefore it will become increasingly 
important to develop new strategies to prevent these serious complications. 
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INTRODUCTION 
Open heart surgery is a prime example of the advances in medicine over the last decade and 
these procedures are now performed routinely on a large scale. In the US approximately 
652,000 open heart surgical procedures were carried out in 1988.' In spite of modern 
surgical techniques, perioperative antibiotic prophylaxis and meticulous care, postoperative 
infections (Pis) remain frequent complications. The consequences of these complications 
can be severe. Apart of the suffering of patients and prolongation of their hospital stay,"" 
infections are associated with significant mortality.10 
In order to target preventive measures, it is necessary to gain insight into the nature and the 
scope of the problem.' We therefore conducted an 18-month prospective surveillance study 
in adult patients, who were operated on at the department of thoracic surgery of the 
University Hospital Rotterdam, Dijkzigt in The Netherlands. 
PATIENTS AND METHODS 
From August 1989 until February 1991 a prospective surveillance for Pis was performed at 
the department of thoracic surgery of the University Hospital Rotterdam, Dijkzigl. This is a 
tertiary referral center for cardiac and pulmonary surgery. The department consists of an 
operating theater, a postoperative intensive care unit and a postoperative ward. 
The day before, surgery patients washed their body and hair with povidone-iodine or with 
chlorhexidine soap. Hair removal was performed using depilatory creams. Perioperatively, 
patients were given cefuroxime for 24 h as systemic antibiotic prophylaxis. The loading dose 
of 1.5 9 was given 1 h before the incision. Subsequent doses of 750 mg were given every 6 
h. If patients reported an allergy to f3-lactam antibiotics, c1indamycin (600 mg every 8 h) was 
given instead. After surgery all patients were taken to the intensive care unit for at least 24 h. 
During the surveillance period the ward was visited by an investigator (JK or MM). The 
medical records of patients were studied for the presence of Pis using criteria as defined for 
this purpose by the Centers for Disease Control (CDC).' These criteria are based upon both 
clinical and laboratory parameters. Hospital identification number, sex, age, admission, 
operation, and discharge date, type of operation, surgeon and first assistant were recorded. 
In Table 1 the types of operation are shown: coronary artery bypass grafting (CASG) 
operations were divided into procedures in which the saphenous vein (SV) was used as graft 
and in procedures in which one or both of the internal mammary arteries (IMAs), whether or 
not in combination with the Sv, were used. Cardiac valve operations (CVOs) were considered 
alone or in combination with CASG procedures. Lung operations, mainly performed for 
exploration andlor resection of malignancies, constituted a separate group. The last group 
were operations that did not belong to one of the categories mentioned above (OTH). This 
group consisted mainly of operations for congenital heart disorders and dissecting aortic 
aneurysms. 
If Pis were present, the site, date of onset, and the microorganism(s) cultured were recorded. 
According to the CDC criteria, the sites of PI were divided into urinary tract infections (UTls), 
respiratory tract infections (RTls), primary bloodstream infections (PSis), incisional surgical 
wound infections (ISWls), deep surgical wound infections (DSWls) and other infections. The 
following intervals were calculated: 
Length of stay: number of days from admission date until discharge or death; 
Postoperative length of stay: number of days from operation date until discharge or 
death; 
Pre-infection length of stay: number of days from operation date until onset of 
postoperative infection; 
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For the calculation of the incidence of surgical wound infections (SWls), the following 
corrections were made: Firstly, if a patient had both an ISWI and a DSWI at different sites, 
this patient was counted only as a DSWI, and secondly if one patient had two or more ISWls 
or DSWls at different sites, this patient was counted only once. 
I! Staphylococcus aureus was isolated, phage typing was performed at the National Institute 
of Public Health and Environmental Hygiene (RIVM, Bilthoven, The Netherlands). 
The results were analyzed using the SAS statistical package." Differences between groups 
were determined by Student's t-test. Logistic regression analysis with forward and backward 
elimination was used to determine dependence between risk factors. The following variables 
were put into the model: sex, age, preoperative length of stay, and type of procedure (Table 
1). Statistical significance was accepted at P< 0.05 (two-tailed). 
RESULTS 
From August 1989 until February 1991 we evaluated 983 patients. The majority, 696 (70.8%), 
were males. The mean age was 59.9 years (range 16-87) for males and 60.7 years (range 
15-83) for females. The mean length of stay was 14.9 days (range 5-125). The total 
postoperative length of stay of 13,395 days. Table 1 shows the number and percentage of the 
various kinds of operations which were performed during the study period. More than half of 
the procedures (61.1 %) involved CABG. In 60% of the CABG-procedures the IMA was used 
as graft. Nearly a quarter (23.9%) of the procedures involved cardiac valve replacement. 
Table 1: Number (N) and percentage of the different kinds of operations performed on patients during 
the study period. 
Kind of operation 
CABG+ using saphenous veins only 
CABG+ using internal mammary artery 
evo' 
cvo* and CABG' using saphenous vein only 
CVO* and CABG+ using internal mammary artery 
Lung operation 
OTHt 
Total 
• CABG = Coronary Artery Bypass Graft 
. eva = Cardiac Valve Operation 
t OTH :0: other procedures 
N 
198 
342 
174 
38 
23 
113 
95 
983 
% 
20.1 
34.8 
17.7 
3.9 
2.3 
11.5 
9.7 
100.0 
In 194 patients (19.7%), a total of 268 Pis were diagnosed (average: 1.4 PI per infected 
patient, range 1-5). The incidence of PI was 2.0 per 100 days of postoperative stay. 
Table 2 shows the mean with standard deviation and the median of the postoperative length 
of stay in patients without and with Pis. The mean postoperative length of stay was 14.1 days 
longer in patients with PI. The median was 7 days longer. In Table 3 the frequencies of the 
various Pis are shown with the accompanying mean and median postoperative and pre-
infection length of stay. All sites were associated with a prolongation of postoperative length 
of stay. The longest prolongation of stay was associated with the DSWls and the group of 
other Pis. 
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Table 2: Post-operative length of stay in days: Mean with Standard Deviation (SO) and median in 
patients without and with postoperative infections. 
Patients 
Without infection 
With infection 
+ N", number of patients 
N' 
789 
194 
Postoperative length of stay in days 
Mean 
10.8 
24.9 
so 
5.5 
21.1 
Median 
11 
18 
Table 3: Postoperative and pre-infecUon length of stay in days: mean with Standard Deviation (SO) and 
median in patients with different sites of postoperative infections. 
Length of stay in days 
Postof2erative Pre-infection 
Site of infection N' Mean SO Median Mean SO Median 
Urinary tract 82 29.1 27.9 19 12.0 15.6 6 
Respiratory tract 89 23.7 21.6 17 5.9 8.1 3 
Incisional surgical wound 37 23.5 14.2 21 11.9 10.3 9 
Deep surgical wound 38 50.7 31.4 41 12.3 10.0 10 
Primary bloodstream 14 27.9 14.3 24 13.1 11.6 9 
Other sites 8 56.9 44.1 45 16.9 17.4 10 
+ N '" number of patients 
Table 4 shows the frequency of isolation of various microorganisms from the different sites of 
infections. From 47 of the 268 (17.5%) sites of infection there was either no culture performed 
or no pathogen isolated. From the remaining 221 sites of infection, 236 pathogens were 
isolated. S. aUfeus was isolated from 12 of the 37 ISWls (32.4%), and from 20 of the 38 
DSWls (52.6%). Five of the DSWls with S. aUfeus were associated with a secondary 
bacteraemia. S. aUfeus was isolated from 32 of the 75 SWls (42.7%). All S. aUfeus isolates 
were susceptible to methicillin and aminoglycosides. Phage typing was performed on 29 of 
these 32 isolates. In this group of 29 isolates only two identical pairs were found. The phage 
types of the other 25 strains were unique. 
In Table 5 the crude relative risks (RR) and the 95% confidence intervals (CI) of various risk 
factors for the development of Pis and for the development of SWls are shown. Women, CVO 
and OTH were associated with a significantly increased RR for the development of Pis (Table 
5). Also the mean age of patients with Pis (63.2 years) was significantly higher than for 
patients without Pis (59.3 years, P ~ 0.0001). None of the surgeons or first-assistants were 
associated with significantly increased or decreased RR (results not shown). To identify 
independent variables for the development of Pis, logistic regression analysis was performed. 
Using this method the following variables showed statistical significance: older age (P ~ 
0.0001), CVO (P ~ 0.005) and OTH (P ~ 0.0001). The risk factors for the development of SWI 
were analyzed separately. The development of SWI was only significantly associated with 
OTH (Table 5). The mean age for patients with SWI was 61.8 years and for patients without 
SWI, 59.9 years (P > 0.05). None of the surgeons or first-assistants were associated with 
significantly increased or decreased RR (results not shown). Logistic regression analysis 
showed that OTH was the only independent variable (P ~ 0.0006). 
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Table 4: Frequency of isolation arm/era-organisms from vadous sites of postoperative infection. 
Site of infection+ 
Microorganism UTI RTI ISWI DSWI PBI Other All 
Staphylococcus aureus 0 4 12 20 1 1 38 
Coagulase negative Staphylococcus 0 0 5 9 1 1 16 
Enterococcus spp. 10 1 1 2 0 2 16 
Streptococcus pneumoniae 0 8 0 0 0 0 8 
Haemophilus influenzae 0 20 0 0 0 0 20 
Aerobic Gram-negative rods 55 18 12 6 9 4 104 
Pseudomonas aeruginosa 7 3 1 1 2 2 16 
Other pathogen 3 8 2 1 3 1 18 
Nopathogen isolated or 
no culture performed 10 32 2 2 0 1 47 
All 85 94 35 41 16 12 283 
+ Abbreviations used for the different sites of infection are explained in the patients and methods section. 
DISCUSSION 
One of the objectives of this study was to determine the incidence of Pis after thoracic 
surgery. This study showed an incidence of 268 Pis in 983 patients (27.3%). The incidence 
was 2.0 postoperative infections per 100 days postoperative stay. Rates found in other 
studies show large variations. There are many reasons for these variations. Firstly, variations 
of infection rates in different institutes are caused by numerous factors, including the patient 
population,' the kind of antibiotic prophylaxis,'" the method of preoperative hair-removal," 
and the use of the IMA as graft."'" There are also differences caused by bias, such as the 
reliability of the surveillance method or the criteria used for the diagnoses of PI. Results from 
different studies are therefore difficult to compare with each other. This matter is discussed 
in more detail by Doebbeling et al.' 
The mean postoperative length of stay of the 194 patients with one or more Pis was 14.1 
days longer than of the patients without infection (Table 2). Pis were thus associated with a 
total of 2,735 days of extra length of stay. This was 20.4% of the total postoperative length 
of stay. Nelson et al." found an extra length of stay associated with PI in patients undergoing 
open-heart surgery of 16.7 days, which compares well with our findings. Table 3 shows that 
all sites of PI were associated with a prolongation of stay. Because of the large standard 
variations of the mean, it is more appropriate to consider the median for comparison of the 
different sites. OTH and DSWls were associated with the longest median postoperative 
length of stay (45 and 41 days respectively). Since OTH was a relatively small and 
heterogeneous group, DSWI is the most interesting group to look at in more detail. The 38 
patients with DSWI alone accounted for 1,516 extra days of postoperative length of stay. This 
was 55.4% of the total extra length of stay associated with Pis. Although the prolongation of 
stay was most pronounced in DSWI, ISWI also had a median length of stay which was 10 
days longer than in uninfected patients. It appears that even these "minor" infections were 
associated with considerable extra length of stay. The median pre-infection length of stay was 
short compared with the median postoperative length of stay for all sites. Thus, although 
infections began shortly after operation, the length of stay after the onset was relatively long. 
This strongly suggests that Pis contributed to the prolongation of stay. This causal relation is 
also shown in the following comparison: The median pre-infection length of stay of ISWI was 
almost identical to DSWI (9 vs. 10 days). However the median postoperative length of stay for 
the more severe infections (DSWls) was 20 days longer, most likely as a result of these 
infections. Prolongation of postoperative stay due to SWI after cardiovascular surgery was 
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also found in other studies. Doebbeling' found a prolongation of 10.4 days for ISWls and of 
29.6 days for DSWls. The median length of hospital stay for patients with SWls in a study by 
Loop et al. " was 41 days. Our findings confirm that SWls after thoracic surgery are serious 
complications, associated with a significant prolongation of the postoperative stay. 
Table 5: Crude relative risks (RR) and 95% confidence intervals (CI) of vadous risk factors for the 
development of postoperative infections and surgical wound infections. 
Postoperative infections 
Risk factor RR (GI) 
Gender: 
women (as opposed to men) 1.31 (1.01 - 1.70) 
Procedure: 
Cardiac valve operation 
(compared with GABG) 1.48 (1.10 -1.70) 
Lung operation 0.94 (0.62 - 1.41) 
other+ 1.71 (1.23 - 2.37) 
Procedures involving IMA* 
(compared to svt only) 0.99 (0.70 - 1.42) 
+ other are the procedures described in the patients and methods secilon as other. 
* fMA is the Internal Mammary Artery. 
t SV is the Saphenous Vein. 
Surgical wound infections 
RR (GI) 
1.03 (0.64 - 1.66) 
0.59 (0.30 -1.16) 
1.07 (0.55 - 2.08) 
2.58 (1.55 - 4.30) 
1.09 (0.60 - 1 .98) 
Table 4 shows the frequency of isolation of different microorganisms from various sites of PI. 
More than 95% of the patients received a urinary catheter perioperatively, which explains the 
incidence of UTI. Most UTls were caused by aerobic Gram-negative rods and Enterococcus 
spp. as was to be expected. Also the majority of PSis were caused by aerobic Gram-negative 
rods. From RTls a broader spectrum of microorganisms was isolated. Streptococcus 
pneumoniae and Haemophilus. influenzae were not isolated from sites other than the 
respiratory tract. The diagnosis of RTI was largely based on clinical findings. This is indicated 
by the high percentage (36.0%) in which there was either no culture performed or no 
pathogen isolated. The majority of the patients with postoperative RTI had clinical signs of 
infection and the production of purulent sputum, which fulfilled the criteria used in this study.' 
However most of these infections resolved either spontaneously or with more intensive 
postoperative physical therapy, but without antibiotic treatment. This indicates that most of 
these RTls were not classical pneumonia's but rather postoperative collections of pulmonary 
secretions which could usually be resolved by expectoration. Nevertheless these infections 
were associated with a significant prolongation of postoperative length of stay, as can be 
seen in Table 3. 
The types of microorganisms isolated from ISWls was somewhat different from those isolated 
from DSWls. The most important differences were that aerobic Gram-negative rods were 
more often isolated from ISWI (32.4% vs. 15.8%), whereas S. aureus was more often isolated 
from DSWI (52.6% vs. 32.4%). Most of the ISWls were infections of the venectomy site on 
the leg. The location near the groins and perineal region might explain the greater portion of 
aerobic Gram-negative rods in this group. The greater amount of S. aureus in DSWI, 
sometimes with secondary bacteraemia) is typical of this.16 To identify crosswinfections or 
common sources of SWI with S. aureus, phage typing was performed. For this analysis 29 
isolates were available. Only two pairs of identical isolates were identified. The majority 
(93.1 %) of cases could therefore not be explained by cross-infection or the presence of a 
common source. In the 1950s and 60s several epidemiological studies indicated that nasal 
carriers of S. aureus have an increased risk for the development of SWI.3.17,1S From these 
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studies it was concluded that many SW[s were caused by infection with the patient's own 
strain. These endogenous-infections could explain the findings in the current investigation. 
Since Pis are associated with severe consequences it is important to identify risk factors 
which might be useful in prevention. Tab[e 5 shows RR for several risk-factors for the 
development of PI. After logistic regression analysis only older age, evo and OTH were 
independent, statistically significant risk factors. For the development of SW[ only OTH was 
a significant risk factor. evo frequently involves the implantation of a prosthetic valve. This 
explains the higher incidence of infections associated with evo. The high incidence 
associated with OTH is probably because this group consisted mainly of extremely 
complicated procedures for congenital heart disease and dissecting aortic aneurysms. [n the 
literature the use of [MA as a graft is frequently reported to be a risk factor for SWI. H." This is 
especially true when both [MAs are used. [n this study it was not recorded if one or both 
[MAs were used. Most of the [MA procedures in our institute however use only the [eft [MA as 
a graft. [n this study, procedures involving [MA were not associated with a significantly 
increased RR compared with procedures using the Sv. The rare use of both [MAs could be 
the explanation. 
There is a trend towards operating older patients and performing more complicated 
procedures' (e.g. evo and OTH) that may increase the incidence of PI. Therefore it will 
become increasingly important to develop new strategies to prevent these serious 
complications. The finding that cross-infection played a very limited role in the pathogenesis 
of SW[ caused by S. aureus, may offer an opportunity for intervention. [f endogenous 
infection plays a major role, elimination of nasal carriage should reduce the SW[ rate. Further 
studies are warranted to evaluate the importance of nasal carriage for the development of 
SW[, and the effect of elimination of nasal carriage on the SW[ rate. 
Acknoweledgement: We thank e. Vandenbroucke-Grau[s, and E. P. F. [Jzerman for he[pfull 
suggestions and critically reading the manuscript. 
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postoperative stay in the intensive care unit; outcome (discharged alive or death); date of 
discharge or death; length of hospital stay; and readmittance (duration was added to the 
postoperative length of stay). Other postoperative infections were determined by CDC-
criteria.' Site of infection, date of onset, and pathogens involved were recorded. 
For cases, these additional variables were recorded: location of sternal wound infection 
(superficial or deep'), date of onset of infection, and the presence of secondary bacteremia. 
Microbiology. All patients had nasal swabs the day before surgery. When a surgical wound 
infection was suspected, the wound and, if present, purulent discharge, were cultured. S. 
aureus was identified by standard microbiological methods. All available S. aureus isolates 
from preoperative nasal swabs and wounds were sent to the National Institute of Public 
Health and Environmental Protection (Bilthoven, The Netherlands) for phage typing. 
Statistical analysis. Results were analyzed with the SAS statistical package.' Differences 
between groups were tested by Student's t test. The imporfance of the risk factors was 
determined by calculation of odds ratios and 95% confidence intervals (Cis). Odds ratios 
determined were Mantel-Haenszel estimates by a stratified analysis in which each stratum 
comprised a case and its controls. Statistical significance was accepted at P<0.05, two-
tailed analysis. 
RESULTS 
Characteristics of patient population. In the study population 40 patients (2.0%) developed 
a sternal wound infection with S. aureus. A total of 120 patients were selected as controls. 
Table 1 shows the general characteristics of the cases and controls. No statistical significant 
differences were found in sex, body mass index (kg/m'), type of surgery, and number of 
coronary arteries involved. The mean age for cases was significantly lower than for controls 
(P=0.026). The median postoperative length of stay was 30 days longer for cases than 
controls (Table 1). The total number of postoperative hospital days accrued by the 40 cases 
was 1901 days versus 1464 days for the 120 controls. Mortality was also significantly higher 
among cases (P=0.014). Four (10%) of the sternal wound infections were superficial and 36 
(90%) were deep. Eighteen (45%) of the 40 sternal wound infections with S. aureus were 
associated with a secondary bacteremia. The median onset of sternal wound infections with 
S. aureus was 8 days after surgery. There was no significant difference in the incidence of 
postoperative infections other than sternal wound infections. 
Analysis of risk factors. Table 2 shows the crude odds ratios with 95% Cis for the most 
important risk factors. Nasal carriage of S. aureus and insulin-dependent diabetes mellitus 
had the highest crude odds ratios. In addition to younger age (Table 1), these were the only 
statistically significant riskfactors. Two of the 4 insulin-dependent diabetes mellitus patients 
had S. aureus in their preoperative nasal cultures. To determine the minimum effect of nasal 
carriage, all 4 insulin-dependent diabetes mellitus patients were removed from the analysis. 
This analysis showed an odds ratio for nasal carriage of S. aureus of 8.8 with a 95% CI of 
3.6-21.8. The variables not shown in table 2, were not associated with significant increased 
or decreased crude odds ratio. 
Phage typing of S. aureus strains. Nineteen cases had positive preoperative S. aureus 
nasal cultures. For 10 of the 19, both pre- and postoperative isolates were available for 
phagetyping; these were identical for all 10. All S. aureus isolates were susceptible to 
oxacillin and aminoglycosides. 
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Table 1: Characteristics of the patient population, types of surgical procedures 
performed, median postoperative length of stay and mortality in controls and cases. 
controls 
Variable (n-120) 
Mean age in years (80+) 63.9 (9.0)' 
Gender (% females) 26.7 
Mean body mass index (80+) 25.4 (3.0) 
Surgery: 
CABG* without Internal Mammary Artery (%) 30.8 
CABG*with Internal Mammary Artery (%) 52.5 
Procedures involving cardiac valve replacement (%) 16.7 
Other procedurest 2.5 
Emergency procedures 5.8 
Mean number of coronary arteries involved (80+) 2.6 (1.3) 
Median postoperative length of stay in days (range) 10(6-50)' 
Mortality (%) O.8 t 
+ so = Standard Deviation 
* CABG :0: Procedure Involving Coronary Artery Bypass Grafting 
t other Procedures are procedures other then CABG or cardiac valve replacement 
:t:P<O.05 
cases 
(n-40) 
59.3 (11.5)' 
17.5 
25.9 (3.5) 
35.0 
54.2 
15.0 
7.5 
10.0 
2.4(1.1) 
40 (9-145)' 
10.0' 
Table 2: Crude Odds ratios and 95 % confidence intervals (e/) of the most important risk factors. 
Risk factor 
Nasal carriage of S. aureus 
Diabetes Mellitus: nonlD~ & 10' 
Diabetes Mellitus: nonlO' 
Diabetes Mellitus: 10+ 
Clindamycin as prophylaxis 
Immunosuppressive drugs 
+ 10 is Insulin Dependent 
number of events/number of 
observations (%) 
controls cases 
15/120 (12.5) 19/36 (52.8) 
9/120 (7.5) 7/40 (17.5) 
9/120 (7.5) 3/40 (7.5) 
0/120 (0) 4/40 (10.0) 
11/120 (9.2) 0/40 (0) 
10/120 (8.3) 6/40 (15.0) 
Crude Odds ratio 
(GI) 
9.6 (3.9-23.7) 
2.7 (0.9-8.0) 
1.0 
21.0 (2.4-185.9) 
0.4(0.1-1.6) 
1.9 (0.7-5.3) 
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DISCUSSION 
Nasal carriage of S. aureus, insulin dependent-diabetes mellitus, and younger age were the 
most important and only statistical significant risk factors for development of sternal wound 
infection with S. aureus. Since patients with insulin-dependent diabetes mellitus have 
increased carriage rates of S. aureus and are probably at greater risk for developing S. 
aureus infections/ these two variables could have influenced each other. Because none of 
the controls had insulin-dependent diabetes mellitus, multiple logistic regression analysis 
could not be used to evaluate this interaction. The minimum effect of nasal carriage was 
therefore calculated by removing all insulin-dependent diabetes mellitus patients from the 
analysis. This analysis showed an odds ratio for nasal carriage of S. aureus of 8.8, which is 
only slightly different from the crude odds ratio of 9.6. Thus, we conclude that nasal carriage 
of S. aureus is an important and independent risk factor for development of sternal wound 
infections with S. aureus. 
The importance of nasal carriage was confirmed by the 10 cases from whom pre- and 
postoperative isolates could be compared by phage typing. The pairs were all identical. The 
important role of endogenous infection also explains the heterogenous pattern of S. aureus 
isolates that caused surgical wound infections in our institution determined in a previous 
study.' 
The nasal carriage rate of the entire 1980 patient study population can be approximated by 
extrapolation of the carriage rate of the controls and cases. By so doing, 264 (13.3%) of the 
1980 patients would be nasal carriers, resulting in overall attack rates of 8.0% for carriers and 
1.1 % of non carriers. This gives an attributable risk for nasal carriage of 86.3%. 
Little attention has been paid to the role of nasal carriage in development of surgical wound 
infections for 25 years or so. In 1959, Williams et al. " reported that 2.1 % of postoperative 
staphylococcal surgical wound infections occurred in 632 patients who never carried S. 
aureus in the nose. In 687 carriers, this incidence was 6.9% (Relative Risk [RR], 3.3; 95% CI, 
1.8-6.1). In about half of the infected carriers, the wounds harbored staphylococci with the 
same phage type as that in the nose. Also in 1959, Weinstein et a/. " analized nasal 
pathogens and postoperative infections in 125 patients undergoing major surgery. Those 
with positive preoperative nasal cultures (n = 43) had an infection rate of 37% versus 11 % in 
82 patients with negative preoperative cultures (RR, 3.4; CI, 1.6-7.0). In the nasal carriers, S. 
aureus was isolated from 94% of the infected wounds; a variety of organisms were cultured 
from the wounds of noncarriers. For nasal carriers with postoperative S. aureus infection, the 
phage types of the S. aureus isolated from the nose and wound were identical in 92% of 
cases. Similar results were reported by Calia et a/.,' who calculated that about half of all 
surgical wound infections in their population were caused by endogenous infection with S. 
aureus. The surgical wound infection rate also correlated with the density of S. aureus in the 
nasal culture. 
Several studies during the 1950s and 1960s attempted to eliminate nasal carriage 
preoperatively, but these attempts were hampered by a lack of effective alimination 
strategies. However, the recent introduction of mupirocin may offer new opportunities. This 
new topical antibiotic is highly effective for elimination of nasal carriage and is more effective 
than any other antibiotic studied to date.'" Thus, it should be evaluated for its value in peri-
operative prophylaxis. 
Sternal wound infeelions with S. aureus were associated with a significant prolongation of 
the postoperative stay and a significantly higher mortality among cases. This high rate of 
severe infection is indicative of the unique pathogenicity of S. aureus in wound infections.11 In 
a previous prospective surveillance study, we found that deep surgical wound infections in 
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thoracic surgery were associated with a median prolongation of postoperative stay of 30 
days.' This is identical to the median prolongation of hospital stay in the present study. 
Although the degree of prolonged hospital stay and mortality rates vary in different studies, it 
is generally accepted that both are common consequences of sternal wound infections. TO 
Because of these severe consequences for patients and the high costs for the health care 
system, it is important to identify risk factors for development of sternotomy wound infections. 
To date, a multitude of patient- and procedure-related risk factors have been identified." The 
current study differs from others in that it evaluates the risk factors for the development of 
sternal wound infections caused by one specific pathogen, S. aureus. Therefore, our results 
are not entirely comparable with those of studies that evaluated the consequences of and risk 
factors for development of sternal wound infections caused by a variety of pathogens. 
In addition to nasal carriage, insulin-dependent diabetes mellitus and younger age were 
identified as risk factors for sternal wound infection with S. aureus. Insulin-dependent 
diabetes mellitus was also identified in other studies." The risk factor of younger age seems 
paradoxical since, when age was identified as a risk factor in other studies, it was always 
older age." One possible explanation is that some very complicated operations for congenital 
heart disorders were done on a small group of relatively young patients in this study. These 
procedures were associated with an increased risk for surgical wound infection in a previous 
study.' 
Surgical procedures are becoming increasingly complicated, and the population of patients 
operated on has more underlying diseases.' This increases the risk for development of 
surgical wound infections. Therefore, new strategies are needed to keep the surgical wound 
infection rate and its associated morbidity and mortality as low as possible. Although the 
significance of nasal carriage of S. aureus for development of surgical wound infections has 
been well defined/12,13 it has not been defined for cardiac surgery. Because of the great 
expense and morbidity and mortality associated with sternotomy wound infections, it is 
important to identify potential preventive measures. Further investigations are warranted to 
evaluate the effect of perioperative elimination of nasal carriage on surgical wound infection 
rates. 
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SUMMARY 
Objective. To test the hypothesis that perioperative elimination of nasal carriage of 
Staphylococcus aureus using mupirocin nasal ointment reduces the surgical site infection 
(SSI) rate in cardio-thoracic surgery. 
Design. Unblinded intervention trial with historical controls. 
Setting. University Hospital, tertiary referral center for cardio-thoracic surgery. 
Patients. Consecutive patients undergoing cardio-thoracic surgery between August 1, 1989 
and February 1, 1991 (historical control group) and between March 1, 1991 and August, 1 
1992 (intervention group). The intervention consisted of perioperative treatment with 
mupirocin nasal ointment (Bactroban nasal'). 
Results. The historical control group consisted of 928 patients and the intervention group of 
868, of whom 752 were actually treated. The 116 patients who were unintentionally not 
treated were considered as a concurrent control group. In the intention to treat analysis a 
significant reduction in S81 rate was observed after the intervention (historical control group 
7.3 % and intervention group 2.8 %; P<O.0001). Also, the 881-rate in the concurrent control 
group was significantly higher than in the treated group (7.8% and 2.0%, respectively; 
P~0.0023). Resistance of S aureus to mupirocin was not observed. 
Conclusion. The results of this study indicate that perioperative elimination of nasal carriage 
using mupirocin nasal ointment significantly reduces the S81 rate in patients subjected to 
cardia-thoracic surgery and warrant a prospective, randomized, placebo-controlled study to 
determine the efficacy. This preventive measure may be beneficial in other categories of 
surgical patients as well. 
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INTRODUCTION 
Cardia-thoracic surgery generally involves extensive procedures, which are associated with 
high rates of postoperative infections. These infections are associated with a significant 
prolongation of hospital stay 6,11,15,19 and mortality.17 Based on the results of a previous study 
at our institute," it was hypothesized that a substantial part of surgical site infections (SSI) 
might be caused by endogenous strains of Staphylococcus aureus. This hypothesis is 
supported by several studies dating back to the fifties and sixties which showed that nasal 
carriers of S. aureus had an increased risk for the development of SSI.'"''' To evaluate the 
importance of nasal carriage as a risk factor for the development of sternal wound infection 
with S. aureus after sternotomy in our population, we have recently performed a case control 
study." Preoperative nasal carriage was identified as the most important risk factor with an 
Odds ratio of 9.6 (95% confidence interval 3.9-23.7). Moreover, phage typing of both the pre-
and post-operative isolates of S. aureus showed that all pairs (n~10) were identical. Based 
on these results we decided to evaluate whether elimination of nasal carriage reduces the 
SSI rate in patients undergoing cardia-thoracic surgery. 
For eradication of nasal carriage, mupirocin calcium ointment was used because it has 
shown to be the most effective agent. 7,122 1 
PATIENTS AND METHODS 
Population. The study population consisted of 1,796 patients undergoing cardia-thoracic 
surgery at the University Hospital Rotterdam, Dijkzigt. This is a tertiary referral center for 
cardiac and pulmonary surgery, and consists of an operating theater, a postoperative 
intensive care unit and a postoperative medical ward. The historical control group consisted 
of 928 and the intervention group of 868 consecutive patients. Patients who underwent more 
than one cardia-thoracic surgical procedure during the study period were included only the 
first time. 
Perioperative procedures. The day before surgery all patients washed their body and hair 
with povidone-iodine soap or with chlorhexidine soap, hair removal was performed using 
depilatory creams, and a nasal swab was taken. Perioperatively, patients were given 
cefuroxime for 24 hours as systemic antibiotic prophylaxis. The loading dose (1.5 g) was 
administered one hour before the incision. Subsequent doses of 750 mg were administered 
every 6 hours. If patients reported an allergy to ~-Iactam-antibiotics, clindamycin (600 mg 
every 8 hours) was given instead. After surgery all patients stayed at the intensive care unit 
for at least 24 hours. These procedures were identical in the historical control and the 
intervention group. 
Intervention. In the intervention group mupirocin calcium ointment (Bactroban nasal", Smith-
Kline Beecham, Pharmaceuticals, UK) was applied to each nostril, according to the 
manufacturers' instructions. The first dose was administered the day before surgery and the 
therapy was continued during five consecutive days, bid. Although it was the intention to treat 
all patients in the intervention group, not all patients were actually treated. The main reason 
why patients in the intervention group were not treated was unintentional omission by the 
nursing staff. This happened more often during the first months of the study. For comparisons 
the following groups were defined: 
Treated group: The patients in the intervention group who had actually been treated 
with mupirocin calcium ointment; 
• Not treated group: The patients in the intervention group who had not received mupirocin 
calcium ointment. This group was evaluated as a concurrent control group. 
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Fallow-up cultures were taken six to eight days after surgery in patients with S aureus in the 
preoperatively taken nasal cultures. 
Surveillance method. During both periods the medical records were examined by one of the 
investigators for the presence of SSI using criteria as defined for this purpose by the Centers 
for Disease Control (CDC)." These definitions are based upon both clinical and laboratory 
parameters. Hospital identification number, sex, age, admission-, operation-, and discharge 
date from the department, in-hospital mortality, application of mupirocin, type of surgical 
procedure, surgeon and first assistant were recorded. Surgical procedures were divided into 
the following categories: (1) coronary artery bypass grafting (CABG) using saphenous veins 
(SV) as a graft only; (2) CABG using the internal mammary artery (IMA) as a graft; (3) cardiac 
valve replacement (CVR); (4) CVR combined with procedure 1; (5) CVR combined with 
procedure 2; (6) lung surgery and (7) other procedures. Lung operations were mainly 
performed for exploration andlor resection of malignancies. Surgical procedures which did not 
belong to either of the other categories accounted for the category of "other" procedures. This 
group consisted mainly of operations for congenital heart disorders and dissecting aneurysms 
of the aorta. 
If SSI were present, the date of onset and the micro-organism(s) isolated were recorded. 
Surgical site infections were divided into incisional SSI (ISSI) and deep SSI (DSSI). The 
calculation of the incidence of SSI was based on the following principles: Only one SSI per 
patient was counted, and if a patient had both an ISSI and a DSSI at different sites, this 
patient was counted only as a DSSI. 
Phage typing of S. aureus strains was performed at the National Institute of Public Health 
and Environmental Protection (RIVM, Bilthoven, The Netherlands). Mupirocin sensitivity was 
determined on all S. aureus strains isolated during the intervention period. The disk diffusion 
method was used as described previously.' 
Statistical analysis. The results were analyzed using the SAS statistical package.~ 
Categorical variables were tested by Chi square test or Fisher's exact test when appropriate. 
Continuous variables were tested by Student's t test. 
RESULTS 
The intervention group consisted of 868 patients and the historical control group of 928 
patients. Of the 868 patients in the intervention group, 752 (86.6%) were actually treated. 
Table 1 shows the demographic variables of the intervention group, the historical control 
group, the treated group and the not treated group. Patients in the intervention group were 
slightly, but significantly younger (p~0.023). There was no significant difference in gender. In 
CABG procedures, the IMA was used more frequently in the intervention group compared to 
the historical control group (P~0.005). Also procedures involving CVR were significantly more 
frequent in the intervention group (P~0.008). There were no significant differences between 
the proportion of lung surgery or "other" procedures between the two groups. The treated and 
not treated group had comparable age distributions. There were significantly fewer males 
(P~0.008) and surgical procedures involving CVR (P<0.001) in the not treated group. The 
nasal carriage rates in the historical control group and in the treated group were comparable 
(15.1% and 16.0%, respectively). Follow-Lip cultures after application of mupirocin were 
available in 86 of the 120 patients with a preoperative nasal culture growing S. aureus. Eighty 
of the 86 (93%) cultures were negative. 
The SSI rates of patients in the historical control, the treated and in the not treated group are 
shown in Table 2. Overall, the SSI-rate was 4.5% lower in the intention to treat group (2.8%) 
compared to the historical control group (7.3%, RR: 0.38, 95%CI: 0.24-0.60, P<0.0001). 
Furthermore, in the intervention group, the SSI rate was significantly lower in patients treated 
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(2.0%) compared to the not treated patients (7.8%, RR: 0.28, 95%CI: 0.12-0.57, P=0.0023). 
The SSI rate in the historical control group (7.5%) was comparable to that in the not treated 
group (7.8%, P>0.5). 
Table 1: DemograpMc variables of patients in the historical control, inteNention, treated and not treatr;:d 
group. 
Historical control Intervention Treated Not treated 
Variable group group group group 
Number of patients 928 868 752 116 
Age 
mean 60.0 58.5 58.3 59.3 
standard deviation 13.2 14.6 14.6 14.2 
median 63.0 61.0 61.0 62.0 
Sex 
malelfemale ratio 2.4 2.0 1.8 3.3 
Surgical procedure 
CABG+ using SV* 193 (20.8%) 122 (14.1%) 104 (13.8%) 18 (15.5%) 
CABG< using IMAt 320 (34.5%) 319 (36.8%) 277 (36.8%) 42 (36.3%) 
CVR' (no CABG<) 165 (17.8%) 194 (22.4%) 183 (24.3%) 11 (9.5%) 
CVR+ and CABG+ using SV* 37 (4.0%) 39 (4.5%) 33 (4.4%) 6(5.2%) 
CVR' and CABG< using IMAt 19 (2.0%) 23 (2.6%) 23 (3.1%) 0(0%) 
Lung surgery 108 (11.6%) 82 (9.4%) 64 (8.5%) 18 (15.5%) 
Other 86 (9.3%) 89 (10.3%) 68 (9.0%) 21 (18.1%) 
+ CABG: Coronary artery bypass graft 
* SV: Saphenous vein 
t IMA: Internal mammary artery 
.f: CVR: Cardiac valve replacement 
Table 2 also shows the principal pathogens isolated from the infection sites. S. aureus and 
coagulase negative staphylococci (CNS) were evaluated as mupirocin susceptible micro-
organisms. There was a highly significant reduction in the intervention group compared to the 
historical control group (RR: 0.44, 95%CI: 0.25-0.75, P=0.0032) as well as in the treated 
group compared to the not treated group (RR: 0.28, 95%CI: 0.11-0.75, P=0.0178). With 
regard to SSI caused by mupirocin resistant micro-organisms there also was a significant 
reduction in the intervention group compared to the historical control group (RR: 0.33, 95%CI: 
0.12-0.91, P=0.0275). The reduction in the treated group compared to the not treated group 
was comparable but not statistically significant (RR: 0.23, 95%CI: 0.04-1.37, P=0.23). 
The reduction of DSSI was more pronounced than that of ISSI when the intervention group 
was compared to the historical control group as well as when the treated group compared to 
the not treated group. 
S. aureus was isolated from 9 of the 24 SSI (37.5%) in the intervention group and from 27 of 
the 68 SSI (39.7%) in the historical control group. All S. aureus isolates were susceptible to 
oxacillin and aminoglycosides. All S. aureus strains isolated from patients during the study 
period were susceptible to mupirocin. In the treated group, seven patients developed a SSI 
with S. aureus. The preoperative nasal cultures of these patients were all negative for S. 
aureus. Preoperative nasal cultures had not been performed in the patients who were 
unintentionally not treated. In the historical control group phagetyping was performed on 25 
of 27 S. aureus strains isolated from SSI. Two pairs of identical strains were found. The other 21 
strains had unique phage types. Comparison of the 9 S. aureus strains isolated from SSI in 
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the intention to treat group showed three pairs and three unique patterns (P~0.009, for 
proportion of pairs compared to the historical control group). Two of the three pairs consisted 
of one patient in the not treated group and one patient in the treated group. In both cases the 
not treated patient had developed the SSI before the patient in the treated group. Also the 
patients had been in the same ward during the same period. The third pair consisted of two 
patients in the treated group who had not been in the same ward during the same period. 
However, the same phagetype had been isolated recently from the nose of one of the nurses 
working on this ward. 
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Figure 1: Surgical wound infection rate per two-month-period in the historical control and intervenUon 
group. 
Table 2: Number of surgical site infections (number/l00 procedures) by type of infection, 
Historical Intervention group 
Controls (N=928) Treated (N=752) 
Principal pathogen SSI DSSI ISS I SSI DSSI ISSI 
Muplrocin susceptible 
s. aureus 27(2.9) 18(1.9) 9 (1.0) 7 (0.9) 2 (0.3) 5 (0.7) 
CNS+ 14(1.5) 9 (1.0) 5 (0.5) 4 (0.5) 3 (0.4) 1 (0.1) 
total 41 (4.4) 27(2.9) 14(1.5) 11(1.4 5 (0.7) 6 (0.8) 
Mupirocin resistant* 16(1.7) 7 (0.8) 9 (1.0) 3 (0.4) 1 (0.1) 2 (0.3) 
No pathogen isolated 10(1.1) 3 (0.3) 7 (7.5) 1 (0.1) 0(0) 1 (0.1) 
Total 68(7.3) 37(4.0) 31(3.3) 15(2.0) 6 (0.8) 9 (1.2) 
+ eNS", coagulase negative staphylococci 
* Mupirocin resistant includes aerobic gram-negative rods, Pseudomonas aeruginosa, and other isolates. 
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Figure 1 shows the SSI rate per two-month-period in the historical control and intervention 
group. It can be seen that there was not an increasing nor decreasing trend in both groups 
and that the effect of the intervention was apparant from the onset. 
DISCUSSION 
The reduction of the SSI rate in the intervention group compared to the historical control 
group was highly significant. This reduction was even greater in the group of patients who 
had been treated with mupirocin calcium ointment. In the group of patients who were 
unintentionally not treated the SSI rate was comparable to the historical control group. The 
reduction is, thus, most likely the result of the application of mupirocin. 
Nasal carriage has been well established as a risk factor for SSI in several excellent studies 
a few decades ago.'''"' Moreover, analysis of risk factors for the development of SSI on the 
department of cardio-thoracic surgery had recently identified nasal carriage as the most 
important independent variable." In hemodialysis patients, it has also been shown 
consistently that nasal carriage of S. aureus is associated with an increased infection 
rate.4,1D..28 Mupirocin calcium ointment for eradication of carriage of in hemodialysis patients 
was highly effective, and resulted in a significant reduction of the S. aureus infection rate.'·" 
Therefore, it is likely that effective perioperative elimination of nasal carriage would also 
reduce the SSI rate. The efficacy of mupirocin to eliminate nasal carriage was 93%, which is 
comparable to the efficacy as reported previously.' 
A major point of criticism is that in this study the comparison was made with a historical 
control group. This type of analysis can be biased by other unnoticed and, therefore, 
uncontrolled temporal changes which may impact upon the SSI-rate. Comparing the 
demographics of the historical control group and the intervention group there was a slightly, 
but significantly lower age in the intervention group. However, in a previous study we have 
found that lower age groups are at an increased risk for the development of sternal wound 
infection with S. aureus." So this would have increased the SSI rate rather than reducing it. 
Surgical procedures in the intervention group included significantly more CVR procedures, in 
addition the IMA was used more frequently as a graft for CABG in this group of patients. In 
the historical control group these procedures were not associated with higher or lower SSI 
rates." In several other studies, however, CVR and IMA have been identified as risk factors 
for the development of SS!."" If so, the observed increase in this types of surgical 
procedures would not have worked in favor of lower SSI rates in the intervention group. 
principal pathogen and study group Table 2: 
Intervention group 
Not Treated (N=116) 
SSI DSSI ISSI 
2 (1.7) 2 (1.7) 0(0) 
4 (3.4) 2 (1.7) 2 (1.7) 
6 (5.1) 4 (3.4) 2 (1.7) 
2 (1.7) 1 (0.9) 1 (0.9) 
1 (0.9) 1 (0.9) 0(0) 
9(7.8) 6 (5.1) 3 (2.6) 
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There are several other arguments which support the conclusion that the observed reduction 
in SSI rates was due to the use of mupirocin. First, the difference in the SSI rates between 
the treated and the not treated patients in the intervention group provides supportive 
evidence for a beneficial effect of mupirocin. Secondly, it was found that the pathogenesis of 
S. aureus infections in the historical control group differed significantly from that in the 
intervention group. The proportion of S. aureus strains having a unique phagetype was 
significantly higher in the historical control group. This would fit in the concept that historical 
control patients were infected predominantly by their own, endogenous, strain of S. aureus 
and that the reduction of the SSI rate in the treated group was mainly due to a reduction of 
the number of endogenous acquired S. aureus infections. It is unlikely that other, unnoticed, 
factors would have such a selective effect on the source of the infecting strains. A third 
argument is that the reduction of the SSI rate was apparent immediately after the start of the 
intervention period. Prior to this moment, there was not a trend towards lower SSI rates in the 
historical control group, again supporting the conclusion that the highly significant reduction 
of the SSI rate was caused by the intervention. However, the finding that not only the SSI rate 
caused by mupirocin susceptible microorganisms was reduced but also the SSI rate caused 
by mupirocin resistant microorganisms provides an argument against the efficacy of 
mupirocin. The reasons for this observation can be that the observed effect was not caused 
by mupirocin but by other unnoticed temporal changes. However, this effect was not 
observed in the concurrent control group. Another explanation could be that nasal carriage 
of S. aureus is not always detected by a single culture due to limitations in sensitivity of this 
technique'" or due to the effect of antibiotic usage in the days prior to cultures were obtained. 
The application of mupirocin to the nares was well tolerated and side-effects were not 
observed. A point of concern Is the development of resistance to muplrocin. Although not 
observed In this study, there have been several reports In the literature recently.""'" should 
be noted that almost all of these observations were related to inappropriate use." This means 
use for longer than five days (sometimes for months), mostly on chronic skin infections. The 
risk for development of resistance with short perloperatlve, Intranasal use Is probably much 
lower. However, careful monitoring for development of resistance when using antibiotics is 
mandatory. 
The results of this study indicate that perioperative elimination of nasal carriage significantly 
reduces the SSI rate in cardio-thoraclc surgery. However, the results of our study do not 
justify the administration of muplrocin as perioperative prophylaxis to all patients undergoing 
cardio-thoraclc surgery unless they are confirmed In a double-blind, randomized, placebo-
controlled study. If it is confirmed that this method of prevention Is effective in thoracic 
surgery, it may apply to other categories of surgical patients as well. Since S. aureus 
continuous to be the most Important pathogen in SSI this new preventive strategy deserves 
to be evaluated further. 
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SUMMARY 
Objective. To assess the cost-effectiveness of perioperative intranasal application of 
mupirocin calcium ointment in cardia-thoracic surgery. 
Design. Cost-effectiveness analysis, intervention study with historical controls. 
Setting. University Hospital Rotterdam; tertiary referral center for cardiac and pulmonary 
surgery. 
Patients. Consecutive patients undergoing cardia-thoracic surgery between 1 August 1989 
and 1 February 1991 (control group, n=928), and between 1 March 1991 and 1 August 1992 
(intervention group, n=868). 
Intervention. Perioperative nasal application of mupirocin calcium ointment (Bactroban", 
Smith Kline Beecham Pharmaceuticals, United Kingdom), started on the day before surgery, 
continued for five days, twice daily. 
Results. Postoperative costs were significantly increased in patients with a SSI, compared 
with uninfected patients (p<0.001). Mean SSI attributable costs were estimated at U$16,878 
(95% CI: U$15,575 - U$18,181). The incidence of SSls was 7.3% in the control group and 
2.8% in the intervention group, mupirocin effectiveness being 62%. The costs of mupirocin 
were U$11 per patient. Thus, the savings per SSI prevented were U$16,633. To validate this 
comparative estimate of SSI attributable costs, a non-comparative analysis of the 
postoperative length of stay (POLS) was performed, according to the Appropriateness 
Evaluation Protocol. Approximately 50% of the comparative SSI attributable POLS was 
judged SSI attributable in the non-comparative analysis. Sensitivity analyses, testing for the 
robustness of our conclusions, indicated that the presented model is rather insensitive for 
variations in the incidence of SSls and for the effectiveness and costs of mupirocin. SSI 
attributable costs were shown to be the only variable with substantial effect on the cost-
effectiveness ratio. However, only when SSI attributable costs would be less than U$245, 
perioperativ8 mupirocin would result in net costs instead of savings. 
Conclusions. SSls in patients undergoing cardia-thoracic surgery are associated with a 
substantial increase in postoperative costs. Provided that perioperative mupirocin reduces 
the SSI rate, this measure will be highly cost-effective in most centers providing cardio-
thoracic surgical services. 
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INTRODUCTION 
Surgical site infections (SSls) constitute a substantial medical and socioeconomic problem, 
due to the prolonged and often severe morbidity resulting in an increased duration of 
hospitalization1,3,5,a,12,15,18,19.25'w and added hospital costs,12,15,22,2S,29 apart from the individual 
consequences for the affected patient. As nasal carriage of Staphylococcus aureus has been 
identified as an important risk factor for the development of a 881/.20 ,3-1,35 elimination of nasal 
carriage might reduce the incidence of SSls. Mupirocin calcium ointment has proven to be 
highly effective in the elimination of nasal carriage of S. aureus.'-"" 
Recently, an intervention study was performed to evaluate the effect of perioperative use of 
mupirocin nasal ointment on the incidence of SSls and mortality in patients undergoing 
cardio-thoracic surgery." The results indicated that perioperative elimination of nasal carriage 
using mupirocin nasal ointment significantly reduces the SSI rate in patients subjected to 
cardio-thoracic surgery. Although this finding could mean an important advance in the 
prevention of SSls in cardio-thoracic surgery, concerns may be expressed about the potential 
costs of perioperative use of mupirocin in this large group of patients. In the present study we, 
therefore, performed a cost-effectiveness analysis of perioperative use of mupirocin nasal 
ointment in patients on cardio-thoracic surgery. The design of the intervention study, using a 
historical control group, has limitations with regard to its cone/us ions about the effectiveness 
of mupirocin. Likewise, the SSI rate and the SSI attributable cost will vary in different settings. 
Therefore, a sensitivity analysis of the cost-effectiveness was performed to test the 
robustness of the presented model to changes of input variables. 
METHODS 
Intervention study. The cost-effectiveness analysis was based on data derived from the 
intervention study mentioned above. An extensive description of the study population, 
intervention, perioperative procedures, and surveillance methods was published previously." 
In brief, the study population consisted of 1,796 consecutive patients undergoing cardio-
thoracic surgery at the department of cardio-thoracic surgery of the University Hospital 
Rotterdam, the Netherlands, a tertiary referral center for cardiac and pulmonary surgery. Nine 
hundred and twenty-eight consecutive patients were operated between 1 August 1989 and 1 
February 1991 and will be referred to as historical control group. Eight hundred and sixty-
eight consecutive patients, operated between 1 March 1991 and 1 August 1992, will be 
referred to as intervention group. 
In the intervention group mupirocin calcium ointment (Bactrobano, SmithKline Beecham, 
Pharmaceuticals, UK) was applied to each nostril, according to the manufacturer's 
instructions. The application was started on the day before surgery and was given twice daily 
for five days. Although it was the intention to treat all patients in the intervention group, 116 
patients (14.4%) were not treated, mainly because of unintentional omission by the nursing 
staff. 
Medical records were examined by one of the investigators for the presence of SSls using 
criteria as defined for this purpose by the Centers for Disease Control (CDC)." Dates of 
admission, surgery, discharge and the time a patient stayed at various wards were derived 
from the Hospital Information System, as well as the number and type of laboratory-, 
radiodiagnostic-, and invasive procedures performed in each patient during the postoperative 
hospital stay. 
Cost-effectiveness analysis. Costs of a five-day course of nasal mupirocin were U$11, as 
listed by the pharmaceutical company Smith Kline Beecham, the Netherlands. Calculations 
of postoperative costs were performed in all patients from the historical control group. The 
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perspective taken in the calculation of costs was the hospital's point of view, i.e. hospital 
costs associated with the postoperative hospital stay were considered. Costs were estimated 
as the product of volume (number of hospital days, laboratory-, radiodiagnostic- and invasive 
procedures) and unit costs. Cost price studies were pertormed to determine unit costs 
reflecting the real use of resources. The year 1991 was used as a gauging year. In 1991 one 
US dollar corresponded with approximately 1.8 Dutch guilders. The cost of hospital days 
were estimated on the basis of the hospital cost accounting system. For each nursing unit 
the average direct and indirect costs of a hospital day have been calculated. Direct costs 
concerned manpower (nurses etc.) and materials (medical devices, medication, etc.), indirect 
costs were related to overheads. The costs per day ranged from U$265 for the medium care 
unit to U$930 for the postoperative intensive care unit. The postoperative length of stay 
(POLS) was defined as the number of postoperative hospital days, including the day of 
surgery and the day of discharge or death. In patients with a SSI, periods of readmission that 
were related to the infection were included in the POLS. The initial surgical procedure which 
could not have been influenced by the intervention with mupirocin was excluded from the 
analysis. The costs of laboratory procedures were also estimated on the basis of the hospital 
cost accounting system. For the radiodiagnostic- and invasive procedures the Dutch tariff 
system could be used as a close approximation of unit costs. 
SSI attributable costs, i.e. additional postoperative costs for a patient with a SSI, were 
assessed by comparing costs in patients with and without a SSI. Since analyses comparing 
infected and uninfected patients are prone to bias due to differences (other than the SSI) 
between both groups that may influence the length and costs of hospital stay, a non-
comparative method was applied to eliminate such bias. As approximately 80% of total 
postoperative costs were covered by costs of postoperative days (fable 1), the 
Appropriateness Evaluation Protocol, a non-comparative method which focuses on the POLS 
was used." The method described in this protocol uses explicit criteria to determine the need 
for each day of hospital care, and enables the assessment of the SSI attributable POLS, i.e. 
that proportion of the total POLS that is attributable to the SSI. Medical records of 54 patients 
with a SSI (79%) were available for reviewing. Each day of hospital care was reviewed twice: 
once including all information related to symptoms and treatment of the SSI, and once 
excluding all this information. Days of hospitalization for which the first review indicated a 
need for hospital care, were considered appropriate. Appropriate days were attributed to the 
SSI if the second review of these days did not indicate a need for hospital care. A cost-
effectiveness ratio, defined as costs per SSI prevented, was calculated. 
Sensitivity analyses were developed to test a number of assumptions used in the construction 
of the model, including varying the incidence of SSls from 1 to 100%; varying the 
effectiveness of mupirocin from 1 to 100%; varying the SSI attributable costs from 0 to 200% 
of the observed costs in patients with a SSI; and varying the costs of mupirocin treatment 
from U$O to U$1000. The results from our previous intervention study" were used to provide 
an estimate of the SSI rate in clinical practice and an observed effectiveness of mupirocin. 
Statistical analysis. Two-sided Student's t tests were used to test for differences in mean 
costs between groups, unless group numbers were smaller than 100 patients and the 
distribution of frequencies was skewed. In that case Mann-Whitney U - Wilcoxon rank sum 
tests were used. 
RESULTS 
The costs of the mupirocin treatment were U$11 per patient treated (one tube of 3 g, 0.2%, 
per patient). Costs associated with adverse events or the development of mupirocin 
resistance were zero, because neither one occurred. In Table 1 the costs of postoperative 
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procedures and postoperative hospital stay in the historical control group are presented. Both 
deep and incisional SSls were associated with a statistically significant increase in 
postoperative costs when compared with patients without a SSI (P<0.001). Mean SSI 
attributable costs were U$16,878 (95% CI: U$15,575 - U$18,181). The incidence of SSls in 
our intervention study decreased from 7.3% in the historical control group to 2.8% in the 
intervention group. Thus, mupirocin effectiveness was 62%, resulting in 45 SSls prevented 
per 1000 patients undergoing surgery in the intervention group. From these observed figures 
the cost-effectiveness ratio was estimated at -U$16,633 per SSI prevented, i.e. U$16,633 
were saved per SSI prevented. 
Table 1: Costs of postoperative procedures and hospital days in patients with a surgical site infection 
(SSI). 
Costs (U$, 1991) 
Category No. patients Mean (SE) SD Median p' 
All patients 928 
Postoperative procedures 2,506 (151) 4,602 1,162 
Postoperative hospital days 5,580 (210) 6,402 4,236 
Total 8,086 (331) 10,071 5,439 
Incisional 5S1 31 
Postoperative procedures 3,857 (830) 4,621 1,987 <0.001 
Postoperative hospital days 8,668(1,311) 7,300 7,000 <0.001 
Total 12,525 (1,926) 10,722 8,998 <0.001 
Deep SSI 37 
Postoperative procedures 10,443 (2,410) 14,660 6,935 <0.001 
Postoperative hospital days 22,669 (3,596) 21,875 15,458 <0.001 
Total 33,112 (5,462) 33,224 21,566 <0.001 
Incisional or deep SSI 68 
Postoperative procedures 7,441 (1,414) 11,660 4,235 <0.001 
Postoperative hospital days 16,286 (2,204) 18,175 9,132 <0.001 
Total 23,727 (3,324) 27,409 14,560 <0.001 
NoSSI 860 
Postoperative procedures 2,116 (109) 3,190 1,096 
Postoperative hospital days 4,733 (100) 2,946 3,972 
Total 6,849 (187) 5,473 5,240 
+ versus no SSI 
As the SSI attributable costs used in the calculation of this ratio may well be overestimated by 
using a comparative method, a non-comparative analysis was performed as well (vide supra). 
Table 2 shows the results of both the comparative and non-comparative analysis of the 
POLS. Based on the observed means of POLS in the comparative analysis, 21.4 days (95% 
CI: 14.0 - 28.8) were attributed to a SSI. In the non-comparative method, however, on 
average only 10.5 days (95% CI: 7.2 - 13.8) were considered to be due to the occurrence of 
an SSI. Likewise, the median number of days assigned to a SSI in the non-comparative 
analysis was only half the difference between the POLS medians of the two groups in the 
comparative analysis (7 days vs. 14 days). 
The robustness of the presented model was tested by changing each input variable, while 
keeping the other variables at the baseline level. As indicated in Table 3 the cost-
effectiveness ratio is relatively insensitive to variations in the effectiveness of mupirocin. 
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Table 2: Postoperative length of hospital stay attributed to the surgical site infection (8SI) estimated 
from comparative and non-comparative analyses. 
Postoperative days 
Analysis No. Mean (SE) SD Median 
patients 
Comparative 
without S81 860 13.4 (0.2) 7.0 11.0 
with SSI 54 34.8 (3.7) 27.3 25.0 
S81 attributable 21.4 (3.8) 14.0 
Non-comparative 
Inappropriate 54 6.8(1.1) 8.0 5.0 
Appropriate, not S81 attributable 54 17.5 (3.3) 24.6 9.0 
Appropriate, S81 attributable 54 10.5 (1.7) 12.6 7.0 
Cost-effectiveness ratios vary from -U$16, 727 to -U$15,371 per SSI prevented with mupirocin 
effectiveness ranging from 100% to 10%. Even with an effectiveness of mupirocin of only 
1 % the ratio is -U$1,809 per SSI prevented. Changes in the incidence of SSls have even less 
impact; the ratio never exceeds -U$15,092 per SSI prevented and is never less than 
-U$16,860 per SSI prevented with incidence rates varying from 1 to 100%. Also, the costs of 
15 Effectiveness of mupirocin 
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Figure 1. Sensitivity analysis reporting cost-effectiveness ratios resulting when the surgical site infection 
(881) attributable costs and the incidence of SS/s are varied. The curved lines represent combinations of 
these variables that have a cost-effectiveness ratio of zero, at three different mupirocin effectiveness 
rates. Costs of mupirocin are U$11 per patient in aI/lines. 
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mupirocin hardly influence the cost-effectiveness ratio; an increase in costs to U$759 per 
patient treated perioperatively would result in a ratio equalling zero. Changes in the 881 
attributable costs, on the other hand, have a substantial effect on the cost-effectiveness 
ratio; a 50% increase in 881 attributable costs would result in a 50% decrease in the ratio (i.e. 
improves cost-effectiveness), while a 50% decrease in costs (e.g. using the non-comparative 
estimate of costs) would result in a 50% increase in the ratio (i.e. reduces cost-effectiveness). 
However, only when the 881 attributable costs would drop below U$245 per patient with a 
881, the cost-effectiveness ratio would exceed zero. 
Figure 1 depicts the sensitivity of the cost-effectiveness ratio of perioperative mupirocin use 
to different assumptions regarding the incidence of 881s without perioperative mupirocin 
use, the effectiveness of mupirocin, and the costs of 881s. The curved lines represent the 
combinations of 881 attributable costs and 881 incidences that all have a cost-effectiveness 
ratio of zero for different mupirocin effectiveness rates. Even if both the incidence of 881s and 
the effectiveness of mupirocin were reduced by 50%, 881 attributable costs should be less 
than U$978 per event to have a ratio of costs to 881 prevented above zero, i.e. not to be cost-
effective. 
Table 3: Sensitivity analysis of the cost-effectiveness of perioperative nasal mupirocin in cardia-thoracic 
surgery. 
Scenario 
Base case' 
Incidence of 881s 
1% 
10% 
50% 
100% 
Effectiveness of mupirocin 
1% 
2% 
10% 
50% 
100% 
Mean 881 attributable costs 
U$O(O%) 
U$245 (1.5%) 
U$1,688 (10%) 
U$8,438 (50%) 
U$25,317 (150%) 
U$33,756 (200%) 
Costs of mllpirocin (per patient) 
U$O 
U$50 
U$100 
U$250 
U$500 
U$759 
U$l,OOO 
Cost-effectiveness ratio (U$ per SS! prevented)* 
-16,633 
-15,092 
-16,699 
-16,842 
-16,860 
-1,809 
-9,344 
-15,371 
-16,577 
-16,727 
+244 
o 
-1,443 
-8,194 
-25,072 
-33,511 
-16,878 
-15,766 
-14,654 
-11,318 
-5,759 
o 
+5,360 
Incidence of 8Sls: 7.3%; effectiveness of mupirocin: 62%; mean 8S1 attributable costs: U$16,878; 
and mupirocin costs: US11 per patient (19). 
* Figures <0 indicate savings per SSI prevented, i.e. perioperative mupirocin is cost-effective; figures >0 indicate net 
losses per SSI prevented, Le. perioperative mupirocin is not cost-effective. 
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DISCUSSION 
A recent report indicates that peri operative elimination of nasal carriage using mupirocin 
nasal ointment significantly reduces the incidence of 881s in patients subjected to cardio-
thoracic surgery.21 Elimination of nasal carriage may become an important tool in the 
prevention of 881s in the near future. However, concerns may arise about the potential costs 
of perioperative use of mupirocin. Our analysis indicates that perioperative use of mupirocin 
nasal ointment in patients on cardio-thoracic surgery is highly cost-effective, with a cost-
effectiveness ratio of -U$16,633 per 881 prevented, i.e. U$16,633 saved per 881 prevented. 
Estimates of costs and effects in our analysis were partly based on a number of assumptions. 
First, the 7.3% incidence of 881s was derived from a recently performed intervention study, 
as mentioned before." As incidence rates of 881s differ between hospitals and between 
cQuntries,30 cost-effectiveness ratios of perioperative use of mupirocin may vary too in 
different settings. Also, the effectiveness of perioperative mupirocin, which may influence the 
cost-effectiveness ratio calculated, was based on the results of the intervention study. The 
design of this study, using a historical control group, could have biased the results. Unnoticed 
and, therefore, uncontrolled temporal changes other than the intervention with mupirocin, 
may have influenced the 8S1 rate. However, as reported previously," the incidence of SSls in 
the intervention group was significantly lower among those patients that actually received 
mupirocin than in those patients that were unintentionally not treated. Moreover, the reduction 
in SSI rate was apparent immediately after the start of the intervention, while no trend 
towards lower SSI rates was discernible before the intervention was implemented. 
Thirdly, the costs of a five-day course of nasal mupirocin (one tube of 3 g, per patient) were 
U$11 as listed by the pharmaceutical company in the Netherlands. In other countries, the 
costs of mupirocin might be different. In our study all patients undergoing cardia-thoracic 
surgery were targeted for perioperative nasal mupirocin. Considering the increasing risk for 
the development of mupirocin resistance with large scale perioperativ8 mupirocin use, one 
might argue to restrict perioperative nasal mupirocin to those patients who have 8. aureus 
isolated from a preoperative nasal culture. Assuming a maximum nasal carriage rate of 50%, 
the costs of the intervention would increase to U$26.5 per patient undergoing surgery (nasal 
culture: U$21; mupirocin: U$5.5). As shown by our sensitivity analysis, however, such an 
increase in costs will have little influence on the cost-effectiveness ratio of the intervention. 
Finally, the calculation of SSI attributable costs may have influenced our estimate of the cost-
effectiveness ratio. Costs were based on a cost profile and tariff system which is specific for 
the Netherlands. In other cost- and reimbursement systems, SSI attributable costs may be 
quite different, and therewith the cost-effectiveness of perioperative mupirocin. A very 
important factor in the assessment of SSI attributable costs is the method used to determine 
which proportion of total costs are SSI attributable. Although several studies have clearly 
shown that the development of a SSI is associated with an increase in the duration of 
hospitalization1,3,5,8.12,15,lB.19.25,29 and associated costs,12.1S,n,25,29 the methods employed in order to 
. estimate the added hospital stay and costs in nosocomial infections (Nls) vary 
considerably." As a result, there are discordant findings depending upon the particular 
method used.''' A frequently used method is the direct comparison, in which the additional 
hospital stay or costs are assessed by comparing the length of stay of infected and 
uninfected patients.1.3,5.8.12,14.15.18,19,22,2:5 Either unmatched3,9,14,22 or matched 1,8,12,18,25,29 control 
patients can be used. A fundamental limitation with the unmatched group comparison method 
is the implicit assumption that any difference in length of stay or costs is attributable to the 
NI, and not related to other inherent differences between those patients who do and those 
who do not acquire a NI (e.g. age, surgical procedure, severity of illness, and comorbidities). 
Studies using matched controls have adjusted for some, but not all, of these known 
riskfactors and do not control for riskfactors that are yet unknown.1,lJ,14,25,29.3J The matched 
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control estimates of NI attributable days have been lower than in the unmatched group 
approach,4,31 however, they may still overestimate the incremental days.1423 In contrast, the 
direct-attribution approaches develop estimates of infection attributable days and costs by 
focusing only on the cases with an infection, thus eliminating problems associated with 
differences between cases and controls. Direct-attribution analyses include the clinician 
judgement approach 4,7,9,14,15,17,31 and the standardized case review approach.31 -3J The 
Appropriateness Evaluation Protocol (AEP) is a standardized case review method, in which 
standardized and objective criteria are used to determine which days of stay should be 
attributed to the NI versus those attributable to other health problems." Under the 
assumption that all perlinent clinical information justifying use of inpatient services is 
contained in the medical record, and that a distinction can be made between information 
related to the original causes for hospitalization and information related to the NI, the AEP is 
known to be a reliable and valid instrument in the assessment of the NI related hospital stay. 
It supplies conservative estimates.3J27,28,30 Our non-comparative analysis of the POLS did 
indeed yield much less SSI attributable days than the comparative analysis did. However, 
even if this conservative estimate of POLS is used to calculate the SSI attributable costs, 
perioperative use of mupirocin would still be cost-effective. 
The effectiveness of mupirocin has not been definitely established, and awaits the results of 
a double blind placebo controlled randomized trial. However, even with an effectiveness of 
only 1 %, our sensitivity analysis revealed that perioperative administration of nasal mupirocin 
will be a cost-effective measure. We, therefore, conclude that, provided that perioperative 
mupirocin reduces the SSI rate, this measure will be highly cost-effective in most groups of 
patients undergoing cardio-thoracic surgery. Restricting perioperative USe of nasal mupirocin 
to nasal carriers of S. aureus has negligible effect on the cost-effectiveness and may, 
therefore, be the best prophylactic strategy that will both be cost-effective and prevent the 
emergence of mupirocin resistance among S. aureus. 
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CHAPTER TWO 
BACTEREMIA IN PATIENTS ON HEMODIALYSIS 
PART ONE 
PREVENTION OF STAPHYLOCOCCUS AUREUS BACTEREMIA IN HEMODIALYSIS 
PATIENTS BY ELIMINATION OF NASAL CARRIAGE USING MUPIROCIN 
Jan Kluytmans, Marie-Jose Manders, Erik van Bommel, and Henri Verbrugh 
Adapted from: Infect Control Hasp Epidemiolln press. 
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SUMMARY 
Objective. To study the efficacy of mupirocin for the elimination of nasal carriage of 
Staphylococcus Bureus in hemodialysis patients and its effect on the incidence of S. aureus 
bacteremia. 
Design. The efficacy of mupirocin was studied in a prospectively followed cohort. The effect 
of this intervention on the rate of S. aureus bacteremia was evaluated using a historic control 
group. 
Setting. Patients on the hemodialysis unit of the University Hospital Rotterdam, a tertiary 
referral center. 
Patients. The study group consisted of consecutive patients on hemodialysis from 1 
February, 1992, until 1 November, 1993. They were screened by taking nasal cultures 
monthly during there time on hemodialysis. If S. aureus was isolated, treatment with 
mupirocin nasal ointment was initiated. The control group consisted of patients treated on the 
same hemodialysis unit from 1 January, 1990 untill 1 January, 1992. 
Results. The study group consisted of 226 patients, of which 172 were evaluable to 
determine the efficacy of mupirocin. Sixty-seven (39%) were identified as nasal carriers. 
Immediately after the initial treatment, 66 (98.5%) nasal cultures became negative. After 3 
months and 6 months, respectively, 63 (94%) and 61 (91 %) of the treated carriers had 
negative cultures. The rate of bacteremia, being the number of episodes of S. aureus 
bacteremia per patient year on hemodialysis, in the 226 patients in the study group was 
significantly lower compared with this rate in the 273 patients in the control group 
(respectively 0.04 and 0.25, P<0.001). Development of resistance and adverse effects were 
not observed. 
Conclusions. Mupirocin nasal ointment effectively eliminates nasal carriage of S. aureus in 
patients on hemodialysis, thereby significantly reducing the incidence of S. aureus 
bacteremia. 
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INTRODUCTION 
Infection is the most common cause of morbidity and the second cause of mortality in 
patients on hemodialysis," Staphylococcus aureus being the most frequently isolated 
pathogenY' Nasal carriage of S. aureus plays an important role in the pathogenesis of these 
infections.""'" Expressed longitudinally, approximately 30% of the normal population will be 
prolonged and 50% will be intermittent carriers, whereas 20% will never be colonized.' The 
underlying mechanisms for these differences are presently unknown. The adherence of S. 
aureus to the nasal epithelial cells seems to be mediated by the lipoteichoic acid moiety in 
the cell wall.' Increased rates of nasal carriage are found among groups of patients in which the 
skin is often punctured, e.g. by needles or intravascular devices. This is especially the case 
in patients with insulin dependent diabetes mellitus,3,18 patients on chronic hemodialysis 3.14 
and intravenous drug addicts.3.17 
Nasal carriage of S. aureus has been associated with an increased risk of infection in 
patients after surgery," in patients on continuous ambulatory peritoneal dialysis (CAPO)" 
and in patients on hemodialysis.7.11 .21 Besides their increased colonization by S. aureus, 
patients on chronic hemodialysis are more prone to infections with S. aureus because of their 
suppressed immunity and the presence of a vascular access site.7 
In hemodialysis patients, several studies have shown that elimination of nasal carriage 
reduces the incidence of S. aureus infections.4. 12.21 In a study by Yu et al.,21 nasal carriage was 
effectively eliminated by oral administration of rifampin. This resulted in a significant 
decrease of infections with S. aureus. However, development of resistance to rifampin was 
observed more than once during this study. This limits the use of rifampin for this purpose. 
Another approach to eliminate nasal carriage is the local application of antibiotics to the 
nose. Topical gentamicin, vancomycin and bacitracin have been studied for this purpose. 
The elimination of nasal carriage was not effective, being shorter than two weeks for all 
regimens.' Mupirocin, a topical antibiotic, represents a new class of antibiotics. Unlike any 
other known antimicrobial agent, it inhibits the bacterial isoleucyl TRNA synthetase, thereby 
blocking protein synthesis and indirectly inhibiting RNA synthesis. Mupirocin has an 
excellent activity against S. aureus, the minimal inhibitory concentrations being $1 mg/1. The 
nasal ointment has proven to be safe and highly effective in eradication of nasal carriage of S. 
aureus in carriers without severe underlying diseases.6.8.16 
To determine the efficacy of elimination of nasal carriage using mupirocin and its effects on 
the incidence of S. aureus bacteremia in the patients on hemodialysis in our hospital, an 
intervention study was initiated. 
METHODS 
Study group. From 1 February, 1992 until 1 November, 1993, all patients on the 
hemodialysis unit of the University Hospital Rotterdam, were routinely screened for nasal 
carriage of S. aureus by taking nasal cultures monthly during their time on hemodialysis. 
Patients with positive nasal cultures for S. aureus were treated initially with mupirocin nasal 
ointment twice a day for 5 days. Two days later a nasal culture was taken to determine the 
immediate efficacy. After the initial treatment, mupirocin was applied once weekly. Patients 
with consistent negative nasal cultures after an initial positive culture were considered cured. 
If the nasal culture became positive again, this was considered as a treatment failure. For all 
patients age, gender, the total number of days on hemodialysis, the number of episodes of S. 
aureus bacteremia and the results of nasal cultures were recorded. Patients from whom no 
nasal culture was performed or who were colonized by methicillin or tobramycin resistant S. 
aureus, were excluded from the evaluation of the efficacy of elimination of nasal carriage. For 
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comparison of the incidence of S. aureus bacteremia, all patients were included for an 
intention to treat analysis. The treated and not treated patients in the study group were also 
evaluated separately. 
The following groups were defined: 
Intention to treat group: All patients on hemodialysis during the study period; 
Treated group: Patients on hemodialysis during the study period, from whom nasal 
cultures were obtained and if positive were treated with mupirocin; 
Untreated group: Patients who were excluded from the study group. 
Control group. All patients of the hemodialysis unit at our hospital between 1 January, 1990 
and 1 January, 1992 were used as an historic control group. During this period nasal swabs 
were not taken routinely, and no efforts were made to eliminate nasal carriage. For all control 
patients age; sex; the total number of days on hemodialysis; and the number of episodes of 
S. aureus bacteremias were recorded. 
Microbiology. Nasal cultures were obtained using a pre-moistened dacron swab, which was 
applied to both anterior nasal vestibules. The swabs were streaked on columbia agar base 
(supplemented with 5% sheep blood) and on mannitol salt agar plates, which were incubated 
for at least 48 hours at 37'C, aerobically. The plates were examined for the presence of S. 
aureus, of which sensitivity patterns were determined, including methicillin, tobramycin and 
mupirocin. The Kirby-Sauer agar disc method was used. 
Statistical analysis. The differences between groups were evaluated by the Chi square test 
or the t test. Significance was accepted when P<0.05. 
RESULTS 
Patient Characteristics. Hemodialysis was performed on 226 patients during the study 
period and on 273 patients during the control period. The malelfemale ratio and age 
characteristics of both groups are shown in Table 1. There were no significant differences 
between the groups. 
Table 1: Patient characteristics in the study and the control group. 
variable 
number of patients 
number of females (%) 
mean age (range) 
median age 
control group 
273 
105 (38.5) 
54.1 (19·85) 
57 
study group 
172 
64 (37.2) 
55.8 (17-87) 
55 
Nasal carriage of S. aureus. Fifty-four patients with a total of 3.8 year on hemodialysis could 
not be evaluated for the efficacy of elimination of nasal carriage, and were excluded from the 
study group. The reason for exclusion are shown in Table 2. This leaves 172 patients who 
were evaluable for nasal carriage and efficacy of mupirocin nasal ointment. In the study 
group 67 (39.0%) of a total of 172 patients were identified as nasal carriers. After the initial 
treatment with mupirocin of 5 days, 66 (98.5%) nasal cultures became negative. After 3 
months and 6 months, respectively, 63 (94%) and 61 (91%) of the treated carriers had 
negative cultures. 
MUPIROCIN IN HEMODIALYSIS 
Table 2: Reasons for exclusion from the study group. 
reason for exclusion 
no initial nasal culture performed 
no control nasal cultures taken after treatment 
aminoglycoside resistant S. aureus isolated 
total 
number of patients 
47 
5 
2 
54 
51 
S. aureus bacteremia. In the study group, 4 episodes of S. aureus bacteremia occurred in 
226 patients with a total of 100.3 years on hemodialysis. This gives an incidence of 0.04 
bacteremia/patient year on hemodialysis in the intention to treat group. One of these 
bacteremias occurred in a patient who was excluded from the study group, and had 
subsequently not received mupirocin. In this group of untreated patients the incidence was 
0.25 bacteremia/patient year on hemodialysis. In the 172 patients in the study group who 
were treated, 3 episodes of S. aureus bacteremia occurred, giving an incidence of 0.03 
bacteremia/patient year on hemodialysis. In the control group there were 273 patients with a 
total of 100.0 years on hemodialysis. Twenty-five episodes of S. aureus bacteremia were 
recorded. This gives an incidence of 0.25 S. aureus bacteremia/patient year on hemodialysis. 
The reduction of the incidence of S. aureus bacteremia in the intention to treat group and in 
the treated group compared to the historic control group was statistically significant. The 
incidences of bacteremia in various groups are summarized in Table 3. 
Table 3: Incidence of episodes of S. aureus bacteremia in the control, the intention to treat, the treated 
and the not treated group. 
Number of Year- P-value 
Total years episodes of incidence of compared to 
on S. aureus S. aureus control 
Group n hemodialysis bacteremia bacteremia group 
Control 273 100.0 25 0.25 
Intention to treat 226 100.3 4 0.04 <0.001 
Treated 172 96.5 3 0.03 <0.001 
Not treated 54 3.8 0.25 >0.5 
Susceptibility of S. aureus. All S. aureus strains were susceptible to mupirocin. Also all 
strains were susceptible to methicillin and all but two were susceptible to tobramycin. 
Adverse events. No side effects occurred during the study period and mupirocin nasal 
ointment was well tolerated. 
DISCUSSION 
In the study group the rate of nasal carriage was 39.0%, which is comparable to the rates 
reported in other studies." The efficacy of the elimination of nasal carriage immediately after 
the initial 5 day treatment course was high (98.5%). After 6 months 91.0% of the nasal 
cultures were still negative. The effect of the intervention on the incidence of infectious 
complications with S. aureus was measured by comparing the rates of bacteremic episodes 
with S. aureus before and after the intervention. The rate of bacteremia with S. aureus was 
chosen because it is an objective parameter, which was well documented in both the study 
group and the control group. The reduction of the rate of bacteremia in the intention to treat 
group as compared to the historic control group was sixfold. This was highly significant. Since 
an intervention study with a .historical control group can be biassed by other, unnoticed 
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changes the interpretations in this study should be made carefully. However, it has been 
shown consistently that effective elimination of nasal carriage in patients on hemodialysis 
lowers the infection rate with S. aureus.4.12_21 The elimination of nasal carriage in this study 
was highly effective, in fact more effective than with any other treatment which has been 
studied. It is therefore unlikely that the reduction of the rate of S. aureus bacteremia was 
caused by other factors. Moreover, in a prospective, randomised, double-blind, placebo-
controlled study, Boelaert et a/.' have shown that mupirocin nasal ointment was effective in 
hemodialysis patients. The nasal carriage rate in the treated group was significantly lower 
than in the placebo group. Also the incidence of S. aureus infections was significantly lower in 
the treated group. Development of mupirocin resistance among S. aureus strains was not 
observed during this study. Therefore we conclude that application of mupirocin nasal 
ointment to hemodialysis patients who are nasal carriers of S. aureus effectively eliminates 
nasal carriage and thereby significantly reduces the rate of bacteremia with S. aureus. 
Although not observed in this study, a matter of concern is the increasing number of 
observations addressing the development of resistance to mupirocin. This resistance consists 
of an intermediate level form (MIC 8-256). This form is clinically less important and depends 
on modifications in the bacterial isoleucyl-TRNA synthetase. On the other hand, a high level 
form, which depends on a plasmid-coded isoleucyl-TRNA synthetase, and which is 
completely resistant to mupirocin (MIC>256), is of clinical importance." Although mupirocin is 
not of substantial therapeutic value, it plays a very important role in the control of MRSA 
epidemics,' and in prevention of infections with S. aureus (e.g. this study). Therefore, when 
mupirocin is used, the development of resistance should be monitored carefully by performing 
routine sensitivity tests. A second consideration is, if this form of prophylaxis in a continuous 
manner is the most optimal. Although resistance was not observed in this study nor in the 
study of Boelaert et a/.,' continuous administration of any antibiotic will increase the potential 
for development of resistance. Holton et al. 12 reported an evaluation in which mupirocin was 
given to nasal carriers in hemodialysis for five days after which it was stopped. The efficacy 
of elimination of nasal carriage was lower in this study compared to our findings. The patients 
who had a negative nasal culture at the completion of five days of therapy (17 of 22 [77%]), 
had a mean time to recurrence of 3.8 weeks. During a three month follow-up period there was 
a significant lower rate of S. 8ureus infection in these 17 patients as compared to a control 
group. Further studies should be performed to evaluate which dosage schedule eliminates 
nasal carriage most effective, while giving a minimal opportunity for resistance to develop. 
Mupirocin nasal ointment effectively eliminates nasal carriage of S. aureus in patients on 
chronic hemodialysis and thereby a significant reduction in the incidence of S. aureus 
bacteremia is achieved. Other categories of patients in which elimination of nasal carriage 
will likely decrease infection rates, are patients on chronic ambulatory peritoneal dialysis" 
and s~rgical patients.19.2O The simplicity, low costs and efficacy of this preventive measure 
warrant further study. 
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SUMMARY 
Resistance of Staphylococcus aureus to jj-Iactam antibiotics can be mediated by three 
mechanisms: l3-iactamase production. tolerance and intrinsic resistance. Intrinsic resistance 
is mediated by a chromosomal gene, the Mec-a gene. This leads to the expression of an 
altered Penicillin Binding Protein (PBP), namely PBP-2a. This PBP-2a has a very low affinity 
for jj-Iactam antibiotics, and consequently these strains, called Methicillin-Resistant S. aureus 
(MRSA), are resistant to all jj-Iactam antibiotics. MRSA is now an important clinical problem 
in nearly all countries. In US hospitals, in 1991 MRSA-rates were 29%. In Europe the MRSA 
rates increase from North to South. In the Netherlands the MRSA rate is well below 5%. This 
low rate is maintained by surveillance and isolation of patients transferred from foreign 
hospitals. Two recent studies have evaluated the phylogenetics of MRSA in collections of 
MRSA with a global origin, gathered during the last 30 years. It can be concluded that 
acquisition of the Mec-a gene by S. aureus is an extremely rare event. Clonal spread 
together with horizontal transfer and recombination can explain the findings. Although the 
problems with MRSA are already huge, an even more worrying threat is the development of 
vancomycin resistance. Since the use of vancomycin is increasing and the resistance in 
other gram-positive organisms is already significant, the development of resistance of S. 
aureus to vancomycin is likely to occur in the near future. Further studies are needed to 
develop new therapeutic and preventive strategies, to deal with this totally resistant S. 
aureus. 
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STAPHYLOCOCCUS AUREUS: MECHANISMS OF RESISTANCE 
The resistance to Il-Iactam antibiotics in S. aureus can be caused by three underlying 
mechanisms, namely fj-Iactamase production, tolerance and intrinsic resistance. The 
production of j3-lactamase gives resistance to penicillin. The introduction of the 
penicillinase-stable derivatives (e.g. methicillin, cloxacillin) largely solved this problem, since 
these antibiotics were not affected by the staphylococcal Il-Iactamase. Tolerance is a 
mechanism first described by Tomasz et al." in 1970. It can be observed both in vitro and in 
vivo. The definitions used differ somewhat. The two definitions for tolerance most often used 
are: 
• a ratio between Minimal Bactericidal Concentration (MBC) and Minimal Inhibitory 
Concentration (MIC) ;,32;" 
a surviving fraction of ;'2% after 24 hours of incubation in the presence of high 
concentrations of an appropriate j3-lactam antibiotic.' 
Since tolerant strains usually do not have an increased MIC, and this test is the method most 
often used to detect resistance, the phenomenon is not recognised in routine sensitivity 
testing. The relevance of tolerance in S. aureus infections was recently studied by Voorn et 
81.15 in an experimental endocarditis model in rats. The efficacies of cloxacillin, and cloxacillin 
combined with gentamicin, were compared for animals infected with a tolerant strain and its 
kill-sensitive variant. Cloxacillin was significantly less effective for treating the tolerant strain 
than for the kill-sensitive strain. The addition of gentamicin to cloxacillin reduced bacterial 
numbers in the vegetations for the tolerant strains to a level comparable to that obtained by 
cloxacillin alone in the kill-sensitive strain, but had no additional effect for the kill-sensitive 
strain. These resuits show that the in vitro phenomenon of tolerance is also relevant in vivo. 
Tolerance constitutes a strong argument for the addition of an aminoglycoside to a j3-lactam 
antibiotic in the treatment of serious S. Bureus infections such as endocarditis. The third 
mechanism of resistance is intrinsic resistance, mediated by a chromosomal gene, the Mec-a 
gene. This gene leads to the expression of an altered Penicillin Binding Protein (PBP), 
namely PBP-2a. This PBP-2a has a very low affinity for j3-lactam antibiotics, and 
consequently these strains are resistant to all j3-lactam antibiotics. Since j3-lactams are the 
mainstay for the treatment of severe staphylococcal infections, the development of intrinsic 
resistance creates important problems in the therapy of these infections. These strains 
possessing the Mec-a gene are called Methicillin-Resistant Staphylococcus aureus, 
abbreviated to MRSA. 
EPIDEMIOLOGY OF MRSA. 
MRSA isolates were first reported in 1961,' within one year of the introduction of methicillin. 
Soon several epidemics were reported in a number of European countries. In the mid-1970s, 
MRSA was recognised as a significant clinical problem in both Europe and the US. Panlilio et 
al. reported the temporal trends of MRSA in US hospitals." In 1981 the fraction of MRSA in 
the total number of S. aureus isolates was generally below 5%. In 1991 this fraction was 
much higher (29%). The MRSA rate correlated with the size of the hospital: in small hospitals 
(less than 200 beds) the MRSA rate in 1991 was 15%, in medium-sized hospitals (200 to 499 
beds) the rate was 20% and in large hospitals (;'500 beds) the highest MRSA rates (38%) 
were found. In Asia high MRSA rates have been reported. In Japan the proportion of S. 
aureus isolates which was resistant to methicillin in 43 university hospitals was as high as 
60% in 1991.' In China one university hospital reported a MRSA rate of nearly 80%, with a 
MRSA carriage rate among health care workers of 68,9%.' In Australia high MRSA rates 
(±25%) were found in Eastern regions and low rates (0,4%) in Western Australia.' Important 
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geographic differences are also found in Europe. A systematic survey showed that 12,8% of 
more than 7000 S. aureus isolates studied were methicillin-resistant. [n Denmark, Sweden, 
Nether[ands and Switzerland the MRSA-rates were [ower than 2%, whereas in France, Spain 
and Italy rates of 30-35% were found.'" 
The [ow rate in the Nether[ands is remarkable, especially since the rates in the neighbouring 
countries are much higher. [n the Nether[ands a huge amount of ~-[actam antibiotics is used. 
Neverthe[ess, no development of resistance of S. aureus under therapy is observed. To put it 
another way, in an "MRSA-free" environment, development of resistance in the population of 
susceptible strains is not observed. Near[y all MRSA strains found in the Nether[ands can be 
traced to patients transferred from foreign hospitals. There is a national guideline to control 
MRSA which is mainly based on surveillance and isolation of patients transferred from foreign 
hospitals. When MRSA is found the patient is isolated and surveillance of other patients and 
health care workers is performed to detect possible spreading of the strain. This policy, is 
called "search and destroy", and apparant[y it can control MRSA-rates to a [ow [evel. The 
conclusion must be that development of resistance to methicillin is not or very rarely observed 
under the selective pressure of the use of antibiotics. Therefore, clona[ spread must have 
been the most important mechanism causing the high rates of MRSA observed worldwide. 
[n contrast, development of resistance due to selection of mutants can be observed with other 
classes of antibiotics. This is illustrated in the following example. A patient was referred to 
the University Hospita[ Rotterdam, with a diabetic ulcer. From this ulcer two S. aureus strains 
were isolated, one being susceptible, the other resistant to gentamicin. This patient had been 
treated with topical gentamicin ointment. Further typing of these two strains using phage 
typing and randomly amplified polymorphic DNA analysis showed that the two S. aureus 
strains were identical. Apparent[y, resistance had developed under the selective pressure of 
topical gentamicin therapy, as has been described before." This clearly is a different 
mechanism from the development of resistance to methicillin. 
MRSA: PHYLOGENET[CS. 
From the epidemiology of MRSA it had already been concluded that inducible resistance 
played a very limited role. Two recent studies have evaluated the role of clonal spread of 
MRSA. The first study was performed by Kreiswirth et al.' They used a collection of 472 
MRSA strains, which were collected worldwide during a 30-year period, the first strain being 
isolated in 1961. DNA hybridisation patterns were analysed, using two probes: first the Mec-a 
probe and second the TN-554 probe, a transposon which codes for spectinomycin resistance 
and is present in the majority of MRSA strains. With the Mec-a probe, six hybridisation 
patterns were found which, combined with the chronological sequence of isolation, fitted into 
one evolutionary tree. Using the TN-554 probe, 27 different patterns were identified. Each 
TN-554 pattem was associated with only one Mec-a pattern. The conclusions were that 
Mec-a may have entered S. aureus just once and that clonal spread together with limited 
horizontal transfer and recombination could explain the worldwide dissemination of MRSA. 
The second study was performed by Musser et al." They used a collection of 254 strains, 
also collected worldwide, but mainly in the USA, over a 30-year time span. They used 
mu[ti[ocus enzyme electrophoresis, with selective staining for 15 different metabolic enzymes. 
The genetic distance between strains was calculated from the difference between the 
electrophoretic types (El). Fifteen different ETs were found. At a genetic distance of 0.2 
(80% homology), 6 clusters were identified. Given the differences between several ETs and 
the large number of different ETs found, they concluded that Mec-a had entered S. aureus on 
several occasions and that horizontal transfer and recombination explained the findings. 
Whatever the exact frequency, it can be concluded from the epidemiological findings, 
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combined with the results from both studies, that acquisition of Mec-a by S. aureus is an 
extremely rare event. Clonal spread together with horizontal transfer and recombination is 
the most probable mechanism, which can explain all the findings. 
FUTURE CONSIDERATIONS. 
MRSA is now practically resistant to all antibiotics available. The only antibiotic to which all 
strains are still susceptible is vancomycin (or teicoplanin). The worldwide use of vancomycin 
has increased dramatically over the last years. Concordantly resistance in other 
Gram-positive micro-organisms has increased significantly, The resistance of Enterococci in 
Intensive Care Units (ICUs) of US hospitals may serve as an example. In 1989, <0.5% of 
enterococci were resistant. In 1992, resistance had increased to nearly 8%,6 It has been 
shown both in vitro and in animal stUdies that high-level vancomycin resistance can easily be 
transferred from Enterococci to S. aureus." Therefore, it seems inevitable that this will also 
happen in clinical settings and vancomycin-resistant S. aureus (VRSA) is like lily to be a 
clinical problem before the turn of the century. 
How to deal with VRSA? At this moment no therapeutic alternatives for VRSA are available. 
No new antibiotics are on the horizon. One application of an already existing drug may be the 
combination of amoxicillin and clavulanic acid. The theory behind this is that amoxicillin and 
penicillin have a high affinity for PBP-2A. Clavulanic acid inhibits the fl-Iactamase and 
therefore the combination would be an effective therapy. This is confirmed by in-vitro and in-
vivo findings. In an animal model of MRSA endocarditis, ampicillin/sulbactam was an 
effective therapy,21n another study it was even more effective than vancomycin,1 However, 
until now no clinical studies have been performed. Do we have to wait for the first VRSA, or 
should a clinical trial with less severe MRSA infections be performed now? 
Another important question is, how to optimalise preventive strategies? Since VRSA most 
likely will have an epidemiological behaviour like MRSA, surveillance and isolation policies, 
as now performed in the Netherlands, could be effective. However, it is necessary to develop 
additional preventive strategies. Carriage plays a crucial role in the spread of S. aureus. 
Some people nearly always carry S. aureus, most people do so intermittently, while others 
never carry it at all. The underlying mechanisms are not understood and might offer a tool for 
new preventive measures, Besides the development of new antibiotics, prevention may be 
the most important way to deal with S. aureus infections in the near future. Further studies 
are needed to optimalize preventive strategies. 
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INTRODUCTION 
Staphylococcus aureus has long been recognized as an important pathogen in human 
disease. Staphylococcal infections occur regularly in hospitalized patients and have severe 
consequences despite adequate antibiotic therapy.OO.21B Due to an increasing number of 
infections caused by methicillin resistant S. aureus (MRSA) strains, which are now most often 
multi-resistant, therapy has become problematic."'; Therefore, prevention of staphylococcal 
infections is now more important. Carriage of S. aureus in the nose appears to playa key role 
in the epidemiology and pathogenesis of infection. This review, discusses the literature on the 
epidemiology of nasal carriage and the risks associated with it. In addition to presenting what 
is known at this time it also focuses on studies that need to be penormed in order to develop 
optimal preventive strategies. 
CARRIAGE OF S. AUREUS 
Epidemiology. The ecological niche of S. aureus strains are the anterior nares. Elegant 
studies have shown that the nares are the most reliable area to isolate this organism.210 
Moreover, when the nares were treated topically to eliminate nasal carriage. in most cases 
the organism also disappeared from other areas of the body.145.15B Over time, three patterns of 
carriage can be distinguished. Approximately 20% of individuals almost always carry one 
strain and are called persistent carriers. A large proportion of the population (±60%) harbors 
S. aureus intermittently and change strains with varying frequency. Such persons are called 
intermittent carriers. Finally, a minority of people (±20%) almost never carry S. aureus and 
are called non-carriers."" Persistent carriage is more common in children than in adults and 
many people change their carrier-type between the age of 10 and 20 years." The reasons for 
these differences in colonization patterns are as yet unknown. Persistent carriage seems to 
have a protective effect on the acquisition of other strains, at least during hospitalization. '" 
This barrier to colonization is reduced when carriers are treated with antibiotics. 153 These 
findings suggest that the acquisition and transmission of antibiotic-resistant S. aureus in the 
hospital mainly concerns intermittent carriers and persistent carriers treated with antibiotics. 
The prevalence and incidence of S. aureus nasal carriage varies according to the population 
studied. The results of studies on nasal carriage as determined in cross-sectional surveys 
are shown in Table 1. In the general population a mean carriage rate of 37.2% was found. 
However, the range of carriage rates reported is large. This may partly be due to differences 
in the quality of the sampling and of the culturing techniques used in these studies. Also, the 
studies were reported between 1934 and 1994, and changes in S. aureus nasal carriage may 
have occurred over the years. The older studies tend to find higher carriage rates. The rates 
in the general population are comparable to those found in health-care workers and in 
patients on admission and during hospitalization (see Table 1). Some studies however, 
reported increased carriage rates when patients were hospitalized (Table 2). Subgroups of 
patients with significantly increased carriage rates include those with insulin dependent 
diabetes mellitus, on hemodialysis, or continuous ambulatory peritoneal dialysis (CAPO), 
intravenous drug addicts, patients with S. aureus skin infections, and those with HIVlAIOS 
(see Table 1). In the first four groups, the common factor seems to be repeated or long-term 
puncture of the skin by needles andlor intravascular catheters. To confirm this association, 
higher carriage rates were also found among relatively healthy patients receiving repeated 
allergy injections." In patients with S. aureus skin infections it is predictable that high nasal 
carriage rates are found since nasal cultures were taken at the time that S. aureus infection 
was present. However in HIV-positive patients the reason for the higher carriage rates is 
unclear. The studies on HIV cited in Table 1 have excluded HIV-positive intravenous drug 
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addicts since their carriage rate would be expected to be high even in the absence of HIV 
infection. Furthermore, the stage of HIV disease did not seem to influence the carriage rate. 
To control for hospitalization as a risk factor, Weinke et al. '" selected patients with other 
types of chronic disease as controls, but nevertheless, the carriage rate in HIV-positive 
patients was higher. They proposed that immunological defects were the basis for the higher 
carriage rate in HIV patients. However, the exact nature of these defects remains to be 
elucidated. In addition to the groups mentioned above there have been some anecdotal 
reports on other groups with high S. auraus carriage rates. Decker et al." found a carriage 
rate of 65.6% in river rafting guides. In this group the S. auraus infection rates were also high. 
Maceration of the skin caused by prolonged contact with water, together with repeated small 
skin injuries, were the proposed reasons. Finally, Gittelman at al. ro found high carriage rates 
in patients with rhino-sinusitis. 
Table 1: Rates of S. aureus nasal carriage in various populations. + 
Population N carriage rate references 
mean range 
General 13,873 37.2% 19.0-55.1 27,38,55,62,83,99,118,123-125, 
135,137,162,178,186,213 
Health care workers 2,568 26.6% 16.8-56.1 37,46,98,100,113,144,162 
Patients on admission* 21,842 35.7% 10.2-85.0 37,70,100,138,160,163,184,212 
Patients hospitalized 3,879 29.8% 14.3-52.5 14,98,100,102,108,144,153 
Diabetes mellitus 
insulin dependent 454 56.4% 24.1-76.4 15, 107, 122, 178, 194 
non-insulin dependent 434 29.0% 11.1-35.0 27, 107, 178, 194 
controls 1,035 32.2% 9.1-44.3 27, 107, 178 
Dialysis 
Hemodialysis 454 51.5% 30.1-84.4 15,61,85,88,131,159,193,217 
CAPO 605 43.3% 16.8-51.4 39,110,142,150,171,172 
Chronic renal fallure only 38 21.1% 14.3-33.3 61,88,193 
Drug addicts (DA) 
Intravenous DA 288 55.2% 33.8-61.4 15, 195 
non-intravenous DA 603 25.9% 9.1-49.0 15,195 
S. aureus skin lesions 1,439 65.9% 42.0-100 72,101,134,182 
HIVIAIDS 
HiV positive 664 35.5% 26.9-54.7 10,13,59,157,207 
controls (HIV negative) 508 20.9% 17.2-30.8 10,13,59,157,207 
+ Only studies in which prevalence rates of nasal carriage of S. aureus were determined are included. 
* For admission rates of surgical patients see also Table 3. 
Molecular basis of the carrier-state. Although S. aureus can be cultured from multiple sites 
of the skin and mucosal surfaces of carriers, the primary reservoir of staphylococci is thought 
to be the vestibulum nasi or anterior nares, the nostrils of the nose. Inside, this part of the 
nose is lined by a fully keratinized epidermis that presents hairs, sebaceous glands and 
sweat glands. The vestibule is limited above and behind by a ridge, the limen nasi, over 
which the skin becomes contino us with the nasal mucous membrane. Apparently, the 
staphylococcal cells flourish here in the relative absence of human defenses and/or they are 
capable to withstand the local antibacterial defenses. In order to adhere, bacterial cells need 
to establish firm interactions with the various types of human cell surfaces, thus preventing 
their rapid elimination by physicochemical mechanisms. To establish successful colonization 
it is thought that surface components of the staphylococcal cell interact with counter 
components on the membranes of the eukaryotic host cells. Bacterial adherence may be non-
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specifically mediated via physicochemical forces including hydrophobic interactions." 
Alternatively, adherence may more specifically be accomplished through binding of certain 
bacterial cell surface moieties (adhesins) to defined structural receptors in the membrane of 
the host cell. A wide array of staphylococcal and host cell determinants have been studied at 
the molecular level in a similarly diverse array of test systems. Table 2 shows factors that 
have been found to be associated with carriage of S. aureus. There appear to be differences 
in adherence between S. aureus strains and between nasal epithelial cells from different 
individuals. S. aureus has a greater affinity for nasal epithelial cells obtained from carriers 
than from noncarriers.5 In addition, S. aureus adheres better to nasal epithelial cells from 
patients with eczema than to cells from patient without eczema.' Also nasal carriage may be 
associated with certain HLA antigens such as DR3, but not with othersY 
Table 2: Factors which may influence the rate of S. aureus nasal carriage. 
Factor 
Adherence to epithelia which is mediated/influenced by: 
Lipo-teichoic acid in S. aureus cell wall 
Surlace associated proteins in S. aureus cell wall 
Carriers versus non-carriers 
Viral infections of the upper respiratory tract 
Nasal abnormalities 
HLA type 
Ecology of nasal flora 
Race 
Age 
Genetic 
Immunological factors 
Repeated needle injections 
Hormonal status in women 
Hospitalization 
references 
2,30 
56 
5 
51 
83 
87 
104, 119 
124,135, 162 
11, 138 
77 
47 
88,89,195 
213 
62,136,144,176,212 
This section will focus on the interaction of S. aureus with epithelia, especially from the 
airways. Also included are studies of their interaction with other cells including the endothelial 
and mesothelial cells that line the vascular bed and major body cavities, respectively. The 
adherence of microorganisms to extracellular matrices of the body was recently reviewed 
elsewhere. g6 
Adherence to airway epithelium. Staphylococci have been shown to adhere well to cells 
scraped from the anterior nares of healthy volunteers,6.9.16'lP 7,200 patients with dermal 
pathologies' and geriatric patients.'" The molecular basis of staphylococcal adherence to 
this site has only partially been elucidated. Host factors are important ~ince early studies 
have shown that recolonization with strains that had been present before is virtually 
impossible. This rejection after reinoculation is indicative for a local immune response.47 The 
involvement of age and genetic background was shown in these and other studies.'·" 
Epithelial antibiotic substances have recently been discovered and they may playa role in the 
prevention of the S. aureus carrier state. 163 
Eukaryotic surface glycoproteins and proteoglycans, present on the mucous membranes, 
contribute to the adhesion of bacteria. There is considerable heterogeneity among nasal 
cells in participating in the adherence of bacteria. Mucin-coated cells seem to adhere 
staphylococci much better than cells without such carbohydrate coat. on Staphylococci will 
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bind to bovine mucin and to mucus in a ferret model of adherence,166.191 but they do not seem 
to adhere to the ciliated cells of the airway epithelium. Other substances found in the 
respiratory tract including secretory IgA,"glycolipids" and surfactant protein Am may also 
constitute receptor sites for staphylococcal adherence. Interestingly, S. aureus was recently 
found to adhere better to a bronchial cystic fibrosis cell line (genotype aF508/w1282X) than 
to matched rescued control cells. Increased binding was to the tetrasaccharide [GaI1.l1-
3GaINacI.l1-4GaI.l1-4Glc] of the asialoganglioside 1 (aGM1). More aGM1 is produced and 
excreted apically by cystic fibrosis epithelia because these cells have impaired 
sialyltransferase activity." The importance of carbohydrates in receptor molecules on the 
surface of epithelial cells is further evidenced by the loss of staphylococcal adherence to 
periodate-treated mucins. m However, hydrophobic interactions and surface charge provide 
forces that are likely involved as well in mediating staphylococcal binding to epithelia.",·,,,·m 
There is significant interindividual variation with higher rates of staphylococcal binding being 
observed for carriers than for non-carriers of S. aureus,8 for older babies than for neonates in 
the first week of life,' for Influenza A virus-infected volunteers compared to control uninfected 
cells" and for moderately ill geriatric patients compared to elderly patients that are seriously 
iII. 161 The dynamic processes underlying these variations in staphylococcal adherence are 
largely unknown. In an in vitro system using canine kidney cells Sanford et al.'" found 
Influenza A virus to induce more and new plasmamembrane receptors for S. aureus binding; 
these receptors were distinct from the hemagglutinins that are also induced by the virus. 
There is no consensus on the surface components of S. aureus that mediate binding to 
epithelial membranes. Cell wall teichoic acid, lipoteichoic acid, fibronectin binding proteins, 
heat-labile and heat-extractable proteins, and even type 5 and type 8 capsular poly-
saccharides have been proposed as major ligandsyo.165.1Bl Purified capsular polysaccharides 
bound well to a human epithelial carcinoma cell line in vitro and induced these cells to 
produce cytokines. 181 However, there is no direct evidence of capsule-mediated adherence of 
staphylococci to epithelial cells. In studies using nasal epithelial cells free teichoic acid 
blocked binding of staphylococci to fully keratinized cells whereas fibronectin partially blocked 
adherence to keratinized cells but not to spinous or low granular epithelial cells,' probably by 
masking teichoic acid binding sites. Staphylococcal adherence is better to the fully matured, 
i.e. keratinized, cells than to granular or spinous cells present deeper in the epidermis.' 
However, pretreatment of the bacteria with proteolytic enzymes, with heat (> 100 0c) or with 
the protein synthesis inhibiting antibiotic clindamycin will reduce their adherence to epithelia 
and to mucin indicating that surtace proteins may be involved as weI1.6.31),174.177 S. aureus 
protein A is probably not involved since isogenic spa-mutants adhered as well as the parent 
strain to Hep-2, Vero and mesothelial cell monolayers.'" Mutation to agr-, however, 
increased staphylococccal adherence twofold indicating that a cellular product is involved that 
is produced during the exponential phase of growth; the gene for this product is in the vicinity 
of the mec gene.'" In contrast to the adhesins for cellular surfaces, protein A and other 
surface proteins that are adhesins for extracellular matrixproteins have been characterized in 
detail; these adhesins recognize, among others, fibronectin, fibrinogen and collagen, and 
have been described as 'microbial surtace components recognizing adhesive matrix 
molecules' (MSCRAMMs)(see reference 146). 
Adherence to bovine mammary gland epithelium. Since S. aureus is one of the major 
pathogens causing mastitis in cattle its adherence to epithelia from the bovine mammary has 
been studied in some detail. S. aureus adheres well, better than most other bacterial 
species, to these epithelial cells. Especially to cells higher up in the gland. Again, not all cells 
participate in the binding of staphylococci; staphylococci only attach to the non-villiated, 
domeshaped, hexagonal cells that seem capable of secretion." The adherence of bacteria to 
the keratinized cells of the teat canal varies with the origin of the cells,''' and is reduced by 
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pretreatment of the bacteria with proteolytic enzymes. Recently a cell wall protein of 145 kDa 
was isolated from a strain of S. aureus that could bind to mammary epithelial cells.'"' 
Interestingly, the adhesion of the bacteria becomes enhanced when bacteria are grown in 
milk-whey instead of in broth. In this circumstance adherence is trypsin-resistant but 
periodate-sensitive indicating that the putative adhesin(s) is of a largely carbohydrate 
nature. '" Adhesion of staphylococci to fat globules in milk has also been demonstrated, and 
it is proposed that such binding promotes dissemination of the bacteria in the mammary 
gland. Although antibody against whole bacteria can block staphylococcal adherence to 
epithelial cell lines derived from high ductular tissues, the surface epitopes involved in 
binding have not been further delineated. '" Thus, the relative contributions of non-specific 
physicochemical interactions and specific interactions between staphylococcal cell wall-
associated moieties and host receptors remain unknown. 
Adherence to endothelium and mesothelium. Staphylococci regularly invade the bloodstream 
and the large body cavities where they encounter endothelial and mesothelial cells, 
respectively. Again, S. aureus avidly binds to these cellular surfaces and may even enter the 
cells."·'" Early studies by Gould et a/. showed extensive staphylococcal adherence to canine 
and human cadaveric heartvalves." Binding to the surface of endothelial cells is probably 
mediated to a large extent by fibronectin since this endothelium-derived molecule is 
ubiquitously present in the vascular space and S. aureus has adhesins for this protein. N1.203 
Fibronectin seems to bind an uronic-amine exopolysaccharide at some distance from the 
electron-dense cellwall. Fibronectin binding to teichoic acid has been reported.' Interestingly, 
data suggest that efficient binding of S. aureus to endothelium is an active process which 
likely requires the synthesis of proteins by the endothelial cells.'" Thus, staphylococcal 
adherence is reduced at 4 'C and if endothelial cell have been preincubated with 
dactinomycin; adherence increases when cells are prestimulated by interleukin-1. Adherence 
can also be modulated by growth factors.N 
The role of fibronectin in mediating S. aureus adherence to mesothelial cells is in doubt.69.154 
It has been shown that antHibronectin antibody reduces adherence of S. aureus to 
fibronectin to a greater extent than to mesothelial cells suggesting an additional receptor site 
on mesothelial cells. Free lipoteichoic acid consistently interfered with staphylococcal binding 
to mesothelial cell monolayers making this cell wall component a likely adhesin-candidate." 
In summary one can conclude that the molecular determinants of S. aureus adherence to 
human epithelia remain to be fully described. As long as such insight into S. aureus 
adherence is lacking, a valid explanation for the carrier state in some individuals and not in 
others, cannot be given. 
Carriage of MRSA. Risk factors for acquisition of MRSA include the administration of multiple 
antibiotics.2t;,36.141 The nasal bacterial flora is modified when systemic antibiotics are given:~ 
Interestingly, older data indicate that increased environmental contamination with penicillin 
was an important risk factor for colonization of the nares of hospitalized patients with 
penicillin-resistant staphylococci or for the transmission of penicillin-resistant S. aureus to 
other patients.'" It has also been shown that administration of tetracycline to patients 
colonized with a tetracycline-resistant strain of S. aureus induced dispersal of the organism in 
the environment" thus contributing to their further spread. MRSA are usually resistant to 
several groups of broad-spectrum antibiotics which are used on a large scale in the hospital. 
This mechanism of increased spreading under antibiotic pressure may have contributed to 
the worldwide increase of the prevalence of MRSA in hospitals."'; 
Molecular typing of S. aureus strains from carriers. An important topic in nasal 
colonisation studies concerns the population characteristics and dynamics of the resident S. 
aureus strain(s). Major questions are whether or not a persistently colonised individual is 
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always inhabiting the same strain, whether strain exchange or replacement can be observed, 
and if persistent strains share certain genetic characteristics which set them apart from the 
strains that display intermittent colonisation only. For answering these questions, medical 
microbiologists have a broad spectrum of technical instruments at their disposal. Varying from 
techniques that monitor phenotypic characteristics to those that involve genetic procedures 
which highlight DNA polymorph isms (for a review, see reference 120). Testing of sensitivity to 
restriction-sensitive bacteriophages is, among the phenotypic procedures, considered to be 
the golden standard. Unfortunately, most laboratories are not equipped to handle phage 
typing, and this technique can only be employed succesfully if performed in an experienced 
reference laboratory.12O Even in this setting a number of strains can not be evaluated since 
they are untypable. DNA-typing procedures are easier to perform and most are able to type 
all strains. Although more easy to handle than phage typing, they are not yet available in 
most routine microbiology laboratories.l92 Genotypic procedures can lead the way to 
elucidating the molecular genetics of colonising S. aureus populations. Especially DNA-typing 
procedures are being applied with increasing frequency and have been proven quite valuable 
for assessing clonality among given strains of many bacterial species including (methicillin-
resistant) S. aureus. 18-3 For staphylococci in general, comparative molecular typing has been 
the subject of a number of recent studies.~·""'" From these studies it was deduced that DNA 
analysis, either by peR mediated techniques or pulsed-field gel electrophoretic separation 
(PFGE) of DNA macrorestriction fragments, can be applied successfully once the techniques 
have reached a sufficient level of reproducibility. This is generally coupled to an excellent 
degree of resolution among non-related strains, whereas epidemiologically clustered isolates 
are identified as being identical. Using these relatively novel techniques in studies of nasal 
populations of S. aureus may provide interesting new insights. At present this type of studies 
is still limited in number (see below). Although most epidemiological studies on S. aureus 
focus on monitoring the spread of particular strains,92,113 sometimes strains isolated from the 
nasal cavities of multiple persons have been analyzed. A recent Japanese study revealed 
that within individual carriers the same strain could be identified upon every positive 
culture." Although this is in contradiction with old data obtained by phage typing of 
staphy[ococcal iso[ates,71 the authors suggest that recolonisation of the anterior nares rarely 
occurs. It is also suggested that bacterial interference may lead to non-carriership: when an 
ecologica[ niche is already occupied, for instance by coagulase negative staphylococci, S. 
aureus does not have the means to replace the resident bacterial population. A recent study 
from our laboratoryl93 revealed that among Danish volunteers, who were longitudinally 
examined for nasal carriership of S. aureus. several "carrier states" could be distinguished. 
Persons could be classified as either persistent (>8 positive cultures upon 10 examinations) 
or intermittent (60-80% positive cultures) carrier; occasional carriers were positive on 10-40% 
of the occasions only. All strains were analyzed phenotypically by phagetyping and by 
measuring the amount of surface-exposed protein A. Genetic typing was done with random 
amplification of polymorphic DNA (RAPD) and restriction fragment length polymorphism 
(RFLP) analysis of the coagulase and protein A genes.""" Based on all results no common 
genetic or phenetic characteristics segregating persistent from intermittent or occasional 
colonisers could be identified. Both protein A and coagulase gene polymorph isms did not 
correlate with the type of carrier state. Apparently, polymorphisms in these genes do not 
seem to play a significant role in the propensity of S. aureus to colonise human nasal 
epithelium. 
The number of studies on the molecular epidemiology and population dynamics of nasal 
populations of S. aureus are still limited in number. Additional analyses are required, the data 
of which may open novel pathways for elimination of resident strains. 
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Application of molecular typing techniques in prevention of nosocomial S. aureus 
infections. Another application of typing techniques is to elucidate the epidemiology of S. 
aureus infections in the hospital environment. Historically, S. aureus has been an example of 
cross-infection.211 Carriers among health care workers or patients have been identified 
frequently as the source of outbreaks. However, other data show that many S. aureus 
infections have their origin in the patients' endogenous flora (see other parts of this review). 
How to deal with S. aureus infections in the hospital setting? The basis of infection control is 
surveillance. This means that the rates of nosocomial infections should be monitored on a 
permanent or semi-permanent basis.w In case of increased rates, either epidemic or 
endemic, the isolates cultured from infections should be typed. In order to be able to do this, 
the microbiology laboratory should store all relevant clinical isolates routinely, for some time. 
When typing results show that there is a high level of clonal relatedness among the strains, 
the investigation should be aimed to identify a common source. However, if there is no 
relatedness among the strains, it is unlikely that there is a common source and therefore, the 
investigation should be directed into another way, for instance looking for breaks in hygienic 
procedures or surgical techniques. For these kind of investigations molecular typing methods 
have proven to be fashionable and reliable. Also it is possible to type nearly all kinds of 
pathogenic micro-organisms using only one procedure.199.200 The application of typing 
procedures has enabled to target epidemiological investigations, and is an important 
instrument in the prevention of nosocomial infections. 
CARRIAGE OF S. AUREUS AS A RISK FACTOR FOR INFECTION. 
Carriage of S. aureUs has been identified as a risk factor for the development of infections in 
various settings (see Table 3 and 4). This has been studied extensively in surgical patients, in 
patients on hemodialysis and, to a lesser extent, in patients on CAPO. Also, anecdotal 
reports have been published for intravascular device-related bacteremia, S. aureus 
bacteremia in HIV-positive patients and about a higher relapse rate in patients with Wegener 
granulomatosis. Carriage of MRSA constitutes a special problem with regard to prevention 
and treatment of infection. Elimination of nasal carriage would theoretically reduce the 
infection rates in populations in which it has been identified as a risk factor. The literature 
available on these subjects will be reviewed in the following sections. 
Surgery. Probably, one of the first observations pointing to the endogenous source of 
bacterial wound infection was made in 1915 by Sir Almroth E. Wright.'" In a report on wound 
infection during world war I, he made the following statement: "During this war every wound is 
heavily infected. The chain of cause and consequence seems to be as follows: The clothes 
and skin of the soldier on war service become contaminated with all manner of filth containing 
pathogenic organisms and spores; the projectile takes these in with it, and it implants them 
far in-in point of fact, far beyond the reach of any prophylactic applications of antiseptics". 
This description is not entirely of an endogenous infection because it implies that most of the 
infecting organisms were contaminating the skin and clothes before they were inserted and, 
thus, were not part of the soldiers' endogenous flora. Nevertheless the description of the 
route of infection is clearly endogenous. In surgical procedures this transmission-route is 
prevented largely by disinfection of the surgical site before incision and covering the patient 
with sterile drapes. Despite these preventive measures a clear correlation exists between 
carriage of S. aureus and the development of S. aureus surgical wound infections. This 
relation was established first in the late 1950's. The major reason for the studies in those 
years was a pandemic of serious staphylococcal infections both in the community and in 
hospitals, '" which involved strains that were resistant to many of the antibiotics available at 
that time. Resistance was considered to enhance the spread and virulence of S. aureus in the 
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hospital.'"''' A great number of studies were pertormed to gain insight into the epidemiology 
of S. aureus in both the community and in the hospital in order to develop preventive 
strategies. For those purposes it was important that phage typing was available, enabling 
comparison of S. aureus isolates. Cross-infection was the primary focus of attention and 
much was learned about the relative importance of patients, health-care workers and the 
environment (both fomites and air) in the transmission of S. aureus (For a comprehensive 
review see reference 211). At some point, the observation was made that some patients 
developed infections with S. aureus strains that had been isolated previously at other sites 
from the same patient and not from other potential sources in the environment. In 1959, three 
independent reports were published which had investigated primarily the relation between 
nasal carriage of S. aureus and the development of surgical wound infections.33.2l.<a.212 In the 
next decennium a number of studies followed, most of which showed a significantly increased 
risk for development of a wound infection by nasal carriers as shown in Table 3. The causal 
relationship was strengthened by showing a correlation between the colonization density of S. 
aureus at the carriage site and the risk for the development of infection as demonstrated by 
Calia et al.," White et al.,"" Bruun," and Kluytmans et al."' Typing of S. aureus showed that a 
variable proportion (30 to 100%) of infections was due to endogenous strains (Table 3). The 
variations between the risk-ratios and proportions of infections due to endogenous strains in 
various studies may be due to differences between the patient populations, the types of 
surgery pertormed, and the perioperative care such as preoperative length of hospitalization, 
antisepsis, asepsis and the perioperative use of systemic antibiotic prophylaxis. These 
factors can influence the overall infection rate, the risk of cross-infection, and probably also 
the degree of endogenous infection. Also the sensitivity of the culture technique employed 
has to be taken into account. As mentioned before the risk of infection correlates with the 
number of staphylococci in the nose. Therefore, studies which use a very sensitive culture 
technique will identify more carriers which are not at increased risk, which will result in a 
lower relative risk. In spite of these differences, it is clear that there is a certain amount of 
endogenous infection with S. aureus in nearly every surgical setting. Considering the results 
of the most recent studies, the proportion of endogenous S. aureus infection as opposed to 
cross-infection may even be higher today than formerly. If the results from the 14 studies 
pertormed unti111970, shown in Table 3, are combined there were 467 S. aureus infections in 
5030 carriers and 348 in 6844 non-carriers. This results in a relative risk of 1.8 with a 95% 
confidence interval from 1,6 to 2.1 for carriers. In the four studies pertormed in the 1990s, 50 
infections were observed in 628 carriers and 33 in 2962 non-carriers, giving a relative risk of 
7.1 with a 95% confidence interval from 4.6 to 11.0. It is not unreasonable to state that the 
risk of cross-infection in the setting of modern hospitals is lower than in the earlier 
investigations. Important improvements have been made in the design of the operating 
theater, the surgical procedures, the administration of perioperative antibiotic prophylaxis, 
and aseptic perioperative care. Therefore, the current importance of nasal carriage of S. 
aureus as a risk factor in various populations of surgical patients, deserves further evaluation 
since it could have important implications for prevention. 
Hemodialysis. Infection is a major cause of morbidity and the second most common cause 
of mortality in hemodialysis patients'M S. aureus is the most frequently isolated pathogen, 
causing infection at the vascular access site which is often associated with bacteremia. In 
Table 4, four studies are shown which evaluated the importance of nasal carriage for the 
development of S. aureus infections in patients on hemodialysis. The infection rate was 
higher in carriers in all studies, with relative risks varying from 1.8 to 4.7. In another study S. 
aureus isolates in carriers and those isolated from the site of S. aureus infection were typed 
(phage- and plasmid-typing) and compared." From 12 infectious episodes, 11 S. aureus 
isolates were identical to the one previously isolated from the patients nares. It can be 
Table 3: Nasal carriage of S. aureus as a risk factor in surgical patients. Ie! 
Reference Infections/patients 
no year no S. aureus carriers non-carriers Relative 95% confidence Identical types 
patients carriage-rate (%) risk interval in carriers 
33 1959 348 30 15/104 51244 7,0 2,6 -18,9 100% 
208 1959 125 34 16/43 9182 3,4 1,6 -7,0 91.7% 
212 1959 1319 52 47/687 13/632 3,3 1,8 - 6,1 59.6% 
155 1960 3056 27 73/821 158/2235 1,3 1,0 -1,6 42,9% 
73 1961 413 46 15/190 41223 4,4 1,5 -13,0 nd 
116 1961 187 40 12/74 11/113 1,7 0,8 - 3,6 nd 
12 1963 520 85 24/442 6178 0,7 0,3-1,7 58% 
2480 55 30/1371 25/1119 1,0 0,6 -1,7 30% 
74 1963 100 68 6/68 2/32 1,4 0,3 - 6,6 50% 
79 1963 330 17 6/57 12/273 2,4 0,9-6,1 33,3% 
86 1963 430 42 57/181 15/249 5,2 3,1 -18,9 94,7% 
209 1963 451 23 20/106 28/345 2,3 1,4 - 4,0 nd 
9 light 4/42 28/345 1,2 0,4 - 3,2 
6 moderate 5/26 28/345 2,4 1,0 - 5,6 
8 heavy 11/38 28/345 3,6 1,9 - 6,6 
106 1967 146 46 25/67 16179 1,8 1,1-3,2 nd 
29 1969 269 36 16/96 16/173 1,8 0,9 - 3,4 100% 
11 light 2129 16/173 0,7 0,2 - 3,1 
12 moderate 3/31 16/173 1,0 0,3 - 3,4 
13 heavy 11/36 16/173 3,3 1,7 - 6,5 
28 1970 2260 48 104/1093 28/1167 4,0 2,6 - 6,0 nd 
" 15 heavy 65/336 28/1167 8,1 5,3-12,3 126 ~ 
1993 306 15 8/47 4/259 9,4 2,9 - 30,2 91% ;;: 
1980 21/264 19/1716 7,2 3,9 - 13,2 100% " 90 1995 13 Si 
164 1996 1049 24 15/248 81801 6.1 2,6-14.1 87% 
" 94 1996 255 27 6/69 2/186 8.1 1.7-39.1 nd iii
9 light 0/23 21186 na ~ 
18 heavy 6/46 21186 12,1 2,5 - 65.4 .., ~ 
Table 4: Nasal carriage as a risk factor in other categories of patients. ~ 
reference 
'2 
no year carriage site of a no non- ~ 
a 
patients rate (%) infection carriers+ carriers+ RR 95% CI remarks Gl 
"' CAPO ~ 172 1982 30 33 exit site 8/10 4/20 4.0 1.6-10.1 ~ 
peritonitis 7/10 1/20 14.0 2.0 - 98.7 
'" G 39 1989 87 23 exit site 14/20 7167 6.7 3.1-14.3 
" 171 1989 43 65 peritonitis 16/28 0115 n.a. '" 
'" 110 1990 140 45 exit site 22163 2177 13.4 3.3 - 55.0 a <"l 
peritonitis 11/63 On7 n.a. '" OJ
tunnel 5/63 2177 3.1 0.6 -15.2 0 
150 1993 138 51 exit site 81n1 31167 2.1 1.7-2.8 ;:; 
peritonitis 38n1 9/67 4.0 2.1-7.6 :t 
tunnel 23m 12167 1.8 1.0 - 3.3 ~ 
111 1993 167 17 all 24/28 18/139 6.6 4.2 -10.5 MRSA carriage and infections only ~ 
Hemodialysis Gl en 
159 1975 32 84 access 8/27 1/5 1.8 0.3 -11.7 a 
." 
61 1978 40 35 all 10/14 10/26 1.9 1.1-3.3 Skin carriage was evaluated co 
"" 217 1986 86 70 all 12/26 3126 4.0 1.3 -12.5 34 carriers are not included since they §5 
were treated for elimination of carriage ~ 85 1988 70 51 access 5/36 1/34 4.7 0.6 - 38.4 
HIVfAIOS 
207 1992 136 53 bacteremia 8n2 0/64 n.a. 
Intravascular device associated bacteremia 
180 1990 107 14 bacteremia 7/15 6/86 6.3 2.6 -17.2 
156 1996 488 30 bacteremia 321147 6/341 12.4 5.3 - 29.0 
MRSA in longwterm care 
129 1991 197 16 all 8/32 6/132 5.5 2.0 - 14.7 
MRSA in intensive care 
121 1994 484 4 all 5/19 6/465 20.4 6.8 - 61.0 
156 1996 488 13 bacteremia 24/63 8184 4.0 1.9-8.3 M RSA-carriers versus MSSA-carriers 
24/63 61341 21.7 9.2 - 50.8 M RSA-carriers versus non-carriers 
Relapse rate in Wegener granulomatosis 
183 1994 57 63 relapse rate 21/36 2121 6.1 1.6 - 23.6 I::: 
.. Episodes of S. aureus Infection/number of patients 
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concluded that patients on hemodialysis have an increased S. aureus. carriage rate and that 
most S. aureus infections in this setting are of endogenous origin. 
CAPD. In patients treated with CAPD, S. aureus infections constitute frequent and serious 
problems, being the leading cause of exit site- and tunnel-infection, often leading to catheter 
[088. 109,151,220 The first study reporting an association between carriage of S. aureus and an 
increased infection rate in CAPD was performed by Sewell et al., in 1982.'" Several others 
followed with the results shown in Table 4. The observed relative risks for carriage are even 
higher than in hemodialysis patients (range: 1.8 to 14.0). As shown in Table 4 several studies 
looked at the risk for infection at various sites (exit site, peritoneum, and tunnel track). All 
sites were at increased risk in carriers. In addition, some studies used typing methods to 
compare S. Bureus isolates from carriage sites with isolates from infections. Luzar et al. 1tO 
found identical isolates in 85% of the patients with infections. Pignatari et 81.149.150 showed 
that in 6 patients with 8 episodes of peritonitis caused by S. aureus, all isolates from the site 
of infection were identical to strains isolated previously from carriage sites. The same 
observation was made by Sessa et al. no in 8 patients with S. aureus peritonitis. These results 
show that patients on CAPD are like those on hemodialysis, in that the carriage rate is high 
and that S. aureus carriage is an important risk factor for the development of S. aureus 
infections. 
HIV, AIDS-related complex (ARC) and AIDS. In patients with ARC and AIDS, increased 
rates of S. aureus bacteremia, deep soft tissue infections and recurrent S. Bureus infection 
have been observed.8-I·179,214 In one of these studies, observations were made in a group of 
patients without other known risk factors for S. aureus infection (e.g. no intravenous drug 
abuse). Theoretically the higher infection rates may be due, in part, to impaired 8-cell 
immune function. However, Ganesh et al.59 found a higher carriage rate of S. aureus in 
asymptomatic HIV-positive homosexuals compared with HIV-negative homosexuals (carriage 
rates: 49 and 27%, respectively, P<0.05). Weinke et al."" studied the carriage rates in 136 
HIV-positive patients with various stages of progression of disease (23.5% asymptomatic, 
26.5% ARC, and 50% AIDS). The carriage rate was somewhat lower in homosexuals 
(40.2%) than in intravenous drug addicts (52.9%), giving an overall rate of 44.1 %. The rate 
was not influenced by the CD4 cell count nor by granulocytopenia. Nevertheless, a higher 
rate was observed in patients with ARC or AIDS compared with HIV-positive, asymptomatic 
patients. In other hospitalized patients with various chronic diseases, a carriage rate of 
30.8% (P>0.05) was found and in hospital staff the rate was 23.4% (P<0.05). Therefore, the 
increased S. aureus infection rates in HIV-positive patients could in part be related to the 
high carriage rates of S. aureus in these patients. In the same report, it was found that S. 
aureus septicemia occurred only in carriers (fable 4) which was statistically highly significant. 
Therefore, in HIV-positive patients carriage rates are also increased and this is a risk factor 
for subsequent infection with S. aureus. It should be noted that the carriage rates in HIV-
positive patients may even be higher than those actually observed if there was not such a 
widespread use of antibiotic prophylaxis (e.g., cotrimoxazole for Pneumocystis cariniI) and 
antibiotic therapy in this particular group of patients. The growing number of HIV patients 
warrants more studies to establish the importance of nasal carriage for development of 
infection in this group of patients. Furthermore, the underlying mechanism of increased 
carriage in this group of patients remains to be elucidated. 
Intravenous device associated bacteremia. After coagulase-negative staphylococci, S. 
aureus is the second most prevalent organism causing intravenous device-associated 
bacteremia.m .167 However, no study has been performed with the primary aim of establishing 
the role of S. aureus nasal carriage in this important setting. Lipsky et al. '" have studied the 
relationship between nasal carriage and intravenous therapy-related phlebitis. They did not 
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find a correlation, but commented that most of their cases of phlebitis were not infectious but 
physicochemical phenomena. In Table 4 the results from a study by Snydman et al. ,ware 
shown. This study evaluated the incidence and risk factors for the development of nosocomial 
bacteremia in patients treated intravenously with interleukin-2. Twenty of 107 (19%) patients 
developed sepsis and S. aureus was the causative organism in the majority of cases (13/20). 
Carriage of S. aureus increased the risk of S. aureus bacteremia 6.3-fold. Desquamation of 
the skin at the catheter insertion site increased the risk 2.0-fold. If both desquamation of the 
skin and carriage of S. aureus were present a relative risk for S. aureus bacteremia of 14.5 
(95% confidence interval, 4.1 to 50.9) was found. Thus, in this specific population with an 
extremely high rate of bacteremia the role of carriage has been clearly established. In 
general, insertion of intravenous devices is not associated with such a high rate of 
bacteremia but it is likely that carriers of S. aureus will have a higher rate of S. aureus 
bacteremia. Pujol et al. '" looked at bacteremia in an intensive care unit. Most of the S. 
aureus bacteremias were caused by an intravascular device. In this study carriers of S. 
aureus had a relative risk of 12.4 for the development of S. aureus bacteremia (Table 4). 
Again, this correlation should be investigated in further studies because it may have important 
implications for prevention. 
Wegener granulomatosis. Wegener granulomatosis is a systemic disease characterized by 
necrotizing granulomatous inflammation of the upper and lower respiratory tract in 
combination with vasculitis and focal necrotizing crescentic glomerulonephritis.53 Treatment 
with cyclophosphamide and cort'lcosteroids has proven to be successful. After remission is 
achieved the clinical course is highly variable and relapses occur in most patients at variable 
intervals. Stegeman et al. l 8-] have recently reported a significant association between nasal 
carriage of S. aureus and a higher relapse rate of disease (Table 4). Also some anecdotal 
reports have stated that treatment with sulfamethoxazole-trimethoprim had a beneficial effect 
on the course of the disease, '"' which could be due to the reduction of S. aureus carriage by 
the antibiotic treatment. The underlying pathophysiological mechanisms remain to be 
elucidated and the effects of elimination of nasal carriage on the relapse rate should be 
studied more specifically. 
MRSA. The difference between MRSA and methicillin-susceptible S. aureus (MSSA) is 
resistance to ~-Iactamase-stable ~-Iactam antibiotics. Often this is associated with resistance 
to multiple other antibiotics, which limits the therapeutic options. MRSA has become an 
important pathogen in many hospitals. In the United States, the proportion of MRSA has 
rapidly increased over the last decennium, being 29% in 1991.'" In this report it was also 
shown that the prevalence generally increased with the size of the hospital. In Europe an 
interesting variation in the geographic distribution of MRSA is found. The prevalence of 
MRSA increases significantly from northern countries to the countries in the south."" The fact 
that carriage of MRSA poses an increased risk of infection over the risk of carriage of MSSA 
has been suggested by several authors. In CAPO patients, Lye et al.'" found that MRSA 
carriers were at increased risk for MRSA infection compared with non-carriers (Table 4). 
Comparing MRSA carriers with MSSA carriers, they found a higher rate of peritonitis and 
exitsite infection in MRSA carriers. Moreover, in the group of MRSA carriers there was a 
significantly higher number of catheter losses and CAPO patient dropouts. Muder et al.'" 
studied the consequences of MRSA carriage in a long-term care facility. MRSA carriers were 
at increased risk for the development of S. aureus infections. The occurrence of S. aureus 
infections in MSSA carriers was comparable to that of non-carriers. Mest et al. '" found that 
perioperative colonization with MRSA significantly increased the risk for postoperative MRSA 
infection in patients on the intensive care unit. Pujol et 81.156 stUdied the rate of bacteremia in 
patients admitted to the intensive care unit. Patients colonized with MSSA in the nares were 
at a significantly increased risk for the development of S. aureus bacteremia (RR: 5.4, 95% 
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CI: 1.9 to 15.2 compared with non-carriers), but patients colonized with MRSA were at a 
much higher risk (RR: 21,7, 95% CI: 9.2 to 50.8 compared with non-carriers). The risk for 
MRSA carriers was significantly higher than the risk for MSSA carriers (RR: 4.0, 95% CI: 1.9 
to 8.3). After adjusting for other predictors of bacteremia the relative risk for S. aureus 
bacteremia was 3.9 with a 95% confidence interval from 1.6 to 9.8 for MRSA carriers 
compared with MSSA carriers. The conclusion of these studies was that MRSA carriage 
constitutes a greater risk for the development of S. aureus infection than MSSA carriage. 
This could be a result of the resistance itself, of an increased intrinsic virulence of MRSA 
compared with MSSA, or of a more vulnerable category of patients being colonized by 
MRSA. A number of studies have failed to show that the virulence of MRSA differed from that 
of MSSA. These studies involved the in vitro production of extracellular hemolysins, 
enzymes, or toxins147 , intra leukocyte survival, or phagocytic destruction l47.202 as well as 
animal lethality studies."·'" Also, a clinical evaluation comparing the outcome of MRSA- with 
MSSA-infections did not reveal significant differences." Since these studies indicate that 
there is no increased virulence of MRSA over MSSA it is most likely that the increased 
infection rate observed in carriers of MRSA is primarily due to the selection of the population 
of patients who become carriers of MRSA. In view of the rapid increase of the prevalence of 
MRSA and the problems associated with its control and therapy, more insight is needed into 
the epidemiology of MRSA colonization and infection to develop more effective, preventive 
strategies. 
THE PATHOGENESIS OF ENDOGENOUS INFECTION 
The nose is regarded as the major site of S. aureus carriage from where the organisms can 
spread to other parts of the body."'''' Reagan ef a/.'" have shown that elimination of nasal 
carriage by using topical mupirocin also eliminates hand carriage. From these observations it 
can be concluded that the nose provides an environment in which S. aureus can propagate 
and maintain itself for prolonged periods. The proposed pathogenesis for a number of 
endogenous infections would be that from the nose, the skin becomes colonized which 
causes subsequent infection in patients with impaired skin sites; e.g., in hemodialysis21 and 
CAPD patients, and in patients with intravascular catheters. For surgical patients there are 
other possibilities to be considered. First, most patients are intubated prior to surgery, 
traumatizing the epithelial lining of the throat which may cause hematogenous spreading of S. 
aureus to the surgical site. However, many surgical procedures include the use of 
antimicrobial prophylaxis which should protect against this route of infection. Another 
possibility is that S. aureus is dispersed from the nose into the air of the operating room and 
then contaminates the surgical site during surgery. This route of transmission could certainly 
have played a role in the early days of surgery when the air conditions in the operating room 
were not as well controlled as at present. A recent report on endogenous infection as a major 
cause of surgical wound infections90 was conducted in an operating theatre with a laminar 
downflow unit positioned directly over the patient. Therefore, this route is not considered 
likely in the setting of the modern operating room. Finally, skin carriage of S. aureus in 
patients who are nasal carriers could be an explanation for endogenous infection. In nasal 
carriers the skin is often colonized by S. aureus. Preoperative disinfection may not be 
effective in the deeper layers of the skin and, thereby, S. aureus becomes a source of 
infection during surgery. It should be emphasized that these are only hypotheses on the 
pathogenetic mechanisms of S. aureus infection, all of which should be confirmed or refuted 
in further studies. These studies are needed because an optimal preventive strategy can be 
developed only when the pathogenesis is fully understood. 
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EFFECTS OF ELIMINATION OF CARRIAGE ON THE INFECTION RATES 
Elimination strategies. In populations in which S. aureus nasal carriage is identified as a risk 
factor for infection it is conceivable that elimination of carriage would reduce the infection 
rate. Three approaches for elimination of carriage are available. First. the local application of 
antibiotics or disinfectants. Most often used are nasal ointments or sprays. sometimes 
combined with the application of disinfecting agents to the skin. In general, the results have 
been disappointing. Both a low efficacy and a rapid emergence of resistance to the agents 
used was observed. Results of such studies have been reviewed by others.31.1M211 Recently, 
mupirocin (Bactroban, Smith Kline Beecham Pharmaceuticals, Philadelphia, USA), a new 
antibiotic has become available for topical use. This agent has been shown to posses 
excellent efficacy for the elimination of S. aureus carriage and, therefore, has offered a new 
opportunity to eliminate S. aureus nasal carriage. Mupirocin is well tolerated and, when used 
appropriately (application to the nose b.Ld. for 5 days) development of resistance has not 
been reported. The results from a limited number of examplifying studies are reported here. 
A more extensive review of the literature on mupirocin has been published recently by 
Hudson." In a randomized, double-blind place bo controlled multicenter study, Doebbeling 
et al." found that when mupirocin was applied to the nose twice daily for 5 consecutive days, 
this resulted in elimination of carriage in 91 % of stable nasal carriers. Four weeks post-
treatment, 87% of the subjects remained free of nasal carriage. In the placebo group the 
post-treatment elimination rates were 6% and 7% respectively (P<0.0001). A subgroup was 
followed up for one year to determine the long-term efficacy of mupirocin. " At six months the 
nasal carriage rate in the treated group was 48% and in the placebo group 72% (P~0.054) 
and at 12 months the rates were 53 and 76%, respectively (P~0.056). Hand carriage at six 
months was significantly reduced in the treated group relative to controls (15% and 48%; 
P~0.04). The recolonizing strains were subjected to plasmid typing. Thirty-six percent were 
recolonized with a new strain at one year, whereas 34% had the original strain. Resistance to 
mupirocin was not observed. Comparable results were found by Fernandez et al." In the 
studies mentioned above mupirocin was applied to healthy volunteers (health care workers). 
In patients on hemodialysis mupirocin was less effective." A reduction from 90 to 33% 
directly after treatment and to 66% after four months was observed. Apparantly, in this group 
of patients other sites exist were S. aureus can maintain itself. The question remains if 
recolonization by an identical strain is the result of inadequate treatment with mupirocin. This 
would mean that the microorganism is able to persist on other sites of the body. Another 
possibility is that succesfully treated subjects are recolonized from external sources, which 
would not be considered a treatment failure. Although development of resistance to mupirocin 
was not observed in clinical studies for eradication of carriage it has been reported repeatedly 
in the literature. Generally, it was found in cases of prolonged use of the skin-preparation." 
Resistance consists of two types, a low level and a high level resistance. The low-level form 
(MIC from 8-256 mg/L) consists of modifications in the target enzyme. The high level form 
(MIC >500 mg/L) consists of a mupirocin-insusceptible, plasmid-encoded enzyme.'" This 
transmissible mechanism causes concern about the future spread of mupirocin resistance, 
when it is used on a large scale. Therefore restricted usage of this valuable and unique 
antimicrobial agent is recommended, in appropriately selected patients and for short 
courses only. 
A second approach to eliminating nasal carriage is administration of systemic antibiotics. The 
results have been disappointing for most agents. To date only rifampicin has proven to be an 
effective agent, but side effects and the rapid emergence of resistant strains have limited its 
use for this purpose. Chow and Yu have given a comprehensive review on this subject.31 
The third strategy is bacterial interference. That is active colonization with a strain of S. 
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aureus (502A) which is considered to posses minimal pathogenic properties but is able to 
prevent colonization by more virulent strains, presumably by competition for the binding 
sites in the nose. However, the exact mechanism for this effect has never been elucidated.1 
Interference was used successfully in nurseries during outbreaks of S. aureus infections in 
the 1960s and to treat patients with recurrent furuncu[osis.25,1o-3,175,185 However, this approach 
was occasionally complicated by serious infections due to S. Bureus 502A18i14 and even a 
fatal infection was reported." Although the report documenting a fatal outcome concluded 
that "The benefits of S. aureus 502A programs far outweigh their hazards", this strategy was 
not pursued further at that time. In conclusion most strategies to eliminate carriage of S. 
aureus have been disappointing. Mupirocin has offered a new opportunity for this purpose 
and is considered by far the most effective agent available at this time. 
Surgery. The concept of elimination of S. aureus carriage has been studied in surgical 
patients when the risk of carriage became evident. These early attempts were generally 
hampered by a lack of effective elimination methods available at that time. In a report by 
Gould and Allan in 1954" a nasal ointment containing tetracycline was used to treat nasal 
carriers among hospital staff members. After this intervention, a reduction of the S. aureus 
infection rate was observed, which was due to a reduction in the number of infections with 
"hospital staphylococci". When the carriage rate among staff members increased after the 
topical therapy was stopped the number of infections with hospital staphylococci also 
increased. In 1959 Weinstein= reported a study in patients who underwent chest surgery. 
The mean length of preoperative hospitalization in this group was extremely long (4 months). 
Most patients were treated for tuberculosis. Nose swabs were taken when surgery was being 
planned. When S. aureus was cultured, topical treatment of the nose with bacitracin-
neomycin ointment !.i.d. was started and continued until the fourth to fifth postoperative day. 
The overall infection rate in carriers was significantly higher despite the treatment. However, 
these results are difficult to interpret because of the high failure rate of the elimination 
therapy. Nineteen carriers who were treated adequately and had follow-up cultures taken, 
were considered evaluable. Twelve of them converted to negative nasal cultures, seven 
remained positive. The infection rate in the unsuccessfully treated carriers was much higher 
(5/7) than in the succesfully treated carriers (0/12). Although the numbers are small, these 
findings suggest a beneficial effect of elimination of nasal carriage on the infection rate. 
The first double-blind, placebo controlled trial of nasal disinfection using naseptin cream was 
reported by Henderson and Williams in 1961!' They observed no effect on the postoperative 
S. aureus wound infection rate in 850 patients (5.0% among treated and 4.6% among 
placebo patients). Again in this study, a high failure rate of elimination of S. aureus nasal 
carriage was found. Another outcome in this study was a higher S. aureus infection rate in the 
non-carriers in the treated group which approached statistical significance (4.6% versus 
1.1 %, P=0.07). A similar trial was performed by Stokes and Milne.'" They found a S. aureus 
infection rate of 12 (3.9%) of 308 treated patients compared with 16 (5.6%) of 285 placebo 
patients (P=0.34). Also the infection rate in non-carriers who were treated was higher than in 
non-carriers who were not treated (4/207 versus 21193 (P=0,69)) and the failure rate of 
successful eradication of carriage was high. Rountree et al. '" also used naseptin but did not 
use a placebo in the control group. They found a significant reduction of the S. aureus 
infection rate in the treated group (3 (3.5%) of 84 versus 16 (16.0%) of 99, (P=0.007)). The 
differences in the effects observed in these studies may be caused by differences in the local 
epidemiology of S. aureus infections, such as the presence of environmental reservoirs not 
influenced by elimination of nasal carriage. The major drawback of these studies, however, is 
the poor efficacy of the treatments used to achieve the primary target, i.e. elimination of 
nasal carriage of S. aureus. 
As stated above this problem of efficacy is now largely overcome by the introduction of 
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mupirocin ointment in the late 1980s. Using mupirocin as a perioperative prophylaxis in a 
surgical population where the risk factor of nasal carriage was clearly established, a highly 
significant reduction of the surgical wound infection rate was found." All patients underwent 
thoracic surgery in the same department and were under prospective surveillance for the 
development of infections. An historical control group (n~928) was compared with an 
intention-to-treat group (n~868) of which 752 were actually treated. The surgical wound 
infection rate in the control group was 7.3% and was 2.8% in the intention-to-treat group 
(P<O.OOO1). The reduction was even stronger in the treated group (1.7%). In the not-treated 
group after the intervention, the rate (7.4%) was comparable to the control group. These 
results look very promising and await confirmation in a randomized, placebo controlled, 
double blind trial. 
Hemodialysis. Several oral and topical antibiotics have been studied for eradication of S. 
aureus nasal carriage in hemodialysis patients. These studies were summarized by Chow 
and YU.31 Rifampicin has been the most effective oral agent used for this purpose. Yu et al.217 
used rifampicin in conjunction with nasal bacitracin and obtained a significant reduction of 
the S. aureus infection rate in their population of hemodialysis patients. However, a rapid 
emergence of rifampicin-resistant strains was observed. Mupirocin has been evaluated in 
hemodialysis in 6 studies reviewed by Boelaert." Using a short term course of therapy of five 
to ten days, a high elimination rate immediately post-therapy was found (average 87%, range 
76 to 100%). However, in some studies the nares were sampled at three months post-therapy 
and a relapse rate of 20 to 77% was found. Therefore, a schedule of continuous mupirocin 
was proposed by Boelaert et a/.n In a randomized, double-blind placebo controlled trial, they 
treated stable nasal carriers with mupirocin for two weeks !.i.d., and then thrice weekly for a 
total of 9 months. A highly significant reduction in the carriage rate of the treated group (only 
6% of the cultures were positive) was observed, accompanied by a significant reduction in 
the S. aureus infection rate (1/104 patient months among treated and 61147 patient months 
among not-treated (P<0.05)). The administration of mupirocin to nasal carriers was later 
adjusted to an initial course of 5 days !.i.d., and thereafter once a week during the remaining 
period on hemodialysis. Using this schedule a highly effective elimination of carriage was 
achieved and this was accompanied by a four to six-fold reduction in the S. aureus-
bacteremia rate.23.S] Although resistance to mupirocin was observed in only one patient,23 it is 
a point of concern with these prolonged treatment schedules. In conclusion, elimination of 
nasal carriage in hemodialysis patients using mupirocin significantly reduces the S. aureus 
infection rates. 
Bloom et a/. 19 performed a cost-effectiveness analysis of mupirocin in hemodialysis. Two 
preventive strategies were compared. First, screen all patients by a nasal culture every three 
months and treat those with S. aureus with mupirocin for 5 days b.Ld (Strategy 1). The 
second strategy was to treat all patients irrespective of their carrier state with mupirocin 
weekly for 3 days b.Ld (Strategy 2). These strategies were compared with eachother and with 
no mupirocin applications, called treat infection only. The annual savings of strategy 1 per 
1000 dialysis patients were $784,000 and of strategy 2 the savings were $1,117,000. Also 
both preventive strategies prevented death and improved the quality of life. Although, from 
this analysis it could be concluded that the treat all strategy is preferrable, the authors 
comment that the risk of development of resistance with such a widespread use of mupirocin 
is increased. Therefore, strategy 2 may be a better choice. Further studies are needed to 
determine which strategy gives maximal efficacy and minimal development of resistance. 
CAPO. Zimmerman et al.219 studied the effects of intermittent administration of rifampicin in 
patients on CAPO in a randomized controlled trial. Sixty-four patients were randomized, 
irrespective of their carrier state, to receive rifampicin 300 mg b.i.d. for five days which was 
repeated every three months or to receive nothing. No significant differences between the S. 
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aureus colonization rates were observed. Also, there was no significant difference in the S. 
aureus peritonitis rates. In the treated group a statistically significant reduction was observed 
in the time to the first catheter-related infection and the catheter infection rate (both those 
caused by S. aureus and the overall rate). However, in the treated group, resistance to 
rifampicin emerged in four patients compared with none of the control patients. Dryden et al." 
found a reduction of the infection rate after an intervention program which included 
elimination of nasal carriage and stringent aseptic care of the exit site. Because a number of 
measures was taken at the same time the effect of elimination of nasal carriage could not be 
established. Until now two reports have been published studying the effects of mupirocin on 
the infection rate in CAPO patients. Perez-Fontan et al. '" used an historical control group 
and compared it with the results from a group that was cultured three times at monthly 
intervals. If S. aureus was isolated, a seven day course with mupirocin ti.d. was given. Seven 
days after this treatment and monthly thereafter a control culture was performed. If 
recolonization was found a new course of mupirocin was given. The initial efficacy was 100%, 
but recolonization occurred frequently, especially after three months. The S. aureus peritonitis 
rate was significantly reduced but the overall peritonitis rate was not, mainly due to a 
significantly higher rate of peritonitis caused by gram-negative bacteria in the treated group 
compared to the not-treated group. Similar observations were made for catheter exit-site 
infections. Due to the severity of S. aureus catheter exit-site infections, there was a significant 
[ower catheter [ass due to exit-site infections in the treated group. During the two-year study 
period a gradual increase of resistance among S. aureus isolates to mupirocin was observed 
which gives great concern for the future developments in this setting. A[though a historical 
control group was used, the reduction in S. aureus infections is like[y to be caused by the 
application of mupirocin. However, the unexplained observation that the rate of infection due 
to other microorganisms was increased makes these results difficult to interpret. Therefore a 
randomized, placebo controlled double blind multi-center study was performed." Nasa[ 
carriers were treated with mupirocin or placebo ointment twice daily for five days. This was 
repeated every four weeks. [n 1,144 patients screened, 267 carriers were identified (23.3%). 
The S. aureus exit-site infection rate was significantly [ower in the treated group (1 in 99.3 
patient months versus 1 in 28.1 patient months, P~O.006). There was no significant increase 
in gram-negative infections and development of resistance to mupirocin was not observed. 
Why resistance was observed in the previous study and not in this one is not clear. 
Neverthe[ess, the possibility of development of resistance should be taken seriously when 
using mupirocin for prolonged periods such as in CAPO patients. [t can be concluded that 
elimination of S. aureus nasal carriage in patients on CAPO decreases the exit site infection 
rate. The effect on the peritonitis rates remains unclear. 
MRSA. In their consensus review Mulligan et al.'" state that indications for eradication of 
MRSA are to stop an outbreak in a health-care setting, or to prevent recurrent infections in an 
individual. In settings where MRSA is endemic, elimination of carriage has not been found to 
be cost-effective and is, therefore, considered not indicated by these authors. [n an outbreak 
situation, the first goal should be to identify all carriers, including patients and health-care 
workers. Then elimination of carriage should be achieved in all so identified.32,92.130 Most 
reports on the effects of elimination of MRSA carriage in outbreak situations also mention that 
other infection control measures were taken concomitantly. These other interventions may 
have played a significant role to control these outbreaks. One report mentioned the complete 
control of an outbreak when only simple infection control measures were taken,03 while 
several others found that only extensive modification of local infection control practices were 
effective17.26.92,132 Therefore, infection control measures should be accompanied by 
identification of carriers and, subsequently, elimination of S. aureus carriage.215 The effects of 
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elimination strategies in settings were MRSA is endemic have not been studied extensively. 
One study in a surgical intensive care unit reported a significant decrease of the colonization 
and pulmonary tract infection rate when all patients were treated during the first week after 
admittance b.Ld.1M 
GENERAL CONCLUSIONS 
"Among the more chastening chapters in the annals of microbiological research is the story of 
our apparently dismal failure to control the depredations of the staphylococcus. Repeatedly, 
fresh light has been shed upon the habits and habitats of these minute clustered spherules, 
and once outmoded hypotheses about their metabolic mechanisms have been refurbished. 
Yet three quarters of a century after Koch first noted their presence in pus, the staphylococci 
(like Francis Thompson's angels) "keep their ancient places", no less ubiquitous but still 
elusive, and (like Lucifer at least) shockingly endowed with apparantly new, malign 
propensities". This quote is from a manuscript describing the first seven decades of 
staphylococcal research by Dolman, published in 1955." Since then, four decades of 
extensive research have passed and it seems that nothing has changed really. New 
staphylococcal diseases have been recognized, like the toxic shock syndrom, and we are still 
unable to control the spread of staphylococci and the development of resistance. World-wide, 
MRSA-rates have increased dramatically during the last decades. The treat of development 
of resistance to vancomycin, the only antimicrobial agent effective against MRSA, is dooming. 
The worldwide use of vancomycin has increased dramatically over the last years. 
Concordantly resistance in other gram-positive micro-organisms has increased significantly. 
The resistance of enterococci in intensive care units (ICU's) of US hospitals may serve as an 
example. In 1989, <0.5% of enterococci were resistant. In 1992, resistance had increased to 
nearly 8%." It has been shown both in vitro and in animal studies that high-level vancomycin 
resistance can easily be transferred from Enterococci to S. aureus.13S Therefore, it seems 
inevitable that this will also happen in clinical settings. This totally-resistant microorganism 
would have dramatic impact on morbidity and mortality in the hospitalized patients. 
Optimalization of preventive strategies is needed to control staphylococci. Therefore new 
strategies have to be developed or, like Dolman stated, old methods have to be refurbished. 
The ability to control staphylococcal infections in the future will depend on many factors, e.g. 
the development of new therapeutic agents, optimalization of infection control measures, the 
introduction of new medical devices with a reduced risk of infection etc. In this review the 
importance of nasal carriage has been summarized. Nasal carriage of S. aureus plays a key 
role in the development of S. aureus infections. It has been clearly established that it is a 
major risk factor for the development of infection in certain groups of patients (e.g. 
hemodialysis, CAPO, surgery, patients with intra-vascular devices and HIV). The underlying 
mechanisms of nasal carriage are as yet unknown. In view of the benefits to be expected 
from elimination of nasal carriage in groups at risk, the pathogenesis of endogenous infection 
has to be elucidated. Only then can the most effective elimination strategy be developed. For 
this moment mupirocin is the most effective drug available to achieve eradication of carriage. 
However, resistance to mupirocin is increasing and it has to be questioned for how long this 
unique agent will be effective. One strategy which has been used succesfully in the past is 
bacterial interference. This alternative approach to controlling staphylococcal infections 
could offer new opportunities if a strain with minimal virulence and maximal competion for the 
binding sites in the nose was developed. 
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SUMMARY 
Fifty-nine isolates of Staphylococcus aureus and a single strain of Staphylococcus 
intermedius were typed by arbitrary primed PCR (AP-PCR). To study reproducibility and 
discriminatory abilities, AP-PCR was carried out in seven laboratories with a standardized 
amplification protocol, template DNA isolated in a single institution, and a common set of 
three primers with different resolving power. The 60 strains could be divided into 16 to 30 
different genetic types, depending on the laboratory. This difference in resolution was due to 
differences in technical procedures (as shown by the deliberate introduction of experimental 
variables) and/or the interpretation of the DNA fingerprints. However, this did not hamper the 
epidemiologically correct clustering of related strains. The average number of different 
genotypes identified exceeded those of the more traditional typing strategies.u Comparison 
of AP-PCR with pulsed-field gel electrophoresis (PFGE) indicated the existence of strains 
with constant PFGE but variable AP-PCR types. The reverse (constant AP-PCR and variable 
PFGE patterns) was also observed. This indicates additional resolution for combined 
analyses. It is concluded that AP-PCR is well suited for genetic analysis and monitoring of 
nosocomial spreading of staphylococci. The interlaboratory reproducibility of DNA-banding 
patterns and intralaboratory standardization need improvement. 
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INTRODUCTION 
Numerous procedures for comparison of bacterial isolates have been developed,2,11.13.15 
These procedures are important in investigations of strain originl clonal relatedness among 
strains, and epidemiology. For Staphylococcus aureus, it has been demonstrated that most of 
the typing procedures can be applied successfully to obtain epidemiologically useful data. 
Tenover et al." compared 12 typing strategies and concluded that DNA-based typing 
methods and immunoblolting are best suited for epidemiological analyses. With the exception 
of biotyping, which appeared to produce too many subtypes, no single technique proved 
overtly superior or inferior. When all procedures were compared, unrelated strains were 
grouped with differing frequencies. This comparative analysis of typing procedures provides 
a reference scheme for rating novel typing strategies against the more established methods. 
Recently, a large number of reports describing the use of the PCR for genetic typing of 
medically important microorganisms have appeared."" By arbitrarily amplifying variable 
regions in the bacterial genome (arbitrarily primed PCR [AP-PCR]), isolate-specific DNA 
fingerprints can be obtained in a rapid and reproducible manner. In most cases, these 
analyses are not accompanied by detailed comparisons with the results of alternative typing 
procedures. For S. aureus, for instance, several studies have compared AP-PCR with only a 
single other technique.ZD.21.25.26 
The present study was undertaken to determine the reproducibility and discriminatory abilities 
of AP-PCR when compared with other staphylococcal typing procedures. To this end, the S. 
aureus strains that were studied previously by Tenover et al." were typed in multiple AP-PCR 
assays with three different arbitrary primers, guided by a standard amplification protocol and 
performed independently in seven different laboratories. 
MATERIALS AND METHODS 
Bacterial strains and description of isolates. Fifty-nine isolates of S. aureus were included 
in this study. All isolates were identified and confirmed to be S. aureus by standard 
biochemical methods." The strains have been described before," and 40 of them were 
derived from five well-documented outbreaks. The 19 additional isolates are epidemiologically 
unlinked. A single isolate of S. intermedius was included. 
The 60 strains were divided into three groups (SA, SB and SC), some of whose key features 
are summarised below (Table 1). Group SA contains the strains involved in outbreaks that 
occurred in two nursing homes (strains labeled NH1 and NH2). Strain SA-04 is ATCC 12600 
(American Type Culture Collection, Rockville, Md.). This set also contains a number of 
independent isolates from the Centers for Disease Control and Prevention, the S. intermedius 
strain, and three isolates of phage type 47/54/75/77 183A. These lalter strains were isolated in 
three different American states during three different years. 
Group SB contains strains from outbreaks I and II, eight unrelated strains, and, again, S. 
aureus ATCC 12600 (SB-07). Strains from outbreak I are methicillin resistant and were 
isolated in the Iowa Veterans Affairs Medical Center (18). Outbreak II was related to a 
contaminated anaesthetic.s 
Group SC contains strains from outbreaks III and IV, an unrelated control, and ATCC 12600 
(SC-03). Outbreak IV was again anaesthetic related,' although it differed from outbreak II. 
Outbreak III was caused by 10 methicillin-resistant strains in the Sepulveda Veterans Affairs 
Medical Center, Sepulveda, California.' 
Bacterial typing studies. All isolates were typed previously by a number of procedures." 
Antibiograms and biotypes were determined, and bacteriophage sensitivity was assayed. 
Restriction fragment length polymorphisms (RFLP) were screened using enzymatic digestion 
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TABLE 1: general swvey of phenotypic and genotypic typing data in comparison with the results from 
the mulUcenter study on ap-pcr mediated dna fingerprinting for 60 Staphylococcus strains 
Anti 
AP-PCR datasetsd Out- bio 810 
Stralna breakb Ox~ Phage type gram typ. I, Ib 
" '" 
IV V 
SA-16 NO S NR 1m' HEH FEF HEG GDH FDF FOG 
SA·04 NO S 6147/54f7S 8 A28 8BB 8B8 B88 8BB 88B 8BG 
SA-12 NO R 47i54f7S{17/83A G A38 AM AM AM AM AM AM 
SA-f8 NO R 47i54fl5f77/83A J A38 AM AM AM AM AM AM 
SA-20 NO R 47i54fl5fl7/83A K A38 AM AM AM AM AM AM 
SA-06 NO I NR G A38 GAG MG GAG GAG AM M8 
SA·07 NO S 53/+ 0 H4 DAD MG DAG MD GM AAD 
SA-08 NO R 54f75fl7i81 E I2B EGE GGD EGO D8E 08G G8E 
SA-If NO R NR F A2B EGF GGD EGE D8F 080 G8F 
SA-Of NHl R 54n7 Al AlB AM AM AM AM AM AM 
SA-09 NHl R 54n7 A AlB AM AM AM AM AM MD 
SA·03 NHl R 47/54f7Sf77 A2 A38 AM AM AM AM AM M8 
SA-13 NHl R 54n7 A3 A18 MG AM AM AM AM AM 
SA-14 NHl S 54n5fll H 818 GOG EDE GDF FGG ~GE EGA 
SA-19 NHl R 54fl7 A4 G1B AM AM AM AM AM MB 
SA-I? NH2 R 54fl5fl7 A 038 AM AM AM AM AM M8 
SA-02 NH2 R 75f77 A A38 AM AM AM AM AM AM 
SA-1S NH2 R 77 A A38 AM AM AM AM AM AM 
SA-OS NH2 R 77 A A38 AM AM AM AM AM AAB 
SA-fO NH2 R 77 A A38 FM OM FM EM EM OM 
S!!:QZ NO s 6147/54f75 G A28 88B BB8 8B8 JB8 8BH ~8G 
SB-03 I R 75/+ A G4 AM AM AFA HEA AE~ AEA 
58-05 I R 75/+ A A4 AM AM AFA HEA AEA AEA 
58-10 I R 751+ A A4 AM AM AFA HEA AEA AEK 
88-12 I R 751+ A G4 AM AM AFA HEA AEL AEK 
S8-15 I R 75177/83 A G4 AM AM AFA HEA AEL AEA 
88-19 I R 75/+ A A4 AM AM AFA HEA AEL AEA 
88-20 I R 75/+ A A4 AM AM AFA HEA AEL AEK 
88·01 NO R 75{77 A A4 AM AM !'FA HEA A£A AEA 
S8-16 NO R 75f77/83A A A4 AM AM !'FA HEA AEL AEA 
88-18 NO R 75/+ A G4 AM AM !'FA HEA AEL AFA 
88-17 NO I 96 E 838 LDL JIM NJM OGO LGO KGM 
88-14 NO R 47/54f75f77J83A Al A38 MG AHL AAl HAP AAN AM 
58-08 NO S 95 Bl G4 JGJ H81 JHI KGM IGI IGI 
58-02 II S 3Af55 8 818 IFI GFH IGH IFK GFG HFH 
58-04 II S 3N55 8 018 IFI GFH IGH IFL HFG ~FH 
58-06 II S 3Af55 8 818 IFI GFH IGH IFK HFG HFH 
S8-11 II S 3Af55 8 838 FFK GFK LGK MFO KHK JFL 
S8-09 NO S 3A 0 038 8FI IOJ KIJ L8N JBJ BBJ 
58-13 NO S 3A 82 038 KFI GGJ MIJ N8N R8M 8BJ 
Se·03 NO S 6/47i54fiS G A28 8B8 BJB 888 J88 08P L8G 
SG-Of III R 75 A A18 MF8 BJB 088 P8B M8P L88 
SC-04 III R 75 A A18 MFB BJB 088 P8B M8P L88 
se-os III R NR Al A18 MFB BJB 088 P88 ~BP L88 
SC-09 III R 75 A A18 MFH 8JB 088 P88 MBP LBN 
se-11 III R 75 E A18 MFB 8J8 088 P88 MBP L8N 
SC-/2 III R 75 A2 A18 MF8 8J8 088 P88 MBP L8N 
SC-14 III R 75 A2 82B MF8 BJ8 OB8 P88 MBP L8N 
SC-IS III R 75 A A18 MF8 BJ8 OB8 P~8 MBP L8N 
se-I? III R 75 A A18 MF8 BJ8 OB8 P~8 MBP L8N 
SC-20 III R 75 A A18 MF8 BJB OB8 P8~ MBP L8N 
se-OB NO s NR 8 83A JHD HKI JHI KGM PII MGI 
SC-02 IV S 52152N80!47i54 8 E18 NGJ HKl JHI KGM Nil MGI 
83N84/95 
se-06 IV s 95 8 J18 JHD HKI JHI KGM PJI MGI 
se-07 IV s 95 0 I1A JHD HKI JHI KGM PJI MGI 
se-to IV s 52N79/80/47i54 8 12A JHD HKI JHI KGM ~II MGI 
75n7/83N9S 
SC-13 IV S 95 81 118 JHD HKI JHI KGM Nil MGI 
se-f6 IV s 95 81 118 JHD HKI JHI KGM PJI MGI 
SC-18 IV S 95 F 138 JHD HKI JHI KGM PJI MGI 
se-19 IV s 95 81 D1A JHD HKI JHI KGM PII MGI 
NO.c;r 3 19 11 15 20 16 18 21 30 21 
type 
a The strain numbers that are underlined are three isolates of a single ATGC strain 
b NO, not in epidemiologically related cluster; I to IV, outbreak number; NH1/2, nursing home pseudo outbreak. 
cOx"', oxacillin susceptibility test result. 
d Columns numbered la through VII give surveys of the AP-PCR data as determined in the different institutions. The 
three letter code summarises the typing results per primer used (first digit, primer 1; second digit, primer 7; third 
digit, primer E2). Data represented by a capitalletler given in a certain column may be different from the same 
character in another column. Underlining in the in the AP-PCR datasets indicates minor differences in DNA staining 
intensities. 
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Coagu 
Plas Rlbo PF FI Immu ML lase 
VI VII mide typef GE GE noblot EE 1,9 PCRh AFlP type 
GFG DDC NP d, VII K F NH 0.0 NH:NH:NH:NH 
MA BBA2 B fi E IV D E NH 2.1 NH:X:4:NH 
MA MAl NP bb J IC2 A AS C 9.0 1:A:1:NH 
ABA MAl I bb J 103 A2 A3 C 9.0 1:A:1:NH 
ABB EMl J bb J ICl Al Al C 9.0 I:A:1:NH 
ABB MAl C 
" 
C III A4 A4 B 9.0 II:NH:1:a 
eBA MAl D be B V e A2 NH 9.0 NH:NH:1:NH 
DDD eB'S E 
"" 
G IIA El Dl D 7.0 I:NH:6:NH 
DDE CS'S E 9d F liB E2 D2 G 7.0 II:NH:6:NH 
MA MAl A ,,1 Kl IB Al Al A 9.0 1:A:5:a 
AEA MAl NP ,,1 K2 IB Al Al A 9.0 1:A:5:a 
AEB MAl NP 
" 
A IA A Al C 9.0 1:A:1:NH 
MA MAl G 
" 
A IA A3 A2 A 9.0 l:A:l:a 
FEF ACA3 H d H VI E3 C NH 9.0 NH:NH:l:NH 
ABB EMl A aal K3 IB Al Al A 9.0 J:A:l:a 
ABB EMl A aa A IA A Al A 9.0 1:A:l:a 
MA MAl A aa A IA A Al Al 9.0 1:A:l:b 
MB MAl A aa A IA Al AS Al 9.0 1:A:1:a 
ABB MAl A aa A IA A Al A 9.0 l:A:l:a 
EM JMl A aa D ID Al B A 9.0 1:A:l:a 
BCC BBA1 D d D 1183 D' B3 NH 2,1 NH:X:4:NH 
HGA EEAl e 
" 
A IA A6 Al E 9,0 I:A:l:a 
HGA EEAl C aa A IA A6 Al E 9,0 I:A:1:a 
HGA HEAl C aa A IA A6 Al E 9.0 I:A:1:a 
HGA MAl C aa Al IA A6 Al E 9.0 I:A:l:a 
HGA AMl C aa A IA A6 Al E 9.0 I:A:l:a 
HGA MAl C aa A IA AS Al E 9.0 I:A:l:a 
HGA MAl e aa A IA AS Al E 9.0 I:A:l:a 
HGA EEAl A aa Al IBl AS Al E 9.0 I:Y:l:a 
HGA MAl A aa Al IBl AS Al E 9.0 I:Y:l:a 
HGA MAl J aa A IA A7 Al El 9.0 I:A:1:a 
NKM ACA6 I fj E IV G A2 NH 6.0 NH:NH:1:NH 
IW' MA3 H oa A2 IB2 AS A3 D 9.0 l:A:t:NH 
JII GFG E ddl F III E5 C NH 2.0 NH:NH:t:NH 
IHH FBD 8 bb B IIA Dl 81 NH 6.0 NH:NH:7:NH 
IHH FBD 8 bb 8 IIA Dl 81 NH 6.0 NH:NH:7:NH 
IHH F8D 8 bb 8 IIA Dl 81 NH 6.0 NH:NH:7:NH 
lJ<K ABE G blb C 1182 D2 81 NH 14.0 NH:NH:7:NH 
KJJ HBE F bb 8 IIA Dl 81 NH 6.0 NH:Z:7:NH 
MIL ABF G bb 81 liSt E6 82 NH 6.0 NH:NH:7:NH 
Bep AEA4 e al C III D 8 NH 2.1 NH:NH:4:NH 
OLN ABM A ab A IA F Al F 10.0 1:A:4:a 
OLN AEM D ab A IA F Al F 10.0 1:A:4:a 
OLN ABM D ab A IA F Al F 10.0 1:A:4:a 
OeN IBA5 D ab A IA F Al F 10.0 J:A:4:a 
OeN IBA5 NP ab A 18 F Al NH 10.0 1:A:4:NH 
OLN !BA5 A ab A IA F Al F 10.0 1:A:4:a 
OLN !BA5 A ab A IA F A2 F 10.0 1:A:4:a 
OeN !BA5 D b2b A IA F Al F 10.0 1:A:4:a 
JIN IBA5 A ab A IA F Al F 10.0 I:A:4:a 
JIN IBA5 D ab A IA F Al F 10.0 I:A:4:a 
JIH GFG E bl9 81 II E7 A3 NH 2,0 NH:NH:l:NH 
JIO GFG 8 bg 8 II E7 el NH 2,0 NH:NH:l:NH 
JIH GFG 8 bg 8 E7 el NH 2,0 NH:NH:l:NH 
JIQ GFG 8 bg 8 E7 el NH 2,0 NH:NH:l:NH 
JIH GFG 8 bg 8 E7 el NH 2,0 NH:NH:1:NH 
JII GFG 8 bg 8 II E7 el NH 2,0 NH:NH:1:NH 
OLi GFG 8 a9 8 II H Dl NH 2,0 NH:NH:l:NH 
OLi GFG 8 bg 8 II E7 el NH 2,0 NH:NH:l:NH 
JOI GFG B bg B II E7 D2 NH 2.0 NH:NH:l:NH 
28 19 10 15 11 7 7 6 B B 17 
e Plasmid, plasmid restriction profile; NP, no plasm ids. 
f Ribotyping results obtained with Hindlll and CIal, respectively, 
9 IS, insertion sequence; NH, no hybridlsalion. 
h Coag PCR, coagulase gene PCR typing. 
i INT, S. intermedius biotype. 
j In the cumulative number of types, subnumbers are counted as a single type number. 
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of plasmid DNA, variable gene probes, or DNA probes derived from insertion elements (IS 
mapping). DNA macrorestriction fragments were separated by field inversion gel 
electrophoresis (FIGE) and pulsed-field gel electrophoresis (PFGE). Multilocus enzyme 
electrophoresis (MLEE) and immunoblotting were also performed, as were ribotyping and 
restriction enzyme analysis of PCR fragments derived from the staphylococcal coagulase 
gene. 
PCR Multicenter study design. Participants were from seven institutions: two Belgian 
institutes (Hopital Erasme, Brussels; and University Hospital of Ghent, Ghent), and five Dutch 
hospitals (University Hospital Radboud, Nijmegen; University Hospital Utrecht, Utrecht; 
Diagnostic Centre SSDZ, Delft; Free University Hospital, Amsterdam; and University Hospital 
Dijkzigt, Rotterdam). The study was coordinated at the Dijkzigt Hospital, where the AP-PCR 
assays were performed in duplicate by two individuals following slightly different experimental 
protocols. All participants had experience in performing AP-PCR. This guarantees 
intralaboratory reproducibility of the assays. For this reason, the participants were also 
allowed to process the S. aureus DNA samples according to their own, optimised AP-PCR 
protocol. Results are presented anonymously, and datasets are numbered from I through VII 
(sets la and Ib derive from the coordinating laboratory). 
To prevent interlaboratory variation due to different DNA extraction protocols, bacterial DNA, 
and not the organisms, was distributed from the coordinating center to the participating 
laboratories. Primers were aliquoted in Rotterdam as well and shipped together with the DNA 
preparations. In this way, the variables of bacterial cultivation, DNA isolation, and primer 
quality were controlled. This implies, however, that the results obtained during this study may 
differ from those that would have been obtained if bacterial strains, rather than DNA, had 
been distributed. DNA amplification was performed in the different laboratories with the locally 
available equipment and PCR ingredients. Gels containing the amplified DNA were 
photographed, and the results were interpreted locally according to the researchers' 
individual standards. Generally, differences in the number of bands indicated a novel type. 
Variations in band-staining intensities were disregarded. Interpretation was performed 
without knowledge of epidemiological relatedness. The fingerprint types were transformed in 
a cumulative three-letter code (one letter per type per primer) and sent to Rotterdam, where 
a comparative analysis was carried out. Results were studied with respect to reproducibility 
of the DNA fingerprints (and the accompanying interpretation and strain grouping), relation to 
the results obtained by other typing procedures, and epidemiological value. When possible, 
data were further analyzed with Gelcompar Software (Applied Maths, Kortrijk, Belgium). 
Pictures were digitized with a Hewlett-Packard HP Scanjet IIc document scanner. After 
conversion and visual normalisation, the data were analyzed. Degrees of homology were 
determined by Dice comparisons, and clustering correlation coefficients were calculated by 
the unweighted pair group method with arithmetic averages (UPGMA). 
AP-PCR. A description of the three PCR-related procedures is given below. This protocol 
served as a reference manual. Specific deviations from this protocol are summarised per 
institute in Table 2. 
(i) Cultivation of bacteria and isolation of DNA. Bacteria were grown in suspension in brain 
heart infusion (BHI) broth for 18 h at 37"C. Approximately 100 ~I of a bacterial pellet was 
suspended in 150 ~I of 25 mM Tris • HCI (pH 8.0)-50 mM glucose-1 0 mM EDTA. Lysostaphin 
(75 ~I of a 1 OO-~gfml solution) was added, centrifuged, and the mixture was incubated at 
37"C for 1 h. Spheroplasts were lysed by the addition of 1 ml of 4 M guanidinium 
isothiocyanate-50 mM Tris. HCI (pH 6.4)-3 mM EDTA-1 % (wtfwt) Triton-X100. To immobilize 
and purify the DNA, 50 ~I of a Celite suspension (0.2 gfml; Janssen Pharmaceuticals, Beerse, 
Belgium) was added. The entire mixture was shaken for 15 s and incubated at room 
temperature for 10 min. After centrifugation, the supernatant was discarded; the pellet was 
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washed once with 1 ml of lysis buffer, twice with lysis buffer without EDTA and Triton X-100; 
twice with 70% ethanol in water, and, finally, once with acetone. The Celite pellet was dried 
in vacuo. Between 100 and 400ftl of 10 mM Tris • HCI (pH 8.0)-1 mM EDTA was added, and 
DNA was eluted by incubation at 56'C for 10 min, interrupted by short periods of vortexing. 
The supernatant containing the DNA was separated from the Celite by centrifugation. The 
DNA concentration was determined by spectrophotometry at 260 nm, and DNA was stored at 
-20'C. Stock solutions of bacterial DNA were adjusted to a concentration of 5 ngf~1. 
(ii)PCR. When Tth polymerase (SuperTaq; HT Biotechnology, Cambridge, United Kingdom) 
was used, the amplification conditions described below guaranteed optimal performance for 
this particular enzyme. The use of other enzymes usually required modification of the buffer 
conditions used during PCR (Table 2) and may lead to different AP-PCR results. PCR was 
performed with a buffer system containing 10 mM Tris • HCI (pH 9.0), 50 mM KCI, 2.5 mM 
MgCI2, 0.01 % gelatin, 0.1 % Triton X1 00, 0.2 mM deoxynucleoside triphosphates (dNTPs), 50 
pmoles of primer and 0.2 U of the Tth polymerase, to which DNA was added (50 ng per 
amplification). The PCR mixtures were overlaid with 1 00 ~I of mineral oil. Cycling was 
performed in Biomed peR machines (Model 60) and consisted of the following steps: 
predenaturation at 94'C for 4 min followed by 35 cycles of 1 min at 94'C, 1 min at 25'C, and 
2 min at 74'C. Amplified DNA was stored at -20'C. The primers used to discriminate S. 
aureus strains were RAPD1 (GGTIGGGTGAGAATIGCACG), RAPD7 (GTGGATGCGA) and 
ERIC2 (AAGTAAGTGACTGGGGTGAGCG).';·"·" 
(iii) Electrophoresis. Amplification products were separated by electrophoresis in 5 mm thick 
1.5% agarose gels (Hispanagar; Sphaero Q, Leiden, The Netherlands). Gels were run in 0.5~ 
Tris-borate-EDTA (TBE) at a constant current of 100 mA for 2 h. Prior to electrophoresis, 
samples were mixed with a fivefold concentrated layer mix consisting of 50% glycerol in 
water and 0.8 mg bromophenol blue per ml. Then 35 ~I of the amplified material was loaded 
on the gel, and a molecular weight marker was run in parallel with the AP-PCR samples. Gels 
were stained after electrophoresis by addition of 1 0 ~I ethidiumbromide (10 mgfml) to a total 
volume of 300 ml of 0.5~ TBE. The gels were photographed with a Polaroid MP4 
Landcamera and Polaroid 57 High Speed films, with an exposure time of 0.125 to 0.25 sec 
(diaphragm F5.6). Table 2 surveys the differences among the electrophoresis conditions as 
applied in the different laboratories. 
RESULTS 
PCR Fingerprinting. An overview of the typing results is given in Table 1. The AP-PCR data 
are displayed in separate columns, one per participating research center, except for the 
coordinating laboratory, where the assays were performed in duplicate (Ia and Ib). Figure 1 
gives an example of a complete set of gel pictures obtained for the 60 strains with the three 
AP-PCR primers. Table 3 displays the number of genotypes that were detected in the 
participants' laboratories. When primer 1 was used, the overall number of types varied from 
10 to 17, with a mean of 14 types. The mean numbers for primers 7 and E2 were 9 and 14, 
respectively. With this set of strains, the discriminatory power of primers 1 and E2 is over 
60% higher than that of primer 7. . 
The overall number of DNA bands generated per primer does not correspond to the number 
of detectable genotypes. Dataset 1\1, displaying 30 different genocodes (Tables 1 and 3) was 
produced from relatively small numbers of DNA fragments synthesised: seven, five, and 
seven fragments for primers 1, 7, and E2, respectively. These are smaller numbers than 
those found by the group describing the smallest number of genotypes (dataset Ib, with 16 
types deduced from fingerprints consisting of 9,9, or 11 bands for individual fingerprints). The 
maximum number of bands was observed when primer 1 was used. 
Table 2: Survey of experimental variables with respect to peR fingerprinting performed in the different participating laboratories 
Value for laboratory 
Variable la Ib II III IV V VI VII 
Incubation volume (I-.d) 100 100 100 50 100 100 50 50 
Polymerase type· Tth Tth Tth Tth Taq Thp Taq Taq 
Amt of polymerase (u) 0.20 0.20 0.25 0.10 1.25 0.25 1.00 0.25 
Mg2+ conc (mM) 2.5 2.5 2.5 2.5 2.5 2.5 2.5 2.5 
dNTP conc (~M) 40 40 40 100 200 40 200 200 
KCI conc (mM) 50 50 50 50 50 50 50 
peR machine Biomed Biomed Biomed Hybaid Biomed P.E. P.E. P.E. 
Sample size (%)t 30 30 30 50 25 30 30 30 
POlaroid+ 57/3.000 57/3,000 52/400 665/80 665/80 667/3,000 667/3,000 665/80 
Type of agarose§ Pron. Pron. Pron. MP Pron. MP UP MP 
% agarose 1.5 1.5 1.5 1.5 1.5 1.5 1.5 1.5 
Voltage 150 150 200 100 100 100 130 150 
Migration (cm) 17 em 10em 10cm 8cm 10cm 10em 8-9 cm 8-10 cm 
Ethidium bromideY + + + + + 
+ Thp (Thermoperiect DNA polymerase, Integro, ZaandruTl, The Netherlands): Tth (Supertaq, Sphaero Q, Lelden, The Netherlands); Taq (Taq polymerase, Cetus, Emeryville, Calif.). 
* in this case no KCI wos present, instead, 50 mM (NH412S04 was included. 
t The sample size indicates the amount of the amplification reaction that hos been separated electrophoretlc<llly. 
::: The description of the photographs Includes tho type and the sensitivity In ASA values. 
§ Pron. (pronarose, Hispanagar, Burgos, Spain); MP (multi purpose agorose Boehringer Mannheim): UP (Ultra Pure Agarose, Gibco/BAL, Breda, The Netherlands). 
¥ The presence (+) or absence (-) of ethldium bromide during tho electrophoresis is Indlc<lted. 
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Table 3: Number of genetic variants detected with the individual PCR primers as independently 
documented by the seven participating laboratories. 
Participating No. detected with primer Overall No. of unique 
center no. strains 
1 7 E2 
la 14 8 11 20 13 
Ib 10 11 11 16 9 
II 15 10 13 18 12 
III 16 7 17 21 16 
IV 17 10 16 30 15 
V 13 7 14 21 11 
VI 15 12 17 28 15 
VII 10 7 12 19 11 
mean 14 9 14 22 13 
Figure 1 AP-PCR for the 60 staphylococcal strains: survey of the experimental results belonging to 
dataset la. From left to right the strains are numbered according to Table 1, from top to bottom the 
primer species (primer 1 J 7 and E2) has been varied. The outer lanes in a/l nine panels contain molecular 
length markers, the size of which is indicated on the right. The interpretation of the banding patterns is 
given in Table 1 in the column identified as la. 
The mean score for this primer, averaged among the groups, is 11.4 DNA fragments. For 
primers 7 and E2, these numbers are 6.6 and 9.6 fragments, respectively. There is no 
apparent variation in the average length of the fragments, as demonstrated by a survey of 
the cumUlative results obtained by application of primer 1 (Figure 2). Although most of the 
types were found in all laboratories, some additional bands gave rise to additional 
genotypes. Discordant results can be observed. The data obtained with primer E2 seemed to 
be the most variable (results not shown). When the overall number of combined genocodes is 
considered, major differences among laboratories are encountered. The number of types 
varies between 16 and 30, with a mean of 22 types identified. 
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When the lengths of the DNA fragments generated by the individual PCR tests were 
investigated, primer 1 was found to generate amplicons with an overall length of 
approximately 11,000 bp. For primers 7 and E2, these values are 4,000 and 5,500 bp, 
respectively. These differences are not reflected in the overall number of detectable PCR 
types (which is 14 for both primer 1 and E2). Primer 7, which detected the smallest number 
of types, is also associated with the shortest cumulative length of the DNA fragments 
synthesised. There is an apparent variation in the number and size of fragments generated 
per primer species. For primer 1, this number varies from 6.4 to 11.4 on average. The 
numbers for primers 7 and E2 are 3.7 to 6.6 and 6.0 to 9.6, respectively. In general, 
fragments vary in length from 0.15 to over 2 kbp. 
Epidemiological considerations. Analysis of the strains from outbreak IV illustrates that the 
data obtained by five of seven laboratories group these isolates into a homogeneous 
genotype that is not encountered in the rest of the collection, with the exception of a single 
strain (SC-08). These data are similar to those obtained by oxacillin susceptibility testing, 
plasmid typing, ribotyping, PFGE, FIGE, immunoblotting, IS mapping, PCR typing and RFLP 
mapping." Two of the seven laboratories detected three to six different types in this group of 
eight bacterial isolates. The results collected for the strains from outbreak III are similar. In 
this case, four of seven datasets demonstrated the homogeneity of this subgroup. Three 
participants identified two or three different types. Interestingly, in two of these laboratories, 
where the same subtypes are established, the differences were limited to data obtained by 
only one of the PCR primers. Again, the PCR data are in general agreement with those 
obtained by the other typing techniques. The four strains from outbreak II are split into two 
types: three are identical (five of seven laboratories) or very similar (two of seven 
laboratories), whereas a single strain (S8-11) appears to be different. The other datasets 
confirm this observation. Results with strains from outbreak I and the nursing home (NH1 and 
NH2) conform to those of the other typing procedures. Since 19 non-outbreak-related strains 
are included in the collection, this implies that the resolution of PCR fingerprinting varies from 
approximately 50% to nearly 90%, since between 9 and 16 unique types were identified 
depending on the institution. It is assumed that all 19 non-outbreak-related strains are indeed 
genetically independent. 
Typeabilily and reproducibility. All strains were typeable by PCR. Four of seven labs 
obtained 100% typeability; negative results seen by other partiCipants were due to technical 
inadequacy not related to bacterial genome structure. The overall mean level of typeability 
was 99.5%. This makes PCR-mediated typing preferable in principle over phage typing, 
plasmid typing, some of the RFLP approaches, and IS mapping, which all leave an 
appreciable percentage of strains untypable. 
Discriminatory power. PCR fingerprinting was not able to detect differences between strain 
SA-12, SA-18, and SA-20. These strains are also identical by phage typing, ribotyping, 
PFGE, and IS mapping. Since these strains were derived from diverse origins, it seems likely 
that certain clones of S. aureus spread easily and remain genotypically constant. On the 
other hand, several other strains belonging to the same phagovar are differentiated by the 
PCR tests. As has been argued previously," PCR fingerprinting provides additional 
discrimination over that provided by phage typing. 
The participants who detected the smallest number of types (n~16) clustered 37 of 40 
epidemiologically linked strains (including the NH1 and NH2 strains) correctly; however, 8 of 
the 20 unrelated isolates could not be distinguished from strains within the outbreak groups. 
When the dataset displaying the maximal number of PCR types (n~30) was evaluated, 29 of 
40 strains were clustered. This is not an improvement when compared with the least 
discriminative data. Among the 20 unrelated strains, six genotypes were detected which 
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Figure 2 Survey of unique peR fingerprints of staphylococcal DNA by primer 7. In panellb through VII a 
survey of the banding patterns as observed by the various participants is shown. Strain numbers and 
peR genocodes are indicated alongside the panels as in Table 1. Note that the migration of DNA 
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Figure 3 Gelcompar analysis of dataset la. The pictures shown in Figure 1 have been digitised by 
scanning procedures. All three AP-PCR DNA banding patterns have been combined into one single lane. 
Degree of homology was subsequently calculated using Dice comparisons and correlation coefficients 
were determined by UPGMA analysis. On the right the strain code as presented in Table 1 is shown, as 
is the deduced three digit genocode (column la, Table 1) and the epidemiological clustering. 
were also found among the epidemiologically linked strains. Apparently, the rise in absolute 
number of detectable PCR genotypes adversely affects the correlation with the 
epidemiological data. 
Comparison with pulsed field gel electrophoresis. PFGE is currently considered to be one 
of the most reliable and reproducible typing procedures, allowing the detection of a high 
degree of DNA polymorphism (15). PCR and PFGE data were compared; the results are 
described in Table 4. First, the PCR codes for the two groups detecting the largest (dataset 
IV) and the smallest (dataset Ib) number of types were simplified. The three-letter code was 
condensed into a single digit, and new types were defined only when more than one 
individual AP-PCR assay gave a different result. In case of a single change (from AAA to 
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MC, for instance) subtypes were defined. The results for set Ib were rearranged into 11 
types and 5 subtypes, and the data obtained for set IV defined 15 types and 9 subtypes. 
PFGE recognized 11 types (A through K) and 5 subtypes, equalling the numbers detected in 
the set Ib experiments. Nearly full epidemiological agreement exists between these latter 
data and PFGE results. The only difference occurs for the NH1 outbreak: PFGE found three 
instead of the expected two types (isolate 14 is also recognised as a deviant type by other 
procedures). The set IV data subdivide strains from outbreak I and IV and, as such, gave rise 
to an overestimation of the number of types. 
Gelcompar analysis. Gelcompar analysis of the results was disappointing. Of eight 
datasets, only four were accessible to scanning reproduction. Of these four datasets only 
one could be used for successful phylogenetic analysis. The other three composite pictures 
could not be analyzed because of lack of contrast, excessive smiling of the gels, and low-
resolution photography. In the single instance in which an interpretable phylogenetic tree 
could be constructed, it appeared that the result was in agreement with visual inspection and 
epidemiological data (Figure 3). The four sets of outbreak-related strains were clustered with 
homology percentages from 79 up to 93%, when data gathered with the three primers were 
combined. Clearly, Gelcompar analysis is heavily influenced by electrophoretic and 
photographic artifacts. 
DISCUSSION 
Approximately five years ago, PCR-mediated procedures enabling genome scanning by 
random amplification of polymorphic DNA were discovered.'''' AP-PCR can be used for 
genetic characterizations and comparisons even among closely related bacterial species 
and isolatesYD.2124-26,28,29 The procedure is used with increasing frequency, facilitated by 
general applicability and high speed. However, only a limited number of studies have 
compared the effecliveness of AP-PCR typing with that of other microbiological typing 
procedures.4,7.16.1e.21.25.26 In the field of staphylococcal typing, numerous studies describe 
conventional or molecular elucidation of clonality or epidemiological relatedness. Recently, 
this was combined in a comparative study on typing of a large panel of S. aureus isolates.ll 
The overall conclusion from the present data is that AP-PCR adequately clusters strains 
isolated from given outbreaks. On the other hand, considerable differences between the 
results from different laboratories have been encountered. This is reflected by the number of 
isolates that are identified by a unique genotype. This number varies from 9 to 16, and 
participants who detect more than one type among epidemiologically clustered strains score 
relatively high in this respect. It has to be emphasised that during this study, several of the 
experimental parameters were standardized. In this respect, it is noteworthy that a relatively 
high degree of heterogeneity between laboratories was encountered as a result of this 
limited number of additional variables (Table 2). Including the DNA isolation protocol in the 
multicenter approach would most probably have led to an even lower degree of 
interlaboratory reproducibility. 
In the single multicenter AP-PCR typing study that has been described to date," the time-
and cost-effectiveness of PCR typing were investigated. This study demonstrated that 
successful AP-PCR depends heavily on the optimal use of PCR protocols.' For this reason, 
it was decided not to study the intralaboratory reproducibility of the AP-PCR tests. These 
items have been addressed in previous studies/· 21 ,23-26 However, the fact that epidemiological 
clusters of strains generate identical DNA-banding patters upon DNA amplification is 
evidence of at least a reasonable degree of intralaboratory reliability. Upon reamplification of 
some of the DNA samples, as performed in two of the participating laboratories, AP-PCR 
profiles appeared to be reproducible. 
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Table 4: Comparison of peR fingerprinting and PFGE on the basis of simplified genetfc codes for the 
peR assay. 
peR code Simplified code 
Strain Ib IV Ib IV PFGE code 
A16 FEF FDF 1 1 I 
A4 888 888 2 2 E 
A12 AM AM 3 3 J 
A18 AM AM 3 3 J 
A20 AM AM 3 3 J 
A6 MC AM 3a 3 C 
A7 MC CM 3a 3a 8 
A8 CCD DBC 4 4 G 
Al1 CCD DBD 4 4a F 
Al AM AM 3 3 Kl 
A9 AM AM 3 3 K2 
A3 AM AM 3 3 A 
A13 AM AM 3 3 A 
A14 EDE -CE 5 5 H 
A19 AM AM 3 3 K3 
A17 AM AM 3 3 A 
A2 AM AM 3 3 A 
A15 AM AM 3 3 A 
AS AM AM 3 3 A 
Al0 OM EM 3b 3b 0 
87 8B8 8BH 2 2a 0 
83 AM AE- 3 30 A 
85 AM AEA 3 30 A 
810 AM AEA 3 30 A 
812 AM AEL 3 6 A1 
815 AM AEL 3 6 A 
819 AM AEL 3 6 A 
820 AM AEL 3 6 A 
81 AM AEA 3 30 A1 
816 AM AEL 3 6 Al 
818 AM AEK 3 6 A 
817 JIM LCO 6 7 E 
814 AHL MN 7 3d A2 
88 HBI IGI 8 8 F 
82 GFH GFG 9 9 8 
84 GFH HFG 9 9a 8 
86 GFH HFG 9 9a 8 
811 GFK KHK 9a 10 C 
89 IOJ JBJ 10 11 8 
813 GGJ RBM 11 12 B1 
C3 8JB OBP 2a 13 C 
Cl BJB MBP 2a 13a A 
C4 8J8 M8P 2a 13a A 
C5 BJ8 -8P 2a 13a A 
C9 BJ8 M8P 2a 13a A 
C11 BJ8 M8P 2a 13a A 
C12 BJ8 M8P 2a 13a A 
C14 BJ8 M8P 2a 13a A 
C15 BJ8 M8P 2a 13a A 
C17 BJ8 M8P 2a 13a A 
C20 BJ8 M8P 2a 13a A 
C8 HKI PII 2a 14 81 
C2 HKI Nil Ba 14a 8 
C6 HKI PJI Ba 15 8 
C7 HKI PJI Ba 15 8 
Cl0 HKI -II Ba 14a 8 
C13 HKI Nil Ba 14a 8 
C16 HKI PJI Ba 15 8 
C1B HKI PJI Ba 15 8 
C19 HKI PII Ba 14 8 
The data sets Ib and IV have been simplified by changing three- into one-letter codes. New types were defined when at 
least two characters from the three letter code had changed; single assay changes result in subtyping (a through d). 
Epidemi%gicalfy related clusters are indicated by returns, strain numbering is as in Tabfe 1. 
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Reproducibility was affected by the nature of the primer used and the identity of the intratube 
thermo profile. Isolates SA-04, S8-07 and SC-03, all of which were S. aureus ATCC 12600, 
were included in the three sets of strains to evaluate the reproducibility of AP-PCR. Only one 
of the participating laboratories unequivocally identified all three strains to belong to a single 
genotype. It must be emphasised that the other typing procedures also detected gross 
differences among these three particular isolates. it has been demonstrated previously that 
genetic variability as measured by PCR can be a consequence of repeated conservation and 
"reviving" of strains; this is probably due to replication defects or the absence or presence of 
lytic phages.' This might be an explanation for the extensive variability encountered among 
the ATCC strains. PFGE, for instance, corroborates the PCR data in six of seven PCR 
datasets by designating genotypes E, D and C. Plasmid types are also very different: 8, D 
and C are the indexes. This, in combination with other experimental results, may be 
indicative of intrastrain heterogeneity or sampling error. Computerised correction of AP-PCR 
artifacts is currently under development. "." It is particularly important to implement this 
approach, which takes reproducibility and erroneous amplification into account, when multi-
center studies are performed. However, on the basis of the resuits of the present study, it is 
expected that interinstitute standardisation will be very hard to achieve. 
PCR typing is currently restricted to laboratories with appropriate equipment and 
experimental expertise. In this respect, the applicability of AP-PCR is as yet limited. it is clear 
from the present study that generation and interpretation of PCR data is likely to vary among 
laboratories. The percentage of variant types identified can be on the order of 27 to 50%, 
based on the application of three PCR tests and a single DNA-processing protocol. The 
variables that still exist between laboratories (Table 2) must be responsible, at least in part, 
for these large discrepancies. From the duplicate experiments performed in Rotterdam, it 
was concluded that gel electrophoresis is a major cause of experimental variability; this has 
been confirmed by a recent report. 10 An increase in electrophoresis time led to improved 
separation, which in turn enabled successful digitization and Gelcompar analysis. It is also 
acknowledged that the present study suffers from the fact that DNA isolation and primer 
quality were standardized. If this had not been the case, differences between laboratories 
may have been even larger. 
AP-PCR shares characteristics with the genome-scanning capacities of electrophoretic 
techniques such as PFGE and FIGE. These last two procedures identify epidemiological 
relations for staphylococci that are in good agreement with the present data (Table 4). 
Recently, guidelines for interpretation of PFGE patterns for outbreak investigations were 
proposed by an American working group.' Since these rules have been used to define 
staphylococcal subtypes in the collection used in the previous and present studies," our PCR 
data may enable the development of similar rules for the definition of PCR subtypes. The 
rules should be based either on differences within the banding pattern generated during a 
single PCR or on differences in compositegenocodes as presented in Table 1 and simplified 
in Table 4. The present study indicates that differences in the combined results of multiple 
AP-PCR assays are better indicators of genetic variability than the results of individual 
assays. It is clear, however, that PFGE subtypes do not fully match the subtypes as defined 
by PCR. It is advisable to perform model studies starting with PFGE-uniform strains on the 
one hand and PCR-uniform strains on the other hand. For studies such as these it is also 
important to start the analysis with a collection comparable to the set of strains in this study: 
it should provide a mixture of unique, solitary isolates together with epidemiologically well-
defined clusters. 
Our data demonstrate that PCR fingerprinting deserves a position among the procedures 
that are well suited for the epidemiological analysis of S. aureus. The procedure seems 
particularly appropriate for the high-speed typing of nosocomial isolates. This conclusion 
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was also drawn previously;' on the basis of theoretical considerations, it was suggested that 
AP-PCR is a cost-effective procedure as well. It is necessary to test multiple primers, since 
differences in discriminatory power are to be expected. Strain-specific amplicons can be 
generated quite easily, even among clonally related isolates of S. aureus. With the exclusion 
of subtype numbering for the other typing strategies, AP-PCR generates the largest number 
of individual types. It exceeds the resolution of PFGE, which detects 11 types and 5 
subtypes. Only phage typing and RFLP mapping approach the average number of types 
detectable by AP-PCR. It must be emphasized, however, that the generation of excessive 
numbers of types introduces the possibility that the relationship between the AP-PCR data 
and epidemiological characteristics will deteriorate. 
Finally, we recommend establishing collections like the one used in this and the previous 
study ~ for other microorganisms as well. The availability of these strains enables the 
individual researcher to establish the value of newly developed typing tools or to use these 
strains as internal controls in typing studies. Well-documented collections or experimental 
protocols can be used for standardization of typing procedures," an initiative important for 
the development of international standards on genetic relatedness or clonality among 
pathogenic microorganisms. 
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SUMMARY 
An outbreak of methicillin-resistant Staphylococcus aureus (MRSA) involving 27 patients and 
14 healthcare workers (HeWs) was studied. The outbreak started in the hematology unit of 
the University Hospital Rotterdam, Dijkzigt, The Netherlands, and spread to the surgical unit. 
Twenty-one patients (77.8%) developed clinical disease, and five died. Subsequently, MRSA 
was detected in food and in the throat of one of the HeW who prepared food for hematology 
patients. Food contaminated by an HeW most likely caused the first case of MRSA 
septicemia. This route of transmission has not been described before. The outbreak strain 
was probably transmitted to the surgical unit by a colonized nurse, where it caused an 
explosive outbreak. Airborne MRSA transrnission played an important role in disseminating 
the organism. The outbreak was controlled within six months by intensifying surveillance, 
temporarily closing the affected wards, treating carriers, and instituting an MRSA ward 
outside the hospital. 
Phage typing, insertion sequence probing, protein A gene typing and DNA fingerprinting by 
peR revealed that all outbreak-related isolates were identical. By pulsed field gel 
electrophoresis, all but one of the outbreak-related isolates were determined to be identical. 
Protein A gene typing identified numerous (11) repeat units in all outbreak-related isolates, 
which supports that the outbreak strain may have been more virulent and more transmissible 
than other MRSA strains. Pheno- and genotypic typing studies underlined the value of DNA 
tingerprinting methods for investigation of MRSA epidemiology. Optimal discriminatory 
power was achieved by combining the results of four genotyping methods. 
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INTRODUCTION 
In Europe, the incidence of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals 
varies considerably from country to country. Generally, the incidence of MRSA increases 
from north to south. In a pan-European surveillance, the incidence was found to be highest 
in Spain, France and Italy (30.3 to 34.4%) and lowest in Denmark, Sweden and The 
Netherlands (0.1 to 1.5%)." Despite the low incidence in Dutch hospitals, outbreaks of 
MRSA occur regularly, especially in the larger teaching hospitals. Most outbreaks are due to 
the import of strains by patients transferred from hospitals in countries with increased MRSA 
incidence." Outbreaks in low prevalence settings offer unique opportunities to determine the 
value of various typing methods, since the clonal relatedness among the MRSA isolates 
involved is obvious. 
Scientists still debate whether one clone of MRSA has spread throughout the world. W." 
However, numerous investigations have demonstrated that the phenotype19.21,JO and 
genotype7.13.14.17.n of MRSA vary. These procedures are particularly useful for comparing 
bacterial isolates involved in nosocomial outbreaks. Recently, it has been shown that 
especially the genotypic assays posses excellent discriminatory power and exhibit subtle 
resolution capabilities.29 
This report describes the epidemiological aspects of an MRSA outbreak which occurred in 
the University Hospital Rotterdam, The Netherlands. The initial reservoir for the outbreak 
strain was probably a dietary worker, who carried MRSA in his throat, and prepared food for 
patients on the hematology unit. Transmission of MRSA by contaminated food has not been 
described before. 
MATERIALS AND METHODS 
Isolation and processing of MRSA strains. Between November 1992 and April 1993, an 
outbreak of MRSA occurred in the University Hospital Rotterdam. MRSA strains were isolated 
from 27 patients (Table 1), 14 healthcare workers (HCWs) and from environmental samples. 
Surveillance cultures were routinely made for patients specimens from the nares, throat, 
perirectal area and, if present, skin lesions (including wounds) and catheter insertion sites. 
For patients who had urinary catheters, urine was also cultured. Surveillance cultures from 
HCW consisted routinely of swabs from the nares and from skin lesions if present. 
The initial cultures were inoculated on Columbia agar base supplemented with 5% sheep 
blood and mannitol salt agar. The plates were incubated at 37"C for 48 hours and inspected 
after 18 to 24 h and after 42 to 48 h. All isolates were identified on the basis of colony 
morphology, positive catalase slide test, and coagulase tube-tests. Additionally, biochemical 
analysis was performed with Vitek" (BioMerieux, Lyon, France). Methicillin resistance was 
determined by inoCUlation of strains on Mueller Hinton agar (Oxoid CM 337, Brunschwig, 
Amsterdam, The Netherlands) with a disk containing 5 ~g of methicillin (Oxoid, Brunschwig). 
Plates were incubated at 30°C for 24 h, and inhibition zones were measured.' Isolates with 
inhibition zones smaller than 17 mm diameter were considered methicillin-resistant. All strains 
were grown as mono cultures in brain heart infusion (BHI) broth and stored as Iyophilised 
powder. 
A sample of 17 outbreak-related isolates, including isolates from patients, HCWs and the 
environment were evaluated by several typing methods (outbreak group; see Table 2). 
Thirteen epidemiologically unrelated strains were included in the typing studies as 
comparison strains: five isolates were obtained in the same hospital from patients transferred 
from foreign hospitals (control group 1), and eight isolates with the same phagovar as the 
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Table 1: Clinical, geographical and bacteriological data for patients colonized or infected with MRSA. 
Patient MRSA isolation week of 
no. ward date (mm/dd/yy) outbreak clinical diagnosis or surgery 
hematology 11/12/92 acute myeloid leucemia 
2 vascular surgery 11/22/92 3 atherosclerotic vascular disease 
3 vascular surgery 11124/92 4 atherosclerotic vascular disease 
4 vascular surgery 11/26/92 4 atherosclerotic vascular disease 
5 vascular surgery 11/26/92 4 atherosclerotic vascular disease 
6 vascular surgery 11/26/92 4 atherosclerotic vascular disease 
7 vascular surgery 11/26/92 4 atherosclerotic vascular disease 
8 vascular surgery 11/26/92 4 aneurysm of aorta 
9 vascular surgery 11/28/92 4 atherosclerotic vascular disease 
10 vascular surgery 12/01/92 5 atherosclerotic vascular disease 
11 vascular surgery 12/03/92 5 aneurysm of aorta 
12 surgicallCU 12/03/92 5 peritonitis 
13 general surgery 12/03/92 5 osteomyelitis 
14 vascular surgery 12/07/92 6 atherosclerotic vascular disease 
15 vascular surgery 12/07/92 6 aneurysm of aorta 
16 vascular surgeI)' 12/07/92 6 atherosclerotic vascular disease 
17 surgical ICU 12/21/92 8 colon surgeI)' for obstruction 
18 surgicallGU 03/01/93 18 liver transplantation 
19 general surgery 03/03/93 18 esophageal cancer 
20 vascular surgeI)' 03/03/93 18 aneurysm of aorta 
21 general surgery 03/06/93 18 colon cancer 
22 general surgeI)' 03/10/93 19 breast cancer 
23 vascular surgeI)' 03/15/93 19 atherosclerotic vascular disease 
24 general surgery 03/17/93 20 colonic diverticulosis 
25 vascular surgery 03/22/93 20 atherosclerotic vascular disease 
26 general surgeI)' 03/30/93 22 colon cancer 
27 general surgeI)' 03/31/93 22 gastric cancer 
+ Y, yes; N, no. 
~ defined as mortality 1 year after MRSA was first Isolated. 
In patients 1,2, and 18, mortality was directly related to infection with MRSA. 
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Table 1 
presence of site of prosthetic vascular 
infection+ infection graW amputation+ outcome* 
y blood N N died 
y wound Y N died 
y wound Y Y survived 
y wound N N survived 
y wound N Y survived 
y wound N Y survived 
y wound Y Y survived 
N y N survived 
y wound Y Y survived 
y wound Y N survived 
N y N survived 
y wound N N survived 
y wound N N survived 
y wound N Y survived 
y wound Y N survived 
y wound Y Y survived 
y wound N N died 
y wound N N died 
y wound N N survived 
y wound Y N survived 
y wound N N survived 
y wound N N survived 
y wound Y N survived 
y wound N N survived 
y wound Y Y died 
y wound N N survived 
N N N survived 
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outbreak-related isolates were obtained from the Dutch National Institute for Public Health 
and Environmental Protection, Bilthoven, The Netherlands, (control group 2). 
Antimicrobial susceptibility testing. In addition to susceptibility to methicillin, the 
susceptibility of the strains to ciprofloxacin, erythromycin, oxacillin, rifampicin, tetracycline, 
phosphomycin, tobramycin, co-trimoxazole, clindamycin, vancomycin and fusidic acid were 
determined. All assays were performed by the method of Bauer et a/.,' using breakpoints 
according the National Committee for Clinical Laboratory Standards guidelines." Resistance 
was classified as 0, intermediate susceptibility as 1, and full susceptibility was clasified as 2. 
Phage typing. Phage typing was performed at the Dutch National Institute of Public Health 
and Environmental Protection, by application of the international set of typing phages and a 
set of typical Dutch phages.'"" Different phage patterns were given a type designation. 
PCR-mediated DNA fingerprinting (arbitary primed PCR [AP-PCR]). AP-PCR was 
performed essentially as described before.'" DNA was isolated from overnight cultures by 
lysostaphin treatment, guanidine isothiocyanate-Iysis,' and subsequent DNA affinity 
chromatography. Approximately 5 ng of DNA was included per PCR mixture. The PCR 
mixture further consisted of 10 mM Tris-HCI (pH 9.0), 50 mM KCI, 2.5 mM MgCI2' 0.01 % 
gelatin and 0.1 % Triton-X100. Deoxyribonucleotide triphosphates were present at 0.2 mM in 
reaction mixture, and 0.5 U of Taq DNA polymerase (Sphaero Q, Leiden, The Netherlands) 
was included. Five differrent primers were included in the typing assays. The designations 
and sequences of the primers were as follows: 
186: (5'-GGTIGGGTGAGAATIGCACG-3'); 
188: (5' -AAGAGCCCGT-3'); 
192: (5'-GTGGATGCGA-3'); 
ERIC1: (5' -ATGTAAGCTCCTGGGGATICAC-3'); 
ERIC2: (5'-AAGTAAGTGACTGGGGTGACGC-3'). 
All primers were applied in separate assays (50 pmol of primer per PCR mixture). The 
amplification was performed in a model 60 thermocycler (Biomed, Thores, Germany) by a 
program consisting of 40 repeated cycles of 1 min at 94°C, 1 min at 25°C, and 2 min at 74°C. 
Prior to cycling, the mixtures were denatured at 94°C for 4 min, and postcycling, the mixtures 
were incubated at 74°C for an additional 1 0 min. PCR samples were analysed by agarose gel 
electrophoresis. The gels, containing 2% agarose in 40 mM Tris-borate (pH 7.8)-2 mM EDTA 
(0.5 X TBE), were run in the presence of ethidium bromide. After photography (Polaroid high-
speed sheet film 57), DNA fingerprints were compared by visual inspection. 
The results for each primer were indexed by numbering, thereby defining the number of 
different DNA fingerprints (i.e. amplicon banding patterns) that could be distinguished by 
single assays. One- and two-band differences between two DNA fingerprints derived from 
different strains were classified as subclonal variation, indicated by adding a prime to the 
index character (see Table 2). The overall PCR type was defined by a combination of the 
results obtained with the five individual primers. If subclonal variations were detected with 
individual primers, this was indicated by subnumbering of the PCR type. 
PFGE. Pulsed-field gel electrophoresis (PFGE) was performed at the University of Iowa, Iowa 
City. Contour-clamped homogeneous electric field (CHEF) analysis was performed using the 
CHEF DR-II (Bio-Rad Laboratories, Richmond, Calif.). Bacteria were embedded in low-
melting-temperature agarose (FMC Corp., Philadelphia, Pa.) and treated with lysostaphin and 
proteinase K-sodium dodecyl sulfate (SDS) according to established protocols.""" DNA 
was digested in situ by Smal (New England Biolabs, Beverly, Mass.) according to the 
manufacturer's instructions. Agarose gels (1 %) were run in 0.5XTBE at 13°C and at 6 Wcm. 
Switching times were ramped from 10 to 90 s for a total run time of 24 h for optimal 
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separation of DNA fragments between 50 and 500 kB in size. Strain differences were based 
on the detection of restriction fragment length polymorphism (RFLP). One- and two-band 
differences were designated subclonal variations, indicated by subnumbering; differences of 
three or more bands were interpreted as indicating different strains. Comparisons and 
calculation of the percent homology were performed manually. Dendrograms were 
constructed by the unweighted pair group method using arithmetic averages (UPGMA) 
subroutine of the PHYLIP Software."" 
Detection of protein A gene polymorph isms by peR. Length polymorph isms in the 
staphylococcal protein A gene were determined by PCR essentially as described before." In 
short, the repetitive region within the protein A gene was amplified by using oligonucleotide 
primers with the following DNA sequences: 
5' -TGTAAAACGACGGCCAGTGCTAAAAAGCTAAACGATGC-3' and 
5'-CAGGAAACAGCTATGACCCCACCAAATACAGTIGTIACC-3'. 
After PCR, DNA was cleaved with the restriction enzyme Rsal (Boehringer GmbH, 
Mannheim, Germany) and RFLPs were determined by electrophoresis in 2% agarose gels 
run in 0.5XTBE. The number of repetitive units present in the genes' variable region was 
estimated by comparisons with molecular weight markers (100-bp marker, Pharmacia, 
Gouda, The Netherlands). 
Insertion sequence probing. Insertion sequence probing was performed at the Dutch 
National Institute of Public Health and Environmental Protection. For RFLP analysis, 
extraction of chromosomal DNA and Southern blotting were performed as described 
previously." Genomic DNA was extracted from 1.5 ml overnight culture by using lysostaphin, 
SDS, and proteinase K. DNA was purified further by extraction with phenol-chloroform and 
ethanol precipitation. Finally, the DNA was dissolved in 1 00 ~I TE (10mM Tris-HCL, 1 mM 
EDTA, pH 8.0). Clal (Boehringer) was used to digest DNA according to the manufacturer's 
instructions.' The digested DNA was analysed by electrophoresis in a 1 % agarose gel at 25 
V overnight in TBE (89 mM Tris-HCI, 89 mM boric acid, 25 mM EDTA, pH 8.2) and stained in 
ethidium bromide (0.5 ~gfml). Southern blots were prepared on hybond N' membranes 
(Amersham International, Amersham, United Kingdom) by using a vacuum mini blot system 
(Millipore Corp., Bedford, Mass.) and stored at 4'C until use. For hybridization, a probe 
based on the IS431 sequence, an insertion-like element which is found frequently among 
staphylococci,' was used. The probe, designed to amplify an 800-bp sequence from IS431, 
was produced by PCR using two primers: 
primer 1, 5'-TACATCATGTIAATAAGGG-3' and 
primer 2, 5' -TIGCGTGAGTGTGGCGAAGC-3' 
The target for amplification was 5 ~I of S. aureus suspension which was also used for the 
digestion as described above. Amplification was performed as described previously" for 35 
cycles of 1 min at 94'C, 2 min at 55'C, and 2 min at 72'C using a thermocycler (Perkin-
Elmer). After amplification the PCR products were divided into aliquots of 1 0 ~I and purified 
by agarose gel electrophoresis using low-melting-temperature agarose (preparative grade, 
Biorad)." After the DNA-fragments were seperated, agarose blocks containing DNA with the 
expected molecular weight were cut from the gel and directly used for labelling or stored at 
-20'C until they were processed. Nonradioactive labelling of probe DNA with horseradish 
peroxidase was performed directly in the agarose blocks by using the enhanced 
chemiluminescence gene detection system (Amersham International) according to the 
manufacturer's instructions. One agarose block containing labeled DNA was used for 
hybridization of one blot. Southern Blot hybridization was performed and recorded as 
described previously.' 
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RESULTS 
Epidemiological surveillance. The first patient involved in the MRSA outbreak was 
identified in the hematology unit, were she was treated for acute myeloid leukemia. Because 
of neutropenia (granulocyte count, <500 X 10'/liter), she was nursed in a private room with 
laminar airflow high-efficiency particulate air filtration, as were all other neutropenic patients 
on this unit. The patient was given oral ciprofloxacin prophylactically, as was the unit's 
routine. Subsequently, she developed sepsis with MRSA of which she died within three days, 
despite immediate treatment with vancomycin. The surveillance cultures, which were 
obtained twice weekly, were negative until the patient developed the bacteremia. Also, two 
sets of surveillance cultures which were obtained for all other patients and the HeWs and 
other contacts on the hematology unit, were all negative for MRSA. No environmental source 
was identified. 
Ten days after the first patient was identified, additional patients who carried MRSA were 
identified on the surgical unit, which was located far from the hematology unit. A nurse on the 
surgical unit was colonized by a MRSA strain (strain 6, Table 2) that was identical to the 
outbreak strain. This nurse probably transmitted the outbreak strain of MRSA to the surgical 
unit, as she had been transferred from the hematology unit to surgery shortly after the first 
patient was identified. After MRSA was detected on the surgical unit, surveillance cultures 
were done repeatedly for all patients and HeWs (nurses, physicians and paramedical 
employees) on this unit. A total of 26 patients and 13 HeWs (including the nurse who came 
from the hematology unit) carried MRSA. Of the 26 surgical patients colonized with MRSA, 
20 (77%) developed a clinically proven MRSA infection. Four of these individuals died (25%); 
two of these deaths were directly related to the MRSA infection. The clinical diagnosis and 
geographical and bacteriological data for the 27 MRSA-postive patients are detailed in Table 
1. 
Figure 1 shows the incidence of MRSA-positive patients during the outbreak period. The first 
episode of the outbreak involved primarily patients who had had vascular surgery who had 
necrotic wounds or had prosthetic vascular grafts that had been implanted recently. Most of 
these patients developed clinically significant wound infections. 
To control this outbreak, the vascular surgery ward was closed and the patients who were 
colonized with MRSA were transferred to an MRSA cohort isolation facility which was created 
outside the hospital in week number 10 after the outbreak began. A separate team of nurses 
and doctors took care of these patients. The surgical ward, including the floors, walls, 
ceillings, and furniture, was cleaned completely and disinfected using 4-chlor-2-benzylphenol 
(2% [wVvol)) and or1ho-phenylphenol (2% [wVvol)). HeWs who were colonized with MRSA 
were treated with nasal mupirocin ointment (Bactroban0; Smith Kline Beecham) and sent 
home until MRSA carriage was eradicated. As can be seen in Figure 1, the first episode was 
rapidly controlled. In week 13, only a single patient remained in the isolation facility. It was 
then decided to close this facility and treat the patient in a regular hospital department, in 
strict isolation (private room with negative air pressure, and gloves, gowns, and masks 
required for everyone who entered the room, and the patient confined to his room as much as 
possible). Despite strict isolation, this particular patient served as a source for the second 
episode of the outbreak. This episode involved fewer patients and HeWs but more surgical 
wards. Most patients probably acquired MRSA in the surgical intensive care unit (leU), where 
they were treated for a few days postoperatively. However, MRSA carriage was not detected 
until after the patients were transferred to other surgical wards. The second episode of the 
outbreak Was controlled by intensifying bacteriological surveillance of patients and HeWs and 
by reinstituting the isolation facility. 
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Figure 1: Incidence of MRSA in patients (Pat.), health care workers (HCVV) and food during the outbreak 
in the Hematology unit, the Vascular Surgery unit, the SurgicallCU and the General Surgery unit. The 
boxed regions indicate the number of new cases per week. The arrows indicate the three strains isolated 
from the dietary worker, from food and from the paUent in the Hematology unit. 
Twenty-two weeks after the outbreak began, routine bacterial cultures of food prepared for 
neutropenic patients in the hematology unit revealed MRSA in a piece of banana, which had 
been peeled by a dietary worker who worked in this unit. Therefore, all personnel who 
prepared food for patients on the hematology unit were screened for MRSA carriage, MRSA 
was cultured repeatedly from throat swabs but not from the nares or the perirectal area of the 
dietary worker. This HCW was working on the hematology unit at the time the first patient 
was detected but never contacted directly patients or HCWs with MRSA. The MRSA strains 
cultured from hematology patient, the piece of banana, and the dietary worker were identical 
(Table 2 strains 1 alb, 2 and 3, respectively). The dietary worker was treated succesfully by 
application of mupirocin nasal ointment twice a day and daily washing of body and hair with 
disinfecting soap for 5 consecutive days. 
Antibiotic sensitivity of MRSA. All outbreak-strains that were evaluated had similar 
antibiograms (Table 2). Except for isolate number 17, all outbreak strains (1 through 17) were 
resistant to methicillin. Also all isolates were resistant to tobramycin, erythromycin, 
ciprofloxacin, rifampicin, clindamycin, and tetracycline. All were susceptible to vancomycin 
and co-trimoxazole. More variability was found regarding susceptibility to phosphomycin and 
fusidic acid. Isolate 17 was sensitive to methicillin as determined by the disk diffusion assay. 
This isolate was obtained from a patient who also carried methicillin-resistant isolates. The 
antibiograms of the isolates in control group 1 (Table 2, isolates 18 to 22) were more 
heterogeneous. The antibiograms of the isolates in control group 2 (Table 2, isolates 23 to 30) 
were generally similar to the outbreak strains. 
Phage typing. All outbreak-related isolates, including the methicillin-susceptible isolate 17, 
were phage type 11129. None of the isolates in control group 2 were of this phage type. 
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Table 2: Comparison of results from phenotypic and genotypic typing methods. 
Group and 
isolation Site of isolate antibiotic phage protein 
date (MIYJ sourcea Ward nC,b susceptibilityc type A typed 
OUTBREAK GROUP 
11/92 blood hematology 1 alb 20020002020 11129 11 
03/93 banana hematology 2 20020002020 11129 11 
03/93 HCW hematology 3 20020002020 11129 11 
11/92 ASP vascular surgery 4 00020002020 11129 11 
11/92 nose vascular surgery 5a1b 00020002000 11129 11 
11/92 HCW vascular surgery 6 20020002020 11129 11 
11/92 HCW vascular surgery 7 20020002020 11129 11 
03/93 wound vascular surgery 8 20020002020 11129 11 
12/92 HCW surgicallCU 9 20020002020 11129 11 
12/92 wound surgical leu 10 20020002020 11129 11 
12/92 wound surgicallCU 11 00020002020 11129 11 
01/93 IVC surgicallCU 12 20020002020 11129 11 
01/93 nose surgicallCU 13 20020002020 11129 11 
03/93 bile surgical leu 14 20020002020 11129 11 
12/92 blood general surgery 15 00020002000 11129 11 
01193 wound general surgery 16 20020002020 11129 11 
04/93 wound general surgery 17 02020002020 11129 11 
CONTROL GROUP 1 
08/92 nose surgery 18 20020002020 11195 9 
12/92 urine plastic surgery 19 10022022220 E1 7 
05/93 wound dermatology 20 20002022200 Z74 9 
11/86 sputum cardiac surgery 21 alb 20022022220 E1 7 
12/86 faeces internal medicine 22 20022002220 E1 7 
CONTROL GROUP 2h 
05/92 NA 23 20020002220 11129 10 
01/92 NA 24 20020002021 11129 11 
02/91 NA 25 20020002020 11129 6 
04/91 NA 26 20020002020 11129 10 
06/91 NA 27 20020002020 11129 NOi 
06/91 NA 28 20020002220 11129 11 
08/91 NA 29 20020002020 11129 11 
11/91 NA 30 20020002220 11129 11 
a ASP, air settling plate; Ive means intravascular catheter; NA, not available. 
b a! b strain typed in duplicate by PFGE. 
c The values shown are far, from left to right, phasphamycin, oxacillin, tobramycin, co-trimoxazole, ciprofloxacin, 
erythromycin, clindamycin, vancomycin, rifampicin, fusidic acid and tetracycline. In the antibiogram, 0 indicates 
resIstance, 2 indicates susceptible and 1 indicates intermediate susceptibility. 
d Number repetitive units present in the protein A gene. 
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Type determined by combined combined 
PCR primer speciese: AP- PFGE; PFGE;AP-PCR; 
18431 PCR PFGE AP-PCR Protein-A;IS431 
type A B C 0 E type' type' type9 type9 
1 ' 1 ' A3 AI/AI 1 ' 1 ' 
1 AI A2 1 
AI A2 
1 AI A2 
1 ' 1 ' A3 AI/AI 1 ' 1 ' 
1 AI A2 1 
AI A2 
AI A2 
AI A2 
AI A3 1 " 1" 
AI A2 1 
AI A2 
A1 A2 
AI A2 
l' 1 ' A3 AI 1 ' 1 ' 
1 1 AI A2 1 1 
1 ' 1 1 A2 C 2 2 
3 1 ' 2 2 B 0 3 3 
2 2 3 2 3 C El 4 4 
2 1 ' 4 3 1 0 F 5 5 
5 2 3 2 3 C E1!E2 4/4' 6/6' 
5 2 3 2 3 C E2 4' 6 
3 1 ' E B2 6 7 
4 4 F A1 7 8 
6 5 5 5 4 G AI 8 9 
6 6 6 6 2 5 H AI 9 10 
6 3 1 1 ' E AI 10 11 
1 3 1 ' 1 ' E' G 11 12 
NO 3 1 ' E A4 10 11 
4 3 1 ' E Bl 6 13 
e A: primer 186, B: primer 188, C: primer 192, 0: primer ERIC1 and E: primer ERIC2_ Primes indicate one- or 
two-band differences. 
f Subnumbering indicates subclonal relationships. Prime indicates one- or two band differences, 
9 Primes indicate subclonal variation. 
h Control group 2 strains were derived from a collection of MRSA strains from various Dutch hospitals in the Dutch 
National Institute of Public Health and Environmental Protection (RIVM). 
i NO, not determined. 
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AP-PCR and PFGE, AP-PCR based on a combination of several primer-dependant 
genocodes, revealed genetic homogeneity in the group of outbreak-related isolates all of 
which were type A (Table 2 and Figure 2), Three subtypes (A 1 to A3) were identified within the 
outbreak-related isolates. As determined by PFGE analysis, all strains but one (isolate 17) 
were type A, although subclonal variation was observed (Table 2 and Figure 3). All strains 
identified as PFGE type A had a similarity index of more than 90%, as determined by 
UPGMA-analysis. Strain 17 was discriminated from the other outbreak-related isolates 
(similarity index of approximately 80%). Both AP-PCR and PFGE distinguished all control 
group 1 isolates from the outbreak-related isolates. Also, there was full agreement between 
PFGE and AP-PCR within this group of strains. Both AP-PCR and PFGE detected genetic 
heterogeneity among control group 2 strains. AP-PCR discriminated four types and PFGE 
detected three types, when sub clonal variation is disregarded. However, some results of AP-
PCR and PFGE typing were discordant. For instance, AP-PCR did not discriminate among 
isolates 23 and 27 to 30, whereas PFGE identified three different types (A, B, and G) within 
this group. On the other hand, PFGE did not discriminate among isolates 24 to 27 and 29 
(PFGE type A), but AP-PCR identified four different types (E through H). 
AP-PCR discriminated eight types and PFGE discriminated seven types in the total group of 
30 strains. The combined results of AP-PCR and PFGE typing differentiated 11 types. 
PCR mediated protein A typing. Protein A gene typing revealed 11 repeats in all outbreak-
related isolates (Table 2 and Figure 4). In contrast, only seven or nine repeats were identified 
in isolates from control group 1. Four of eight isolates from control group 2 also contained 11 
repeats. 
564 
ERIC 2 
Figure 2: Representative examples of the results of peR mediated DNA fingerprinting using primer 
ERIC2. The iso/ate number is indicated above the lanes (in accordance with table 1). On the left, right and 
in the middle, molecular weight markers (marked urn"; Lambda DNA, cut with Hindll/) are indicated in 
basepairs. 
18431 probing. Table 2 shows the results of IS431 typing. All outbreak-related isolates and 
three of eight isolates from control group 2 were IS431 type 1, whereas none of the isolates 
in control group 1 were of this type. 
Combination of genotypic methods. Together the genotyping methods (AP-PCR, PFGE, 
Protein A and IS431) discriminated 13 different types among all isolates tested. All outbreak 
strains but one (the methicillin-susceptible isolate 17) were similar when subclonal variation 
was disregarded. Eleven different strains were identified among the 13 isolates from control 
group 1 and 2. The two control group 1 strains that could not be distinguished from each 
other (21 and 22) were isolated from patients who, within a 3-week period, were transferred 
to our hospital from the same foreign hospital. 
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S 1 2 3 4 5 6 7 8 9 10 11 12 S 
485 kb-
242.5 kb 
48.5 kb 
Figure 3: PFGE mediated DNA typing of MRSA strains. DNA was digested with the restriction enzyme 
Smal. Lanes marked S contain concatemeric forms of lambda DNA, differing in size from 48.5 to 485 
kilobasepairs as indicated on the left. Lanes marked 1 to 12 contain DNA from the following strains, 
respectively: 1. strain 4, PFGE type A2; 2. strain 17, PFGE type C; 3. strain 10, PFGE type A3; 4. strain 
Sa, PFGE type AI; 5. strain 23, PFGE type 82; 6. strain 29, PFGE type A4; 7. strain 18, PFGE type 0; 8. 
strain 19, PFGE type El; 9. strain 21, PFGE type E2; 10. strain 20, PFGE type F; 11. strain 28, PFGE type 
G; 12 strain 30, PFGE type 81. 
23 4 5 181920 m 25262829 
-300 
Figure 4: Typing of protein A gene polymorphisms by PCR and Rsal RFLP analysis. Shown are 
representative examples of a/l types that were encountered during the analysis. Isolate numbers are 
displayed above the lanes. The fane marked "m" shows molecular weigth markers (Pharmacia 100 bp 
ladder). On the right the length of some of the markers is indicated in basepairs. Be/ow the lanes the 
length of the variable fragment is indicated in repeat unit number. 
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DISCUSSION 
Despite the low incidence «5%) of MRSA in Dutch hospitals, this organism regularly causes 
outbreaks." In order to prevent outbreaks and decrease the endemic incidence of MRSA, we 
need to define the mechanisms by which this multiresistant microorganism is transmitted. 
Numerous investigators have used traditional epidemiological and molecular typing methods 
to identify risk factors for acquisition of MRSA, the reservoirs occupied by MRSA, and the 
means by which it is transmitted, yet we have much to learn about the epidemiology of this 
important pathogen. 
We used several pheno- and genotyping methods to investigate an unusual explosive 
outbreak of MRSA in the University Hospital Rotterdam. The likely source of this outbreak 
was a dietary worker who prepared food for patients on the hematology unit. We identified 
this individual, who had no direct contact with patients, because we found the epidemic strain 
in a routine surveillance culture of a banana which the dietary work had pealed. A subsequent 
culture of the dietary worker's throat revealed that he carried the epidemic strain. In contrast, 
the index patient's surveillance cultures were negative for 3 weeks before she developed 
MRSA sepsis. To our knowledge, this is the first time investigators have implicated 
contaminated food in the transmission of MRSA. In general, ingestion of MRSA should not 
lead to subsequent infection because the gastriC acid and the normal gastrointestinal flora 
should prevent this organism from colonizing the gastrointestinal tract. Moreover, the immune 
system usually eliminates transient invading microorganisms. The index patient, however, 
was severely immunocompromised, and she had taken both antacids, which would 
neutralize the gastric acid, and oral ciprofloxacin, which may have selected the ciprofloxacin-
resistant outbreak strain. We postulate that the index patient ingested food contaminated by 
the outbreak strain, which then colonized the patient's gastrointestinal tract. Subsequently, 
while the patient was neutropenic the outbreak strain translocated through the gastrointestinal 
mucosa into the bloodstream, causing the patient's fatal infection. 
A nurse who initially worked on the hematology unit probably transmitted the outbreak strain 
between wards when she was transferred to the vascular surgery unit. In the latter unit, the 
outbreak strain caused an explosive MRSA epidemic. By using stringent infection control 
measures, we terminated the outbreak within 6 months, and we eliminated the outbreak strain 
from our hospital. Although many infection control experts consider instituting an isolation 
facility outside of the hospital an extreme measure, we feel that in this particular outbreak it 
was better than other systems of isolation. First, because the outbreak strain was airborne 
and hence contaminated the environment extensively, we think the isolation unit enabled us 
to control this outbreak more quickly than we could have if the patients have been cared for 
within the hospital. Second, because all patients in the isolation facility had MRSA the 
patients were not kept in strict isolation. The patients were able to move about the ward as 
they desired, which may have enhanced their recovery. It should be remembered that in The 
Netherlands there is a national guideline for the control of MRSA, aimed at total elimination of 
MRSA and not confinement to a low endemic level. 
The ratio of MRSA-infected to MRSA-colonized patients in this outbreak (78%) was much 
higher than that observed in previous outbreaks (up to 40%)." The increased frequency of 
infection and the high mortality rate (5 of 27; 18.5%) may have been related in part to the 
severity and nature of the patients' underlying diseases. The index patient was severely 
immunocompromised, and the patients on the vascular surgery unit had large, poorly healing 
wounds and many had prosthetic vascular grafts. In addition, we think the outbreak strain 
might have been more virulent than other MRSA strains. For methicillin-susceptible S. 
aureus, it has been shown that there are differences in virulence between strains.36 Because 
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protein A modulates opsonization and chemotaxis," the outbreak strain, which had more 
copies of the protein A gene than did many control isolates, might have evaded host 
defenses more readily than other strains, 
We routinely evaluate the ability of all patients with MRSA to disperse the organism into the 
air and hence to contaminate the environment. Of the 20 patients with MRSA who were 
transferred to our hospital from foreign hospitals before the outbreak, none dispersed MRSA 
to the extent that we observed in this epidemic, Air-settling plates for 16 of those 20 patients 
were negative and for 4 patients contained <5 CFU per plate. [n contrast, air settling plates in 
the rooms of several patients from this outbreak contained >100 CFU. Furthermore, despite 
the patients kept in strict isolation, air settling plates in the corridors outside of patients' rooms 
were also positive for the outbreak strain. We think that the positive air pressure in the 
patients' rooms carried MRSA from the contaminated rooms into the hallway. A[though staff 
who carried the outbreak strain may have contaminated the settling plates in the corridors, we 
do not think that this was the like[y mechanism. We made cultures from specimens from the 
staff twice weekly to identify those who acquired MRSA, and we tested all positive staff" to 
determine whether they dispersed the organism. We did not identify any staff members who 
dispersed MRSA during their tests. 
Particular characteristics of the affected patients and the outbreak strain may have facilitated 
the profuse environmental contamination noted in this outbreak. Boyce et al. previously 
reported that patients who had MRSA in a wound or in their urine contaminated the 
environment more frequently than did patients with MRSA in the nares or sputum (34% 
versus 2% of the surfaces cultured were positive, respectively).6 Therefore, our patients who 
had large, poorly healing wounds may have been more like[y to disperse MRSA. 
Other investigators have observed differences in the transmissibility of S. aureus strains.s.tO 
Recently, Frenay et al. proposed that the number of repetitive elements in the spacer region 
of the staphylococcal protein A gene correlated with the ability of MRSA strains to cause 
outbreaks." They argued that higher numbers of repeats enhanced the accessibility of the 
immunog[oblin G binding region of protein A and thereby contributed to epidemic spread of 
the organism. Our outbreak strain had 11 copies of the protein A gene, which is within the 
epidemic range (more than 7) defined by Frenay et al." 
[n summary, we hypothesize that patients who had wounds that were colonized or infected 
with the outbreak strain dispersed MRSA into the air. The airborne organisms subsequently 
contaminated many surfaces in the patients' rooms and corridors. HCWs who touched these 
contaminated surfaces and who did not subsequently wash their hands transmitted the 
epidemic strain to other patients. As in the study of Boyce et al.,' HCWs may also have 
contaminated their clothing and transmitted the outbreak strain in this manner. 
Because the incidence of MRSA in The Nether[ands is extremely [ow, isolates obtained 
during outbreaks are likely to be c[onally related. Therefore, we evaluated isolates from our 
outbreak by several molecular typing methods, and we compared the results of the different 
methods. AP-PCR and PFGE most clearly discriminated outbreak-associated isolates from 
control isolates. [n our study, PFGE identified more subc[ones than did PCR. Saulnier et al. 
noted similar results," but further analysis determined that the discriminatory abilities of 
PFGE and PCR depended, respectively, on the number of restriction enzymes and the 
number of primers usedY Furthermore, as demonstrated in Table 2, some peR primers 
detected more variability than did others; four primers identified five or more types, whereas 
primer ER[C1 identified only two types. To date, no one has determined which primers and 
how many primers should be used to evaluate MRSA isolates. 
At present, we do not know why MRSA isolates obtained during the course of an outbreak 
had minor genomic differences. However, Van Be[kum et al. noted similar variability among 
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Legionelfa pneumophila." Perhaps this variability reflects the intrinsic genetic flexibility of the 
microbes or their ability to adapt to a host. 
Both PFGE and PCR were more discriminatory than protein A typing or IS431 typing. We 
identified the most strain variability when we combined the results of these four genotypic 
typing methods. Using the combined results, we considered all but one of the outbreak-
related isolates (isolate 17) to be the same strain. We did not identify the outbreak strain 
among the control isolates. 
Only PFGE and methicillin susceptibility discriminated isolate 17 from the other outbreak 
isolates. Isolate 17 possessed the MecA gene (documented by PCR) but did not express 
methicillin-resistance. At present we do not know the mechanism by which this isolate 
remains susceptible to methicillin. 
None of the typing methods distinguished between two isolates in control group 1 (isolates 
21 and 22). We subsequently learned that these isolates were obtained from two patients who, 
within a short time period, were transferred to our hospital from the same foreign hospital. 
Hence, the patients may have acquired the same strain while they were in the other hospital. 
In summary, our MRSA outbreak displayed several unusual features, including transmission 
of the outbreak strain by food and by air, and a very high infection-to-colonization ratio. We 
think the patients' wounds and particular characteristics of the outbreak MRSA strain 
allowed that strain to spread explosively on our vascular surgery unit. Furthermore, we think 
the isolation unit helped us terminate the outbreak expeditiously. Finally, PFGE and AP-PCR 
discriminated the outbreak-related isolates from control isolates, and protein A typing 
suggested that the outbreak strain might be more transmissible and virulent than other MRSA 
isolates. 
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SUMMARY AND CONCLUSIONS 
The purpose of the studies presented in this thesis was to gain more insight into the current 
epidemiology of S. aureus in the hospital setting and to develop strategies to prevent these 
infections. 
In Chapter 1 surgical wound infections in cardio-thoracic surgery are studied. Part 1 shows 
the results of an 18-month prospective surveillance of postoperative infections in the 
department of thoracic surgery of the University Hospital Rotterdam-Dijkzigt, The 
Netherlands. Out of 983 patients, 194 (19.7%) developed one or more postoperative 
infections. A total of 268 postoperative infections were diagnosed, resulting in an incidence 
of 2.0 infections per 100 days of postoperative stay. The mean postoperative length of stay 
of the 194 patients with postoperative infections was two weeks longer than that of patients 
without postoperative infections. Deep surgical wound infections were associated with the 
longest prolongation of the median postoperative length of stay in the hospital (one month 
longer). Incisional surgical wound infections were also associated with a significant 
prolongation of stay (median 10 days longer). S. aureus was the most important pathogen 
associated with surgical wound infections. Phage typing of 29 strains causing surgical 
wound infections showed two identical pairs. Thus, only a small minority of wound infections 
with S. aureus could be explained by cross-infection. It was subsequently hypothesized that 
endogenous strains of S. aureus, i.e. those already present on the patient at time of 
admission, playa major role in the development of wound infection. To evaluate the relative 
importance of nasal carriage of S. aureus as a risk factor for the development of wound 
infection at the sternotomy site after cardiac surgery, a case control study was performed 
(part 2). The study population consisted of 1,980 consecutive patients. Cases were all 
patients who developed a sternal wound infection from which S. aureus was cultured. Forty 
cases were identified, and 120 controls were selected. Preoperative nasal carriage of S. 
aureus, insulin dependent diabetes mellitus and younger age were identified as significant 
riskfactors. The crude odds ratio of nasal carriage was 9.6 (95% confidence interval: 3.9-
23.7). The median postoperative length of stay in cases was 30 days longer than in controls. 
Also, mortality was significantly higher among cases than controls (10.0% and 0.8%, 
respectively). The conclusion was that nasal carriage of S. aureus is a major risk factor for the 
development of sternal wound infections after cardiac surgery. These findings suggested 
that perioperative elimination of nasal carriage could reduce the incidence of surgical wound 
infections. In part 3 this hypotheSis was tested, using mupirocin nasal ointment to eliminate 
nasal carriage in patients undergoing cardiothoracic surgery. In 928 patients without 
mupirocin the surgical wound infection rate was 7.3%. After the introduction of mupirocin 
the rate dropped to 2.8% (n=868, P<O.OOOI). Mupirocin prophylaxis was wei tolerated and 
showed no side-effects. Development of resistance was not observed. However, the 
interpretation of these promising results should be made cautiously, because a historic 
control group was used. General application of this new preventive strategy should await 
confirmation of its efficacy in a double-blind, randomized, placebo-controlled trial. The costs 
and benefits of perioperative nasal mupirocin in cardio-thoracic surgery were evaluated in 
part 4. Using an appropriateness evaluation protocol, the savings in postoperative length of 
stay corresponded with $115 per patient and the savings in procedure related costs were 
$225 per patient. Since the costs of mupirocin were only $11 per patient, the net effect was 
financially highly profitable. The estimated savings were $329 per patient undergoing 
cardiothoracic surgery. 
Another group of patients who are at high risk for infection with S. aureus, are those treated 
with hemodialysis because of renal failure. In this group of patients extremely high carriage 
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rates are observed and most S. aureus infections are endogenous. The effect of elimination 
of nasal carriage using mupirocin is described in Chapter 2. Of the 226 hemodialysis patients 
during the study period, 172 were evaluable. Sixty-seven (39%) were identified as nasal 
carriers. Immediately after the initial treatment, 66 (98.5%) of them had negative nasal 
cultures. After 3 months and 6 months, 63 (94%) and 61 (91 %) of the treated carriers still had 
negative cultures, respectively. To study the effect of elimination of nasal carriage on the 
incidence of S. aureus infections, the rate of bacteremia in the 226 patients in the study 
group was compared with this rate in a historic control group of 273 patients. In the study 
group four episodes of S. aureus bacteremia occurred on a total of 100.3 years on 
hemodialysis. In the control group 25 episodes occurred on 100.0 years (P<0.001). 
Development of resistance and adverse effects were not observed. Therefore, it was 
concluded that mupirocin nasal ointment effectively eliminated nasal carriage of S. aureus in 
patients on hemodialysis, and, thereby, significantly reduced the incidence of bacteremia. 
Since S. Bureus has been recognized as an important pathogen for human disease for more 
than a century, the literature available on its epidemiology is extensive. In Chapter 3 the 
literature is reviewed with respect to the global epidemiology of methicillin-resistant S. 
aureus (MRSA) in part 1 and the epidemiology of nasal carriage in part 2. In part 1 it is 
concluded that the incidence of MRSA as a nosocomial pathogen is rapidly increasing. In 
many countries the incidence of MRSA now equals or exceeds the incidence of methicillin-
susceptible isolates. Genetic typing studies of MRSA strains consisting of isolates from all 
over the world which were collected from 1961 untill the early 1990's, showed that MRSA 
strains have a high level of genetic relatedness. The gene encoding for methicillin resistance, 
called the Mec-a gene, is not easily acquired by S. aureus. One studied concluded that this 
may have happened only once. Therefore, clonal dissemination together with horizontal 
transfer and recombination are the most likely explanations for the current pandemic of 
MRSA. The future with respect to MRSA is to be feared, because there is only one 
antimicrobial agent left, i.e. vancomycin, for which S. aureus is uniformally susceptible. 
However, in experimental studies it has been shown that vancomycin resistance can be 
transferred from vancomycinHresistant enterococci into MRSA. For such a microorganism no 
effective treatment would be available, and consequently the morbidity and mortality of 
infection with it would be enormous. Further insight into the epidemiology of MRSA and into 
the effectiveness of various control measures should help to keep this problem under 
control. In part 2 a review of the literature concerning nasal carriage of S. aureus is given. It 
is concluded that nasal carriage of S. aureus is a major risk factor for infection in several 
groups of patients. These include patients on hemodialysis. on continuous ambulatory 
peritoneal dialysis (CAPO), on surgery, with intravenous devices and with HI\/, All these 
groups will increase in number in the near future, probably increasing the number of 
associated infections. In patients on hemodialysis, CAPO and surgery it has been shown that 
elimination of nasal carriage reduces the infection rates. In order to develop an optimal 
strategy for prevention it is important to gain insight into the underlying mechanisms of nasal 
carriage and into the epidemiology of S. aureus infection at the molecular level. 
Therefore, typing methods are of utmost importance. The recent developments in molecular 
microbiology have resulted in several promising new techniques which are studied in 
Chapter 4. One of these techniques, arbitrarily primed polymerase chain reaction (AP-PCR), 
was evaluated for its reproducability and discriminatory power (part 1). A well defined 
collection consisting of 59 S. aureus and 1 S. intermedius isolates was used. Seven centers 
collaborated and used a standardized amplification protocol, template DNA isolated and 
distributed from our istitute, as was a set of three primers. Between the seven centers a 
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significant variation in discriminatory power of their AP-PCR procedure was observed. 
However, the clustering of epidemiologically related strains was correct in all centers. AP-
PCR was found to be more discriminative than the more traditional typing strategies. 
Although the interlaboratory reproducibility needs improvement, it was concluded that AP-
PCR was well suited for epidemiological investigations of S. aureus. In part 2 an outbreak of 
methicillin-resistant S. aureus (MRSA) in the University Hospital Rotterdam was analyzed by 
different typing methods. In this oulbreak several interesting observations were made. The 
outbreak was probably caused by the contamination of food by a health care worker on the 
department of hematology. The strain subsequently spread to the department of surgery. 
Here an explosive outbreak occurred in large part caused by airborne transmission. The 
institution of a special MRSA-unit outside the hospital proved to be an effective measure to 
control the outbreak. The high morbidity and mortality of patients colonized with the 
outbreak strains were remarkable. Of the 27 patients colonized, 21 (77.8%) developed 
infections and five of them died. In three cases death was clearly caused by the MRSA 
infection. Analysis of the outbreak strains and collection of unrelated MRSA revealed that the 
outbreak strains were all identical. Furthermore, the discriminatory power of genotypic typing 
methods was superior to phenotypic methods. Optimal results were achieved by 
combination of several genotypic methods. 
In conclusion, this thesis has focussed on the role of nasal carriage as a risk factor for 
infection in specific groups of patients. It was also shown that elimination of nasal carriage in 
high risk groups reduces the incidence of infection. This new strategy gives new 
perspectives in our ecological interactions with this species. In addition to endogenous 
infection it has been noted that cross-infection is an important mechanism for this 
opportunistic pathogen as well. To keep pace with the ongoing adaptation of S. aureus, new 
strategies have to be developed. The role of nasal carriage appears to be crucial both in the 
development of self-infection and in the spread of the organism. More insight into the 
underlying mechanisms of the carrier-state should lead to new strategies for treatment and 
prevention which are essential to control staphylococcal infections in the future. 
SAMENVATTING EN CONCLUSIES 
Het doel van de onderzoeken beschreven in dit proefschrift was om meer inzicht te 
verkrijgen in de epidemiologie van Staphylococcus aureus infecties in het ziekenhuis en om 
nieuwe strategien te ontwikkelen om dergelijke infecties te voorkomen. 
In Hoofdstuk 1 worden chirurgische wondinfecties in de cardio-pulmonale chirurgie 
bestudeerd. Deel 1 toont de resultaten van een prospectieve surveillance gedurende 18 
maanden in de afdeling cardio-pulmonale chirurgie van het Academisch Ziekenhuis 
Rotterdam'Dijkzigt. Van de 983 patienten ontwikkelden 194 (19.7%) een of meer 
postoperatieve infecties. In totaal werden 268 postoperatieve infecties vastgesteld, hetgeen 
resulteert in een incidentie van 2.0 infecties per 100 dagen post-operatieve opnameduur. De 
gemiddelde postoperatieve opnameduur van de 194 patienten met postoperatieve infecties 
was 2 weken langer dan die bij patienten zonder infecties. Diepe chirurgische wondinfecties 
gingen gepaard met de langste opnameduur verlenging (mediaan: 30 dagen). Oppervlakkige 
chirurgische wondinfecties waren oak geassocieerd met sen significante verlenging van de 
opnameduur (mediaan: 10 dagen). S. aureus was het belangrijkste pathogene micro-
organisme bij wondinfecties. Faagtypering van de 29 stammen die bij chirurgische 
wondinfecties waren ge'lsoleerd toonde 2 identieke paren. De conclusie was dat slechts een 
kleine minderheid van de wondinfecties met S. aureus kon worden toegeschreven aan sen 
kruisinfectie. Dit leidde tot de hypothese dat het merendeel van de infecties veroorzaakt 
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werd door endogene S. aureus stammen. Hiermee wordt bedoeld die stammen die reeds 
preoperatief deel uitmaken van de patient zijn of haar eigen flora. 
Om het relatieve belang van neusdragerschap van S. aureus als een risicofactor voor 
wondinfecties met dit microorganisme na sternotomie te bepalen werd een patient-controle 
onderzoek verricht, zoals beschreven in dee I 2. De studiegroep bestond uit 1.980 opeenvol-
gende patienten die hartchirurgische ingrepen ondergingen. De defintie van een patient was 
dat deze een stemotomie wondinfectie ontwikkelde waaruit S. aureus werd gekweekt. Er 
werden 40 patienten geidentificeerd en 120 controles geselecteerd. Preoperatief neus-
dragerschap met S. aureus, insuline afhankelijke diabetes mellitus en jonge leeftijd werden 
als onafhankelijke, significante risicofactoren geidentificeerd. De ongecorrigeerde odds ratio 
van neusdragerschap was 9.6 (95% betrouwbarheidsinterval: 3.9-23.7). De mediane post-
operatieve opnameduur van patienten was 30 dagen langer dan die van controles. Ook de 
stertte was significant hoger bij patienten (10%) in vergelijking met de controles (0.8%). De 
conclusie was dat neusdragerschap met S. aureus een belangrijke risicofactor is voor het 
ontwikkelen van een sternotomie wondinfectie na hartchirurgie. Deze bevindingen maken 
het aannemelijk dat perioperatieve eliminatie van neusdragerschap de incidentie van 
wondinfecties kan verminderen. In deel 3 werd deze hypothese getoetst, door mupirocine 
neuszalf perioperatief toe te dienen bij patienten die cardio-pulmonale chirurgie onder-
gingen. In 928 patienten zonder mupirocine was de incidentie van chirurgische wond-
infecties 7.3%. Na de introductie van mupirocine daalde deze incidentie tot 2.8% (n=868, 
P<0.0001). Mupirocine prophylaxe werd goed verdragen en er waren geen belangrijke 
bijwerkingen. Resistentie tegen mupirocine werd niet waargenomen. Opgemerkt dient te 
worden dat zorgvuldigheid geboden is bij de interpretatie van deze bevindingen omdat er 
een historische controle groep werd gebruikt. Aigemene toepassing van deze nieuwe 
preventieve maatregel kan pas aanbevolen worden na bevestiging in een dubbel-blinde, 
gerandomiseerde, placebo-gecontroleerde studie. De kosten en de baten van mupirocine in 
cardio-pulmonale chirurgie werden geevalueerd in deel 4. Met behulp van een 
"appropriateness evaluation protocol" werden de besparingen ten gevolge van minder 
postoperatieve opnameduur bepaald op NLG 207 per patient en de besparingen ten gevolge 
van verrichting gerelateerde kosten op NLG 405 per patient. Omdat de kosten van 
mupirocine slechts NLG 19.8 per patient waren, was de eindbalans in hoge mate kosten-
effectief met een besparing van NLG 592 per patient die cardio-pulmonale chirurgie 
ondergaat. Nadere analyse toonde dat variaties in de kosten van mupirocine, in de incidentie 
van chirurgische wondinfecties en in de effectiviteit van mupirocine nauwelijks van invloed 
waren op de kosten-effectiviteits verhouding. Aileen variaties in de hoogte van de meer-
kosten van wondinfecties was van invloed. 
Een andere groep patienten die een hoog risico hebben op infecties met S. aureus zijn 
patienten die vanwege terminale nierinsufficientie met hemodialyse worden behandeld. In 
deze groep is ook de incidentie van dragerschap hoger dan normaal en worden de meeste 
infecties veroorzaakt door endogene S. aureus stammen. Het effect van eliminatie van 
neusdragerschap met behulp van mupirocine op de incidentie van S. aureus infecties in deze 
groep wordt beschreven in hoofdstuk 2. Van de 226 hemodialyse patienten in de studiegroep 
waren er 172 evalueerbaar; van deze laatste groep was 67 (39%) neusdrager. Direkt na de 
behandeling van de dragers waren de neuskweken van 66 patienten (98.5%) negatief 
geworden. Na 3 en 6 maanden waren respectievelijk 63 (94%) en 61 (91 %) nog steeds niet 
gerekoloniseerd. Om het effect van de eliminatie van neusdragerschap op het voorkomen 
van bacteremien met S. aureus te bestuderen werden de incidenties hiervan in de 
mupirocine behandelde groep vergeleken met die in een historische controle groep (n=273). 
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In de behandelde groep werden 4 episoden van bacteremian met S. aureus waargenomen 
op een totale expositieduur van 100.3 hemodialyse jaren. In de controle groep waren 25 
episoden in 100.0 hemodialyse jaren (P<0.001). Ontwikkeling van resistentie tegen 
mupirocine en bijwerkingen werden niet waargenomen. De conclusies waren dat mupirocine 
neuszalf effectief het neusdragerschap met S. aureus elimineerde en op die manier de 
incidentie van bacteremien significant verminderde. 
Aangezien S. aureus reeds meer dan een eeuw herkend wordt als een belangrijk pathogeen 
voor de mens, is de literatuur over dit microorganisme zeer uitgebreid. In hoofdstuk 3 wordt 
deze samengevat met betrekking tot de mondiale epidemiologie van methicilline resistente 
S. aureus (MRSA) in deel 1 en de epidemiologie van neusdragerschap van S. aureus in deel 
2. In deel 1 wordt allereerst vastgesteld dat de incidentie van MRSA als een verwekker van 
ziekenhuisinfecties zeer snel toeneeml. In vele landen is de isolatie-frequentie van MRSA nu 
gelijk aan of groter dan die van gevoelige S. aureus stammen. Met behulp van genetische 
typeringstechnieken zijn grote aantallen MRSA stammen die wereldwijd verzameld zijn 
tussen 1961 en 1990 onderzochl. Hierbij werd een hoge mate van verwantschap gevonden. 
Het gen dat codeert voor methicilline resistentie, het Mec-a gen genaamd, wordt kennelijk 
niet makkelijk in het genoom van S. aureus opgenomen. Een studie concludeerde dat dit 
mogelijk slechts esn maal gebeurd is. De huidige pandemie van MRSA lijkt het gevolg van 
clonale verspreiding in combinatie met sporadische horizontale overdracht naar sen nieuwe 
cloon. Met betrekking tot de toekomst van MRSA moet het ergste worden gevreesd, omdat 
er nog maar een antibioticum is waarvoor aile stammen gevoelig zijn, namelijk vancomycine. 
In experimentele setting is echter aangetoond dat vancomycine resistentie kan worden 
overgedragen van vancomycine-resistente enterococcen op MRSA. Voor een dergelijk 
microorganisme zou op dit moment geen effectieve behandelingsmogelijkheid meer zijn, 
hetgeen zeer ernstige gevolgen met betrekking tot morbiditeit en mortaliteit zal hebben 
indien het zich verspreid. Een beter inzicht in de epidemiologie van MRSA en in de waarde 
van verschillende controlerende maatregelen zouden dit probleem beheersbaar moeten 
houden. In deel 2 wordt de literatuur over neusdragerschap van S. aureus weergegeven. De 
conclusie is dat neusdragerschap van S. aureus een belangrijke risicofactor is voar infecties 
in verschillende groepen patienten. Deze omvatten patienten met hemodialyse, met continue 
ambulante peritoneaal dialyse (CAPO), chirurgische patienten, met intravasale lijnen en met 
HI\( AI deze groepen zullen in de nabije toekomst in omvang toenemen, hetgeen het aantal 
daarmee geassocieerde infecties zal verhogen. Bij patienten die hemodialyse, CAPO of 
operatieve ingrepen ondergaan is gevonden dat eliminatie van neusdragerschap de kans op 
infectie sterk vermindert. Dit kan een uitermate belangrijke preventieve maatregel blijken. 
Om de optimale strategian voor behandeling en preventie te ontwikkelen is het van groot 
belang om op moleculair niveau inzicht te verkrijgen in de onderliggende mechanism en van 
neusdragerschap en in de epidemiologie van S. aureus infecties. 
Het inzicht in de epidemiologie van S. aureus infecties vereist goede typeringstechnieken. 
Recent ontwikkelingen in de moleculaire biologie hebben een aantal nieuwe technieken 
opgeleverd, welke in hoofdstuk 4 werden bestudeerd. In deel 1 werd een van de nieuwe 
technieken, namelijk arbitrarily primed polymerase chain reaction (AP-PCR), op zijn 
reproduceerbaarheid en onderscheidend vermogen getest, in verschillende centra. Een 
goed gedefinieerde collectie bestaande uit 59 S. aureus en 1 Staphylococcus intermedius 
werd hiertoe gebruikl. De 7 aan dit onderzoek deelnemende centra gebruikten een 
gestandaardiseerd amplificatie protocol, het DNA werd gersoleerd in het Academisch 
Ziekenhuis Rotterdam, evenals een set van 3 verschillende primers. Tussen de verschillende 
centra werden grate verschillen in discriminerend vermogen van de door hun uitgevoerde 
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AP-PCR procedure waargenomen. Tach was de herkenning van epidemiologische relaties 
tussen de stammen in aile centra correcl. AP-PCR discrimineerde beter dan de meer 
traditionele typeringstechnieken. Hoewel de reproduceerheid tussen de verschillende 
laboratoria voor verbetering vatbaar is, was de conclusie dat deze techniek goed bruikbaar 
is am epidemiologische studies van S. aureus te verrichten. In dee I 2 wordt een epidemie 
met MRSA in het Academisch Ziekenhuis Rotterdam geanalyseerd met behulp van 
verschillende typeringstechnieken. De epidemie werd waarschijnlijk veroorzaakt door de 
besmetting van voedsel door een personeelslid op de afdeling hematologie. De stam werd 
daarna verspreid naar de afdeling heelkunde, waar een heftige epidemie ontstond ten 
gevolge van verspreiding via de luchl. Het instellen van een speciale MRSA-unit buiten het 
ziekenhuis bleek een effectieve maatregel am de epidemie onder controle te brengen. De 
hoge morbiditeit en stertte onder patienten die gekoloniseerd werden met de epidemische 
MRSA-stam was opmerkelijk. Van de 27 gekoloniseerde palienten ontwikkelden 21 (77.8%) 
een infectie en 5 overleden. In 3 gevallen kon het overlijden direct in verband worden 
gebracht met de MRSA-infeclie. Analyse van de stammen gersoleerd lijdens de epidemie en 
een colleclie van niet-gerelateerde MRSA stammen toonde aan dat de stammen uit de 
epidemie allen identiek waren. Verder was het onderscheidende vermogen van de 
genotypische typeringsmethode superieur aan die van de phenotypische methoden. Het 
beste resultaat werd verkregen als de gegevens van meerdere genotypische methoden 
gecombineerd werden. 
Concluderend: Dit proefschrift beschrijft onderzoek dat zich gericht heeft op de risicofactor 
neusdragerschap van S. aureus. In verschillende belangrijke palienten groepen blijkt 
neusdragerschap geassocieerd te zijn met een sterk verhoogde kans op infeclie. Eliminatie 
van neusdragerschap in risico~groepen vermindert de kans op S. aureus infecties aanzienlijk. 
Deze preventieve maatregel biedt nieuwe perspectieven in onze om gang met dit belangrijke 
microorganisme. Om de voortdurende evolutie van S. aureus bij te houden dienen meer van 
dergelijke nieuwe prevenlieve maatregelen te worden ontwikkeld. Neusdragerschap lijkt een 
sleutelrol te vervullen in het ontstaan van endogene infecties en in de verspreiding van het 
microorganisme. Een beter inzicht in de onderliggende mechanismen kan resulteren in 
nieuwe preventieve methoden die essentieel zijn om S. aureus infect/es in de toekomst 
beheersbaar te houden. 
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CURRICULUM VITAE 
De schrijver van dit proefschrift werd geboren op 19 juni 1962 te Oisterwijk. In 1980 werd het 
diploma Atheneum B gehaald aan het Sint Odulphus Lyceum, te Tilburg. In dat jaar werd de 
studie geneeskunde aangevangen aan de Erasmus Universiteit te Rotterdam. Het arts-
examen werd op 20 november 1987 behaald. Van januari 1988 tot maart 1989 werd de 
militaire dienstplicht vervuld als medisch officier bij de Koninklijke Luchtmacht. In juli 1989 
werd de opleiding medische microbiologie aangevangen (Opleider Prof. Dr. M. F. Michel) in 
het Academisch Ziekenhuis Rotterdam. Deze opleiding werd op 1 juli 1993 voltooid. Vanaf 
deze datum was hij staflid van de afdeling bacteriologie van het Academisch Ziekenhuis 
Rotterdam en als zodanig hoofd van de afdeling ziekenhuishygiene. Deze positie werd 
vervuld tot 1 februari 1995, waarna hij toetrad tot de Maatschap Artsen-microbioloog 
Brabant. De werkzaamheden vinden plaats in de Ziekenhuizen van Breda, te weten het 
Ignatius Ziekenhuis, het ziekenhuis de Baronie en het Medisch Centrum de Klokkenberg. 
De in dit proefschrift beschreven studies werden aangevangen gedurende de opleiding tot 
medisch microbioloog op de afdeling bacteriologie in het Academisch Ziekenhuis 
Rotterdam. 
